Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000570	f-elast1	ug/g (ug/g)	6772	9441	2.14%
3000570	f-elast1	— (—)	5595	6801	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Intestinal infectious diseases

2545

8639

2.35

319.46

1.5

1.4

267.75

280.30

ug/g

1.71

1522

4868

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2627

6922

2.38

318.27

1.5

1.4

242.68

291.18

ug/g

23.21

1588

3960

Other antidepressants

2729

6120

2.38

317.84

1.4

276.63

271.25

ug/g

0.50

1531

3580

Diarrhoea and gastroenteritis of presumed infectious origin

1961

7068

2.60

313.87

1.5

1.4

267.88

280.73

ug/g

1.38

1167

3961

Other soft tissue disorders, not elsewhere classified

2436

6352

2.43

310.28

1.4

285.96

272.21

ug/g

2.14

1370

3622

Irritable bowel syndrome

1642

2074

8.86

307.65

1.5

1.4

313.22

273.67

ug/g

8.37

906

1176

Collagenous colitis

569

786

8.47

307.65

1.6

1.4

272.13

288.08

ug/g

0.85

365

440

Noninfective enteritis and colitis

1713

4930

3.66

307.65

1.5

1.4

273.98

278.91

ug/g

0.39

1038

2798

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1694

3757

3.74

307.65

1.5

1.4

197.83

281.41

ug/g

42.28

1075

2211

Oxycodone

1135

3158

3.65

307.65

1.5

1.4

226.23

270.24

ug/g

9.09

699

1804

Acute pancreatitis (for exclusion)

1211

1911

7.20

307.65

1.7

1.4

214.67

275.37

ug/g

10.08

737

1124

Anaemias

823

711

8.10

307.65

1.5

1.3

254.74

342.99

ug/g

15.27

498

365

Other noninfective gastroenteritis and colitis

1186

2365

5.47

307.65

1.5

1.4

274.31

280.30

ug/g

0.40

748

1363

Pain in joint

1467

3052

3.27

307.65

1.4

287.59

274.43

ug/g

1.33

820

1787

Other diseases of intestines

3717

5692

3.95

307.65

1.4

284.04

275.34

ug/g

1.21

2104

3228

Malignant neoplasm of pancreas

589

501

15.39

307.65

1.6

1.4

158.84

282.57

ug/g

24.23

342

297

Other diseases of biliary tract

556

596

10.99

307.65

1.6

1.3

164.32

299.74

ug/g

27.61

315

336

Abdominal and pelvic pain

3034

4641

3.39

307.65

1.5

1.3

269.39

281.35

ug/g

1.57

1742

2695

Diseases of the digestive system

1627

4858

3.52

307.65

1.7

1.4

228.22

275.86

ug/g

13.82

976

2848

Acute pancreatitis

1211

1467

9.43

307.65

1.7

1.3

214.67

299.31

ug/g

18.10

737

849

Benign neoplasm of colon, rectum, anus and anal canal

1682

4076

3.07

307.65

1.5

1.4

273.96

283.53

ug/g

0.96

1023

2329

Other functional intestinal disorders

1783

3457

5.23

307.65

1.5

1.4

275.20

268.49

ug/g

0.54

1020

2002

Other diseases of pancreas

670

506

17.05

307.65

1.8

1.3

177.51

306.53

ug/g

28.89

437

291

Adenocarcinoma and ductal carcinoma of pancreas

360

272

18.75

307.65

1.6

1.5

134.47

275.40

ug/g

18.39

186

161

Noninfectious colitis NAS

634

1193

5.83

307.65

1.5

1.4

273.27

283.66

ug/g

0.52

406

666

General symptoms and signs

3049

6023

2.60

307.65

1.4

273.58

280.55

ug/g

0.82

1757

3424

Nausea and vomiting

926

1875

5.14

307.65

1.5

1.3

263.60

285.27

ug/g

2.04

559

1109

Intestinal malabsorption

529

366

20.37

307.65

2.2

1.4

152.71

293.00

ug/g

22.87

324

214

Cholelithiasis, broad definition with cholecystitis

2314

5827

2.80

307.65

1.5

1.3

269.68

305.46

ug/g

9.10

1366

3335

Diverticular disease of intestine

2125

4259

3.44

307.65

1.4

275.25

264.38

ug/g

1.32

1274

2513

Symptoms and signs concerning food and fluid intake

534

793

7.52

307.65

1.5

1.4

292.73

280.51

ug/g

0.51

304

454

Fever of other and unknown origin

1514

4776

3.04

307.65

1.5

1.4

247.74

275.37

ug/g

4.70

877

2719

Tramadol

2411

5120

3.13

307.65

1.5

1.4

263.23

283.26

ug/g

3.97

1446

2869

Diseases of oesophagus, stomach and duodenum

3476

7041

3.11

307.65

1.5

1.4

274.28

274.23

ug/g

0.00

1995

4045

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

360

227

22.55

307.65

1.6

1.4

134.47

294.91

ug/g

18.62

186

131

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

896

651

18.66

307.65

1.6

1.4

154.80

288.20

ug/g

36.60

532

393

Symptoms and signs involving the digestive system and abdomen

3039

4644

3.38

307.65

1.5

1.3

269.61

281.37

ug/g

1.54

1756

2697

Examination and observation for other reasons

1881

3241

3.66

307.65

1.4

273.34

268.61

ug/g

0.37

1114

1875

Chronic pancreatitis

1818

837

33.76

307.65

1.9

1.3

118.08

304.39

ug/g

103.30

1081

493

Opioids

2626

5519

2.56

307.65

1.5

1.4

269.76

286.43

ug/g

3.04

1526

3041

Gastro-oesophageal reflux disease

2056

6270

3.01

307.65

1.5

1.4

284.59

271.04

ug/g

1.99

1156

3635

Insulin, intermediate and long-acting

1810

5913

3.14

307.65

1.6

1.4

218.50

277.60

ug/g

26.37

1110

3455

Disorders of gallbladder, biliary tract and pancreas

4132

6239

4.52

307.65

1.6

1.3

223.67

306.62

ug/g

75.56

2467

3560

Alcohol-induced chronic pancreatitis

473

538

10.65

307.65

1.7

1.4

162.73

271.15

ug/g

15.81

253

329

Cholelithiasis

2208

5760

2.77

307.65

1.5

1.3

269.66

305.18

ug/g

11.36

1302

3298

GASTRO-related operations

2213

3003

3.80

307.65

1.5

1.2

272.20

311.68

ug/g

10.57

1248

1622

Constipation

2747

7130

2.86

307.65

1.5

1.4

269.56

275.30

ug/g

0.66

1632

4110

Gastrointestinal diseases

1488

1482

5.17

307.65

1.4

1.2

289.04

318.70

ug/g

3.72

808

804

Any gastric operation

2213

3003

3.80

307.65

1.5

1.2

272.20

311.68

ug/g

10.57

1248

1622

Malignant neoplasm of digestive organs

1286

3865

3.46

307.65

1.5

1.4

198.72

272.58

ug/g

28.98

816

2319

Insulin, combination of fast acting with intermediate-acting or long-acting

1938

6318

2.94

307.65

1.6

1.4

218.25

278.44

ug/g

29.09

1180

3671

Insulin, fast-acting or short human

1289

3857

3.52

307.65

1.6

1.4

214.04

281.94

ug/g

23.39

797

2220

Insulin, fast-acting

1284

3666

3.69

307.65

1.6

1.4

212.91

285.13

ug/g

25.72

793

2109

Insulin medication

1937

5540

3.11

307.65

1.6

1.4

218.25

284.81

ug/g

33.83

1180

3201

Malaise and fatigue

1400

3892

3.11

305.24

1.5

1.4

269.28

272.21

ug/g

0.18

834

2238

Diabetes, insulin treatment (Kela reimbursement)

2723

7444

2.29

304.60

1.5

1.4

242.50

287.76

ug/g

21.37

1650

4278

Pain in throat and chest

2240

5650

2.48

298.38

1.5

1.4

278.64

269.87

ug/g

1.02

1284

3234

Codeine

2371

5460

2.44

296.01

1.4

279.26

285.85

ug/g

0.59

1414

3023

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2602

8426

2.27

295.25

1.5

1.4

261.69

279.11

ug/g

3.72

1596

4777

Diabetes mellitus

2683

7212

2.27

292.38

1.5

1.4

245.21

293.30

ug/g

22.91

1616

4071

Benign neoplasm: Colon

1456

3862

3.01

292.23

1.5

1.4

269.10

283.12

ug/g

1.60

894

2210

Medical observation and evaluation for suspected diseases and conditions

1766

3270

2.83

287.00

1.5

1.4

282.41

268.09

ug/g

1.31

1002

1886

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

249

177

18.78

284.73

1.6

1.3

143.39

297.11

ug/g

14.75

134

108

Diabetes, varying definitions

2659

7211

2.25

284.73

1.5

1.4

244.54

293.30

ug/g

23.38

1599

4077

Mood disorders, excluding more controls

2474

6661

2.31

282.51

1.4

283.21

272.35

ug/g

1.23

1366

3906

Pain (limb, back, neck, head abdominally)

1774

3247

2.80

280.26

1.5

1.4

275.31

274.90

ug/g

0.02

1008

1896

Diabetes medication

2666

7457

2.22

277.42

1.5

1.4

244.52

292.39

ug/g

23.25

1617

4221

Persons encountering health services for specific procedures and health care

2783

8091

2.18

277.11

1.5

1.4

256.88

285.37

ug/g

7.66

1698

4521

Infections, IBD-co-morbidities

542

651

6.38

276.86

1.5

1.4

268.78

277.08

ug/g

0.31

326

387

Benign neoplasm of colon, rectum, anus and anal canal

1772

6459

2.57

274.36

1.5

1.4

272.34

264.04

ug/g

0.90

1081

3775

Depression or dysthymia

1866

4069

2.63

272.09

1.5

1.4

278.09

263.11

ug/g

1.51

1041

2427

Headache

1656

5374

2.64

271.25

1.4

294.53

282.01

ug/g

1.38

898

3036

Metabolic disorders

2491

7100

2.23

262.93

1.5

1.4

260.29

279.79

ug/g

4.17

1487

4078

Abnormalities of breathing

2252

5851

2.34

262.11

1.4

291.23

271.67

ug/g

3.53

1246

3329

Autoimmune diseases excluding thyroid diseases

2635

6796

2.20

260.91

1.5

1.4

264.50

280.57

ug/g

3.05

1586

3827

First line medication for Crohn's disease

2800

7262

2.15

260.63

1.4

274.05

280.37

ug/g

0.72

1592

4122

Other symptoms and signs involving the digestive system and abdomen

566

1170

5.14

258.49

1.5

1.3

275.76

282.33

ug/g

0.28

339

678

Pain in limb

1984

6145

2.39

255.14

1.4

280.31

271.28

ug/g

1.02

1122

3511

Adenocarcinoma of pancreas

249

219

15.11

251.06

1.6

1.4

143.39

275.39

ug/g

13.38

134

129

Weight loss

477

882

6.05

250.71

1.5

1.4

300.31

283.03

ug/g

0.79

271

507

Abnormal weight loss

453

800

6.39

250.51

1.5

1.4

299.96

281.08

ug/g

0.84

254

461

Functional dyspepsia

851

2446

3.66

249.25

1.4

297.22

276.17

ug/g

2.01

471

1400

Type 1 diabetes

817

2281

3.75

248.94

1.7

1.4

218.43

297.78

ug/g

19.51

541

1284

Autoimmune diseases excluding thyroid diseases, strict definition

2532

6599

2.18

246.97

1.5

1.4

263.95

279.77

ug/g

2.88

1532

3712

Hernia of abdominal wall, postoperative

501

980

5.37

242.97

1.6

1.3

279.13

291.88

ug/g

0.35

318

556

Paralytic ileus and intestinal obstruction

722

1887

4.00

242.38

1.5

1.4

235.24

268.62

ug/g

3.36

454

1134

Depression

2438

7971

2.15

242.08

1.4

284.94

276.34

ug/g

0.87

1324

4615

Endocrine, nutritional and metabolic diseases

1930

4091

2.45

237.92

1.5

1.3

273.01

301.20

ug/g

5.33

1112

2229

Mood [affective] disorders

2593

8319

2.09

237.51

1.4

284.90

274.72

ug/g

1.18

1424

4823

Mood disorders

2596

8335

2.09

236.33

1.4

284.99

274.73

ug/g

1.19

1425

4832

Anxiety disorders, excluding more controls

2073

6151

2.29

235.80

1.4

291.44

276.18

ug/g

1.75

1127

3594

Inflammatory bowel disease treatment related agents

2833

8043

2.04

234.14

1.4

280.20

275.27

ug/g

0.53

1622

4590

Cholecystectomy

1890

7429

2.31

234.05

1.5

1.4

270.05

273.48

ug/g

0.28

1121

4298

Other bacterial diseases

2400

7995

2.12

230.03

1.4

240.43

282.72

ug/g

17.55

1444

4609

Depression medications

694

745

4.80

229.75

1.4

1.3

293.88

338.42

ug/g

3.92

364

376

Type 2 diabetes

2436

6925

2.13

228.37

1.5

1.4

248.47

290.73

ug/g

16.47

1459

3938

Recurrent or chronic depression

1058

2502

3.15

228.30

1.4

287.58

279.86

ug/g

0.33

554

1444

Low back pain

1819

6124

2.34

226.56

1.5

1.4

280.17

271.19

ug/g

0.94

1038

3516

Benign neoplasm: Colon

1474

5908

2.54

225.97

1.5

1.4

268.21

264.02

ug/g

0.33

906

3498

ILD medications: prednisolone, methylprednisolone, prednisone

2712

7663

2.04

223.53

1.4

276.09

276.14

ug/g

0.00

1539

4375

Dorsalgia

2429

6282

2.13

223.22

1.4

282.42

272.53

ug/g

1.25

1349

3593

Certain infectious and parasitic diseases

2438

5828

2.13

219.22

1.5

1.4

273.40

288.95

ug/g

2.14

1409

3233

Implicit Sepsis

1887

6660

2.26

216.04

1.5

1.4

260.93

272.23

ug/g

1.48

1148

3860

Alcohol-induced acute pancreatitis

264

308

10.48

215.55

1.8

1.4

163.23

271.25

ug/g

9.96

160

181

Dysphagia

654

1748

3.91

212.80

1.6

1.4

274.50

275.10

ug/g

0.02

385

1051

Alcohol use disorder, Swedish definition

1451

5585

2.48

212.77

1.5

1.4

239.20

272.65

ug/g

6.19

815

3263

Benzodiazepine use

2464

8801

2.03

212.64

1.4

276.16

274.66

ug/g

0.10

1391

5086

Persons encountering health services in other circumstances, wide

2919

7891

1.95

209.67

1.5

1.4

274.64

275.62

ug/g

0.08

1683

4534

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

801

1051

3.90

208.96

1.4

1.3

294.24

281.82

ug/g

0.65

440

583

Symptoms and signs involving the circulatory and respiratory systems

2416

5873

2.10

208.69

1.4

290.27

271.74

ug/g

3.40

1343

3342

Type 1 diabetes, wide definition, subgroup 1

633

1676

3.95

208.55

1.7

1.3

224.76

301.67

ug/g

16.99

444

921

Other disorders of fluid, electrolyte and acid-base balance

917

2958

3.13

207.80

1.5

1.4

237.11

274.16

ug/g

5.46

570

1749

Parasetamol

1838

4076

2.34

207.16

1.4

276.49

283.08

ug/g

0.56

1009

2327

ILD medications

2741

7744

1.98

206.86

1.4

278.34

276.82

ug/g

0.12

1554

4410

Unspecified jaundice

253

290

9.83

206.26

1.4

1.3

148.07

276.34

ug/g

11.75

127

175

Any mental disorder

2701

6887

2.00

204.93

1.4

279.29

272.16

ug/g

0.71

1505

4048

1489

5829

2.41

204.63

1.5

1.4

240.10

273.03

ug/g

6.13

837

3388

Codeine or tramadol medication

2766

7953

1.96

204.31

1.4

279.86

273.74

ug/g

0.63

1664

4480

Cholangitis (primary sclerosing, PSC)

288

394

8.18

202.73

1.5

1.3

174.10

312.13

ug/g

16.55

172

229

Psychiatric diseases

2644

6731

2.00

201.55

1.4

279.66

272.54

ug/g

0.70

1481

3947

1542

6006

2.36

201.40

1.5

1.4

240.59

273.87

ug/g

6.51

868

3494

Type 2 diabetes, wide definition

1913

5763

2.21

200.93

1.5

1.4

251.38

285.95

ug/g

10.29

1193

3332

Autoimmune diseases

2631

6841

2.00

200.63

1.5

1.4

266.63

280.65

ug/g

2.37

1532

3849

Benign neoplasm of other and ill-defined parts of digestive system

614

1657

3.96

198.93

1.5

1.4

246.32

292.53

ug/g

5.86

397

953

Other special examinations and investigations of persons without complaint or reported diagnosis

1569

3270

2.48

197.91

1.5

1.4

278.28

268.09

ug/g

0.93

910

1886

Oral corticosteroids

2533

7862

1.99

197.91

1.4

278.46

273.04

ug/g

0.57

1451

4506

Budesonide

513

1223

4.49

197.05

1.5

1.4

283.80

281.59

ug/g

0.08

312

693

Other dorsopathies, not elsewhere classified

2399

6305

2.04

195.97

1.5

1.4

282.44

272.79

ug/g

1.00

1347

3604

General examination and investigation of persons without complaint and reported diagnosis

1498

3264

2.49

194.49

1.4

290.58

268.31

ug/g

3.09

856

1884

Diseases of liver

1005

3691

2.84

193.46

1.5

1.4

265.67

271.88

ug/g

0.36

589

2176

Hypothyroidism (congenital or acquired)

568

719

4.65

193.13

1.4

1.3

290.40

337.93

ug/g

4.11

305

369

Selective serotonin reuptake inhibitors

2348

6145

2.05

192.71

1.4

286.65

271.47

ug/g

1.93

1303

3595

Condition for Implicit Sepsis (Organ dysfunction codes)

2076

7398

2.08

191.93

1.5

1.4

262.76

276.81

ug/g

2.25

1254

4295

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2620

7848

1.94

188.25

1.4

280.72

276.01

ug/g

0.48

1526

4515

Hypothyroidism and >3 levothyroxin purchases

558

713

4.61

188.08

1.4

1.3

293.79

336.63

ug/g

3.31

295

365

Hypothyroidism, levothyroxine purchases

558

713

4.61

188.08

1.4

1.3

293.79

336.63

ug/g

3.31

295

365

Lower back pain or/and sciatica

2449

8875

1.95

187.44

1.4

281.01

273.79

ug/g

0.84

1380

5113

Complications of surgical and medical care, not elsewhere classified

2342

8684

1.97

186.25

1.5

1.4

261.27

277.40

ug/g

3.03

1437

4927

Anxiety disorders

2165

7725

2.03

185.21

1.4

293.35

276.27

ug/g

2.19

1162

4467

Neurotic, stress-related and somatoform disorders

2144

7653

2.03

184.91

1.4

294.16

276.76

ug/g

2.23

1149

4426

Anxiety (asthma-related co-morbidities)

1401

4720

2.39

184.83

1.4

299.72

287.31

ug/g

0.82

722

2643

Bacterial infection, other or unspecified

1363

5272

2.40

184.71

1.4

234.59

273.47

ug/g

9.24

835

3088

Renal tubulo-interstitial diseases

2091

8097

2.02

180.53

1.5

1.4

250.97

279.69

ug/g

8.04

1297

4573

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

112

57.46

178.97

1.6

1.3

111.47

306.01

ug/g

5.60

Used for control exclusion in common control thyroid runs

2430

6355

1.97

178.22

1.5

1.4

269.55

279.72

ug/g

1.32

1406

3562

Other diseases of anus and rectum

714

2268

3.26

176.97

1.4

278.07

270.39

ug/g

0.38

381

1341

Substance abuse, excluding more controls

1309

4899

2.40

176.50

1.5

1.4

257.70

267.19

ug/g

0.77

733

2890

Pain, not elsewhere classified

721

2315

3.23

176.05

1.5

1.4

277.15

283.25

ug/g

0.29

416

1313

Type 1 diabetes, wide definition

644

1939

3.46

174.67

1.7

1.3

225.33

294.67

ug/g

14.95

451

1097

Use of hypnotics and sedatives

2513

7778

1.90

171.58

1.4

276.37

274.46

ug/g

0.14

1450

4481

Other or unspecified ileus, impaction or obstruction

496

1281

4.05

169.57

1.5

1.4

226.73

265.84

ug/g

3.65

308

782

Nerve, nerve root and plexus disorders

2487

8426

1.89

169.24

1.5

1.4

271.74

274.11

ug/g

0.18

1445

4858

Other gastritis (incl. Duodenitis)

658

2068

3.33

167.24

1.5

1.4

277.56

275.95

ug/g

0.06

405

1228

Other specific joint derangements/joint disorders

1708

5476

2.13

165.58

1.4

288.82

274.14

ug/g

1.87

962

3058

Any reimbursement code in KELA

1232

2461

2.55

165.28

1.5

1.2

276.85

334.48

ug/g

13.91

713

1227

Dyspnoea

2100

8397

1.95

164.69

1.4

291.49

269.11

ug/g

4.90

1183

4874

Soft tissue disorders

2348

6424

1.93

163.28

1.4

292.19

272.92

ug/g

2.91

1319

3659

Benign neoplasm of other and ill-defined parts of digestive system

614

1888

3.46

163.14

1.5

1.4

246.32

276.38

ug/g

2.89

397

1116

Sub-endpoint used in defining T1D endpoints

820

2900

2.88

163.00

1.7

1.4

217.17

279.19

ug/g

15.23

544

1667

Diaphragmatic hernia

1015

4079

2.59

162.85

1.5

1.4

286.72

264.85

ug/g

2.77

623

2420

Asthma, unspecified (mode), excluding more controls

1230

4143

2.39

160.90

1.5

1.4

280.31

276.77

ug/g

0.23

762

2356

Spondylopathies

1847

5566

2.06

158.74

1.5

1.4

275.19

266.95

ug/g

0.88

1085

3266

Ductal carcinoma of pancreas

112

40.44

158.31

1.6

1.5

111.47

246.77

ug/g

4.08

Asthma, excluding more controls

1750

4484

2.12

157.61

1.5

1.4

285.04

278.05

ug/g

0.63

1030

2536

Symptoms and signs involving cognition, perception, emotional state and behaviour

2236

8436

1.89

156.79

1.5

1.4

281.85

272.20

ug/g

1.01

1255

4891

Shoulder lesions

1835

5598

2.05

156.39

1.5

1.4

273.26

266.09

ug/g

0.57

1103

3278

All anxiety disorders

1412

5243

2.21

156.33

1.4

301.09

284.88

ug/g

1.24

731

2948

Dorsopathies

2322

6327

1.90

154.41

1.5

1.4

287.81

273.13

ug/g

1.83

1294

3619

Other intervertebral disc disorders

1903

5906

2.01

154.31

1.5

1.4

275.87

270.16

ug/g

0.54

1130

3431

Renal failure

1108

4311

2.43

153.43

1.5

1.4

239.65

266.05

ug/g

4.15

719

2580

Asthma, unspecified (mode)

1245

4351

2.32

153.27

1.5

1.4

280.74

275.63

ug/g

0.36

771

2484

Complications of procedures, not elsewhere classified

1871

8389

1.97

152.95

1.5

1.4

257.93

277.47

ug/g

3.58

1147

4762

Asthma

1792

4724

2.07

152.64

1.5

1.4

284.55

276.77

ug/g

0.76

1058

2686

Other diseases of the digestive system

840

3179

2.74

152.13

1.5

1.4

248.30

273.28

ug/g

2.48

498

1897

Benign neoplasm: Pancreas

172

182

11.57

151.20

1.6

1.4

218.61

309.28

ug/g

4.71

127

105

Implicit bacterial Sepsis

998

3758

2.51

149.66

1.5

1.4

248.32

266.54

ug/g

1.92

605

2260

Other diseases of intestine

363

819

4.70

149.24

1.5

1.4

252.02

271.61

ug/g

0.96

251

500

Other anxiety disorders

1046

3878

2.45

148.94

1.4

304.74

287.64

ug/g

0.99

539

2149

Follow-up examination after treatment for conditions other than malignant neoplasms

1009

2632

2.57

147.70

1.4

280.33

268.62

ug/g

0.59

573

1517

Hypertensive diseases (excluding secondary)

1252

3159

2.35

147.68

1.5

1.4

273.04

294.90

ug/g

2.64

743

1721

Other medical care

1018

4178

2.45

146.86

1.4

214.24

270.76

ug/g

14.45

616

2423

Bacterial Sepsis

1101

4228

2.39

146.68

1.5

1.4

248.27

268.05

ug/g

2.33

661

2501

Non-selective monoamine reuptake inhibitors

978

3915

2.50

146.52

1.5

1.4

279.97

271.85

ug/g

0.37

549

2344

Hypertension, essential

1806

5195

2.02

146.36

1.5

1.4

265.37

282.54

ug/g

2.59

1083

2938

Other disorders of urethra and urinary system

1589

5883

2.07

145.07

1.4

280.38

275.83

ug/g

0.35

892

3389

Asthma (mode)

1740

4765

2.04

143.54

1.5

1.4

282.81

276.39

ug/g

0.57

1017

2702

Type 2 diabetes, definitions combined

2095

6722

1.89

142.21

1.5

1.4

257.60

289.12

ug/g

8.33

1231

3857

Other (not insulin) diabetes medications

2150

7045

1.87

141.51

1.5

1.4

254.91

287.75

ug/g

9.52

1271

4048

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2018

6754

1.90

141.35

1.4

261.73

279.49

ug/g

3.03

1188

3878

2018

6754

1.90

141.35

1.4

261.73

279.49

ug/g

3.03

1188

3878

Benign neoplasms

1629

4523

2.07

141.16

1.5

1.3

284.84

295.91

ug/g

1.16

943

2437

Chronic gastritis

729

2674

2.83

140.43

1.5

1.4

264.81

270.56

ug/g

0.30

448

1612

Intestinal stricture

832

3265

2.65

140.38

1.5

1.4

235.43

271.89

ug/g

5.41

537

1932

Complications of medical and surgical care

1694

8388

1.96

138.90

1.5

1.4

260.07

276.04

ug/g

2.37

1027

4824

Benign neoplasms

2147

6525

1.86

137.76

1.5

1.4

278.62

275.23

ug/g

0.24

1274

3663

Persons encountering health services for examination and investigation

1412

3270

2.20

137.63

1.4

276.46

268.09

ug/g

0.66

798

1886

Other septicaemia

918

3725

2.50

137.51

1.5

1.4

237.51

276.54

ug/g

5.89

528

2206

Autoimmune diseases related-to ILD

1926

9197

1.88

137.37

1.4

278.92

275.19

ug/g

0.32

1086

5276

Explicit Sepsis

1033

4314

2.36

136.73

1.5

1.4

240.94

271.09

ug/g

4.07

586

2521

Type 2 diabetes, strict (exclude DM1)

2101

6850

1.86

135.93

1.5

1.4

257.50

287.04

ug/g

7.43

1232

3928

Nutritional anaemias

1185

5335

2.22

135.88

1.5

1.4

255.43

273.57

ug/g

2.29

727

3089

Cardiac arrhythmias

1319

4065

2.19

135.79

1.4

1.3

291.20

298.92

ug/g

0.63

738

2211

Spondylosis

1246

5004

2.19

135.09

1.5

1.4

278.58

264.12

ug/g

1.60

728

2942

Septicaemia

997

4150

2.38

134.07

1.5

1.4

240.03

275.15

ug/g

5.22

569

2454

Type 2 diabetes, definitions combined, including avohilmo

2089

6767

1.86

134.01

1.5

1.4

256.68

288.23

ug/g

8.26

1218

3869

Neoplasms

1585

4191

2.06

133.39

1.5

1.3

270.02

299.15

ug/g

5.49

950

2212

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2143

8152

1.82

131.78

1.5

1.4

265.79

280.72

ug/g

2.51

1304

4596

Abnormalities of heart beat

835

3344

2.54

131.36

1.5

1.4

290.15

268.07

ug/g

2.16

467

1934

Asthma (only as main-diagnosis), excluding more controls

1522

4484

2.06

131.13

1.5

1.4

286.04

278.05

ug/g

0.71

878

2536

Other diseases of urinary system

2254

7135

1.80

130.53

1.4

277.96

274.82

ug/g

0.27

1256

4109

Cystitis

1886

6177

1.90

130.22

1.4

280.78

276.86

ug/g

0.31

1046

3553

Glucagon-like peptide-1 (GLP-1) analogues

1333

5335

2.11

130.19

1.5

1.4

248.34

270.66

ug/g

3.39

782

3163

Influenza and pneumonia

2329

8801

1.77

129.95

1.4

264.42

281.61

ug/g

3.25

1360

4988

Symptoms and signs involving the urinary system

1778

7356

1.91

129.89

1.4

272.54

269.27

ug/g

0.20

979

4330

Diseases of the skin and subcutaneous tissue

2274

6384

1.81

129.88

1.5

1.4

275.07

276.03

ug/g

0.07

1340

3621

GI-bleeding

798

3185

2.59

129.56

1.5

1.4

250.37

272.84

ug/g

2.02

479

1904

Other pulmonary diagnosis

1824

4766

1.95

129.38

1.5

1.4

274.55

276.52

ug/g

0.13

1030

2710

Other bacterial intestinal infections

514

1635

3.29

128.32

1.5

1.4

262.59

273.43

ug/g

0.55

312

963

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

519

1664

3.29

128.31

1.5

1.4

216.59

286.10

ug/g

10.04

310

996

Bleeding

1899

7570

1.86

127.26

1.5

1.4

254.62

270.55

ug/g

2.53

1150

4400

Personality disorders, excluding more controls

585

2008

3.00

126.92

1.4

300.38

286.91

ug/g

0.40

317

1114

Asthma (only as main-diagnosis)

1551

4724

2.01

126.74

1.5

1.4

284.29

276.77

ug/g

0.67

896

2686

Cardiovascular diseases

1257

3156

2.20

126.32

1.4

1.3

290.27

307.24

ug/g

1.70

678

1662

Faecal incontinence

292

635

4.92

126.11

1.6

1.3

293.42

295.11

ug/g

0.04

167

368

Excluding asthma or asthma-COPD overlap

1812

4766

1.93

126.10

1.5

1.4

274.05

276.52

ug/g

0.17

1024

2710

Neurological diseases, wide definition

642

1037

3.16

125.62

1.4

1.3

305.22

296.82

ug/g

0.33

331

573

Cardiovascular diseases (excluding rheumatic etc)

1371

3815

2.11

125.44

1.5

1.3

282.24

305.16

ug/g

3.09

790

2001

Hypertension

1777

5320

1.92

125.11

1.5

1.4

267.04

284.28

ug/g

2.56

1056

3000

Hypertensive diseases

1775

5323

1.92

124.43

1.5

1.4

266.94

284.35

ug/g

2.60

1055

3001

Mental and behavioural disorders due to psychoactive substance use

1345

6349

2.04

124.27

1.5

1.4

257.78

272.65

ug/g

1.54

753

3689

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1003

3928

2.31

123.80

1.4

219.19

283.08

ug/g

18.08

628

2309

Neurological diseases

1900

5146

1.89

123.11

1.4

283.05

274.67

ug/g

0.84

1053

2934

Substance abuse

1309

6228

2.05

122.89

1.5

1.4

257.70

272.21

ug/g

1.45

733

3624

Other heart diseases

1079

3192

2.28

122.69

1.4

271.77

297.48

ug/g

3.32

619

1734

Temporomandibular joint disorders

375

998

3.89

122.61

1.5

1.3

293.97

279.52

ug/g

0.60

207

575

Intracranial trauma

1219

4353

2.13

121.28

1.4

276.60

275.39

ug/g

0.06

688

2486

Disorders of lipoprotein metabolism and other lipidaemias

1839

6308

1.87

121.05

1.5

1.4

261.27

274.32

ug/g

1.80

1117

3692

Benign neoplasm: Colon, unspecified

625

2279

2.84

120.90

1.4

266.10

283.59

ug/g

1.23

381

1353

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

128

122

12.70

120.84

1.7

1.3

126.22

306.13

ug/g

12.61

Pneumonias (Asthma/COPD co-morbidities)

2196

8811

1.75

120.64

1.4

259.77

281.79

ug/g

4.93

1300

4997

ILD differential diagnosis

1790

4765

1.91

120.23

1.5

1.4

274.38

276.39

ug/g

0.13

1013

2702

Other headache syndromes

1000

4548

2.25

120.20

1.4

298.75

278.43

ug/g

2.10

528

2589

COPD differential diagnosis

1790

4767

1.91

120.09

1.5

1.4

274.57

276.32

ug/g

0.11

1012

2703

All pneumoniae

2206

8846

1.75

119.73

1.4

260.39

281.60

ug/g

4.63

1305

5023

Gastroduodenal ulcer

638

2375

2.77

118.67

1.5

1.4

243.17

266.31

ug/g

1.81

394

1429

Episodal and paroxysmal disorders

2425

7304

1.72

118.00

1.4

285.65

273.56

ug/g

1.48

1352

4205

Benign neoplasm: Pancreas

172

248

8.43

117.84

1.6

1.5

218.61

280.51

ug/g

2.70

127

147

Chronic kidney disease

725

2881

2.59

117.75

1.5

1.4

238.87

266.12

ug/g

3.08

472

1739

Sciatica+with lumbago

1123

5121

2.13

116.12

1.4

283.18

270.75

ug/g

1.10

626

2968

Implicit viral Sepsis

517

1750

3.08

115.91

1.5

1.4

278.35

280.15

ug/g

0.07

314

1041

Viral Sepsis

517

1752

3.08

115.67

1.5

1.4

278.35

280.11

ug/g

0.07

314

1043

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2149

8806

1.74

115.58

1.5

1.4

259.08

281.06

ug/g

4.85

1276

5005

Other disorders of skin and subcutaneous tissue

1548

7627

1.90

115.06

1.5

1.4

268.04

271.65

ug/g

0.29

915

4450

Care involving dialysis

277

625

4.77

114.68

1.6

1.4

231.78

283.95

ug/g

3.76

188

383

Pneumonia, organism unspecified

1990

8250

1.77

114.46

1.4

259.16

279.54

ug/g

4.02

1175

4729

Rotator cuff syndrome

1378

5245

1.99

113.70

1.5

1.4

269.03

264.96

ug/g

0.30

829

3093

Dizziness and giddiness

1657

7364

1.86

113.69

1.4

287.09

270.68

ug/g

1.75

941

4291

Hernia

2071

8138

1.75

113.33

1.5

1.4

281.43

272.99

ug/g

0.81

1242

4683

Oedema, not elsewhere classified

701

2785

2.58

113.32

1.5

1.4

271.85

272.37

ug/g

0.02

402

1618

Concussion

1045

4235

2.18

113.07

1.4

280.40

274.99

ug/g

0.32

587

2414

Other/unspecified dorsalgia

857

3730

2.34

112.99

1.4

275.52

272.50

ug/g

0.15

498

2133

Insulin, fast-acting (human)

407

1214

3.50

112.64

1.7

1.4

225.87

301.98

ug/g

12.15

289

652

Aplastic and other anaemias

1057

4771

2.16

112.40

1.5

1.4

241.88

268.20

ug/g

3.85

663

2803

Dialysis, with operation codes

397

1174

3.58

112.17

1.6

1.4

231.15

276.05

ug/g

4.20

277

699

Disorders of eyelid, lacrimal system and orbit

1854

8277

1.79

111.11

1.4

281.89

271.39

ug/g

1.35

1078

4779

Hypokalaemia

368

1043

3.74

110.96

1.5

1.4

234.88

277.83

ug/g

3.69

247

616

COPD/asthma/ILD related infections

2295

6759

1.72

110.89

1.4

275.37

279.57

ug/g

0.38

1301

3881

COPD/asthma related infections

2295

6759

1.72

110.89

1.4

275.37

279.57

ug/g

0.38

1301

3881

Other diseases of liver

507

1754

3.03

109.65

1.4

284.11

278.65

ug/g

0.22

301

1030

Acute renal failure

549

1985

2.89

109.26

1.5

1.4

237.55

269.26

ug/g

2.79

360

1198

Polyarthropathies

1458

5103

1.94

109.14

1.5

1.4

270.03

269.65

ug/g

0.02

871

2891

Hypothyroidism, drug reimbursement

298

480

4.56

108.38

1.5

1.3

289.22

329.10

ug/g

2.05

177

246

Rheumatism, unspecified

432

1377

3.30

107.84

1.5

1.4

288.95

274.62

ug/g

0.66

235

803

Inflammatory bowel disease

783

3373

2.39

107.50

1.5

1.4

277.07

277.22

ug/g

0.01

447

1918

Bacterial intestinal infections, IBD co-morbidities

514

1811

2.96

107.39

1.5

1.4

262.38

276.25

ug/g

0.78

311

1075

Sleep disorders (combined)

2137

8303

1.71

106.90

1.4

290.83

271.58

ug/g

2.82

1177

4871

Other joint disorders

1876

5626

1.80

106.87

1.5

1.4

293.10

273.95

ug/g

2.25

1035

3140

Other heart diseases, wide

1995

7184

1.75

106.31

1.4

278.31

281.01

ug/g

0.22

1145

4042

Fall on same level

2461

8406

1.66

105.59

1.4

266.90

280.99

ug/g

2.36

1415

4784

Heart failure, not strict

1709

6612

1.82

105.12

1.5

1.4

251.30

271.04

ug/g

2.66

1085

3837

Nephropathy related operations

382

1150

3.52

105.04

1.6

1.5

236.54

273.17

ug/g

2.83

261

693

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1013

4903

2.11

103.56

1.5

1.4

249.92

267.34

ug/g

1.52

558

2893

Antihypertensive medication - note that there are other indications

1211

3272

2.05

102.39

1.4

1.3

291.38

299.93

ug/g

0.62

668

1739

Mental and behavioural disorders due to alcohol

1125

5521

2.02

102.38

1.5

1.4

251.79

269.74

ug/g

1.75

626

3226

Continuous positive airway pressure

437

1219

3.19

101.70

1.5

1.3

263.33

280.56

ug/g

0.85

260

720

Biguanides

2054

7507

1.71

101.33

1.5

1.4

252.57

280.00

ug/g

6.80

1214

4351

Lumbar disc prolapse

1335

5617

1.92

101.28

1.5

1.4

273.41

269.04

ug/g

0.32

808

3264

Osteopathies and chondropathies

1256

6262

1.94

100.96

1.4

272.96

272.89

ug/g

0.00

761

3582

Pure hypercholesterolaemia

1574

5849

1.84

100.35

1.5

1.4

253.88

271.80

ug/g

2.79

964

3420

Injuries to the head

2297

9209

1.65

99.24

1.4

272.47

278.13

ug/g

0.58

1316

5262

2415

7864

1.64

98.98

1.4

280.36

274.83

ug/g

0.58

1352

4552

Other anaemias

960

4473

2.12

98.69

1.5

1.4

243.66

269.65

ug/g

3.48

602

2638

Other disorders of lacrimal gland

824

3765

2.25

98.54

1.5

1.4

288.84

274.38

ug/g

1.13

468

2179

Somatoform disorder

444

1516

3.05

98.11

1.4

314.31

277.73

ug/g

2.81

233

875

Other and unspecified anaemias

951

4440

2.13

97.99

1.5

1.4

243.83

269.95

ug/g

3.48

596

2619

Genitourinary diseases

1244

3137

2.02

97.83

1.4

279.55

272.20

ug/g

0.48

709

1808

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1336

7230

1.88

97.63

1.5

1.4

259.75

274.89

ug/g

1.83

818

4165

Alcohol use disorder, ICD-based

940

4533

2.12

97.45

1.5

1.4

247.35

267.90

ug/g

1.84

521

2665

Hypo-osmolality and hyponatraemia

464

1629

2.96

97.02

1.5

1.4

247.44

272.94

ug/g

1.72

275

977

Dental caries

612

2445

2.55

96.99

1.5

1.4

250.69

273.57

ug/g

1.86

368

1398

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

562

2179

2.64

96.48

1.4

277.51

288.53

ug/g

0.54

316

1212

Asthma-related infections

1254

6589

1.91

96.28

1.4

284.03

276.45

ug/g

0.63

755

3747

Asthma, hospital admission 2, infections

1254

6589

1.91

96.28

1.4

284.03

276.45

ug/g

0.63

755

3747

Disorders of lacrimal system

970

4772

2.09

95.51

1.5

1.4

287.67

273.15

ug/g

1.35

555

2762

Diseases of the eye and adnexa

1710

4837

1.79

94.96

1.4

281.53

282.05

ug/g

0.03

991

2658

Persons encountering health services in other circumstances

831

3856

2.20

94.88

1.5

1.4

273.93

279.87

ug/g

0.30

443

2187

Non-invasive ventilation

441

1418

3.00

94.83

1.6

1.3

250.83

286.80

ug/g

2.97

276

804

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

207

432

5.15

94.25

1.6

1.4

173.75

287.54

ug/g

10.19

126

263

Syncope and collapse

894

3760

2.15

94.13

1.5

1.4

271.02

268.04

ug/g

0.16

507

2187

Other reaction to severe stress, and adjustment disorders

774

3505

2.26

94.02

1.5

1.4

287.01

286.10

ug/g

0.04

432

1948

ILD medications: immunosuppressive drugs

1301

6789

1.87

93.77

1.4

279.02

276.89

ug/g

0.13

778

3889

Myalgia

534

2055

2.68

93.57

1.5

1.4

301.49

273.47

ug/g

2.14

305

1187

Asthma (diagnoses ohter than nonallergic)

1815

9250

1.70

93.52

1.5

1.4

286.65

275.31

ug/g

1.47

1088

5239

Vocal cord dysfunction

305

780

3.75

93.11

1.3

300.36

278.78

ug/g

0.95

177

439

Fibromyalgia

269

699

4.07

91.96

1.5

1.4

323.06

290.82

ug/g

1.39

145

387

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

969

2955

2.12

91.69

1.4

276.58

295.53

ug/g

1.17

571

1606

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

27.15

91.49

2.0

1.2

198.51

320.51

ug/g

2.51

Gastric ulcer

433

1519

2.96

90.92

1.4

252.41

270.02

ug/g

0.95

269

912

Benign neoplasm: Colon, unspecified

625

2635

2.46

90.79

1.4

266.10

265.47

ug/g

0.02

381

1584

Dentinal caries

549

2162

2.61

90.78

1.5

1.4

248.21

272.61

ug/g

1.88

331

1244

Other nutritional deficiencies

1342

7314

1.82

89.62

1.4

285.91

279.03

ug/g

0.55

740

4158

Behavioural syndromes associated with physiological disturbances and physical factors

698

3091

2.31

89.56

1.4

307.21

287.70

ug/g

0.79

376

1698

Iron deficiency anaemia

923

4525

2.07

89.08

1.5

1.4

258.05

274.09

ug/g

1.51

550

2628

Exposure to unspecified factor

1997

9543

1.65

89.07

1.4

275.71

277.36

ug/g

0.12

1163

5440

Neuroendocrine tumor and carcinoma of pancreas

25.17

88.40

2.0

1.5

198.51

272.51

ug/g

1.36

Cough

864

4005

2.11

88.33

1.4

298.85

266.20

ug/g

4.31

521

2345

Enterocolitis due to Clostridium difficile

321

971

3.49

87.53

1.6

1.4

257.79

277.19

ug/g

0.87

196

568

Disorders of other endocrine glands

971

4852

2.01

87.00

1.5

1.4

276.48

279.85

ug/g

0.19

577

2755

Disorders of thyroid, IBD co-morbidities

339

727

3.47

86.99

1.4

1.3

277.45

285.60

ug/g

0.26

207

412

Haemorrhoids and perianal venous thrombosis

561

2290

2.51

86.47

1.5

1.4

280.27

267.78

ug/g

0.67

322

1358

Migraine

984

4244

2.01

85.94

1.4

314.64

285.89

ug/g

3.78

499

2346

Factors influencing health status and contact with health services

625

1241

2.57

85.45

1.4

279.37

274.61

ug/g

0.19

379

718

Diseases of arteries, arterioles and capillaries (FINNGEN)

590

1678

2.53

84.85

1.5

1.4

248.96

276.21

ug/g

2.38

371

958

Spinal stenosis

1076

4420

1.95

84.29

1.5

1.4

267.94

260.01

ug/g

0.63

650

2648

Finngen Rheumatological endpoints

2004

7043

1.64

83.77

1.4

288.93

273.02

ug/g

2.48

1159

3964

Chronic lower respiratory diseases

2486

8711

1.56

83.42

1.4

281.31

276.31

ug/g

0.53

1461

4940

Falls/tendency to fall

2298

7292

1.60

83.28

1.4

278.20

280.74

ug/g

0.18

1298

4136

Intestinal adhesions without obstruction

224

553

4.27

82.12

1.6

1.4

233.86

280.00

ug/g

2.42

146

335

Transplanted organ and tissue status

289

853

3.58

82.00

1.4

265.89

275.35

ug/g

0.31

192

503

Hypothyroidism, strict autoimmune

1456

5535

1.77

81.84

1.4

280.15

277.54

ug/g

0.17

811

3131

Other and unspecified iron deficiency

725

3395

2.19

81.37

1.5

1.4

262.57

275.50

ug/g

0.94

428

1963

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1834

6601

1.66

81.28

1.5

1.4

246.02

291.34

ug/g

15.39

1107

3727

Malignant neoplasm, wide definition for exclusion

1834

6602

1.66

81.24

1.5

1.4

246.02

291.28

ug/g

15.35

1107

3728

KRA_PSY_EATING, excluding more controls

190

413

4.76

81.09

1.3

318.76

320.97

ug/g

0.04

200

Heartburn

244

645

3.94

81.03

1.4

1.3

278.10

289.69

ug/g

0.33

128

375

Other diseases of stomach and duodenum

206

484

4.55

81.01

1.6

1.4

232.91

280.69

ug/g

2.55

121

285

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1833

6607

1.66

80.80

1.5

1.4

245.86

291.33

ug/g

15.47

1106

3730

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

387

1368

2.96

80.72

1.5

1.4

255.22

262.87

ug/g

0.25

223

819

Polyneuropathies and other disorders of the peripheral nervous system

536

2224

2.50

80.68

1.6

1.4

243.00

268.98

ug/g

2.08

339

1328

Pain and other conditions associated with female genital organs and menstrual cycle

424

1496

2.79

80.32

1.3

336.37

283.66

ug/g

4.77

208

757

Care involving use of rehabilitation procedures

1296

7013

1.78

80.00

1.5

1.4

269.96

281.33

ug/g

1.23

835

3994

Ascites

202

471

4.55

79.97

1.5

1.3

233.24

275.15

ug/g

1.86

132

278

Extracorporeal dialysis

211

514

4.44

79.49

1.6

1.5

234.22

278.87

ug/g

2.21

139

309

Diseases of the musculoskeletal system and connective tissue

1059

2721

1.98

79.28

1.4

293.76

277.71

ug/g

1.31

570

1500

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1220

6875

1.81

79.07

1.5

1.4

258.35

273.47

ug/g

1.73

748

3976

Other and unspecified polyneuropathies, also in other diseases

476

1890

2.62

78.83

1.6

1.4

241.45

263.74

ug/g

1.60

301

1136

Infections of the skin and subcutaneous tissue

1179

6557

1.82

78.65

1.5

1.4

261.73

277.81

ug/g

1.80

722

3727

932

4794

1.97

78.63

1.4

289.81

279.88

ug/g

0.74

552

2697

Other retinal disorders

1341

6202

1.77

78.01

1.5

1.4

250.73

267.97

ug/g

2.47

839

3655

Glomerular disorders in diseases classified elsewhere

321

1043

3.23

77.80

1.6

1.4

212.25

282.35

ug/g

8.22

232

612

Nonorganic sleeping disorders, excluding more controls

384

1372

2.88

77.76

1.4

320.13

283.23

ug/g

1.01

213

780

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

248

471

4.01

77.37

1.4

286.30

267.54

ug/g

0.27

151

291

Dermatitis and eczema

2198

9322

1.56

77.32

1.4

281.27

275.28

ug/g

0.62

1235

5363

Other disorders of glucose regulation and pancreatic internal secretion

256

729

3.71

76.76

1.7

1.4

204.92

287.05

ug/g

6.82

155

421

Fentanyl

254

722

3.67

75.85

1.5

1.4

206.29

277.65

ug/g

6.08

151

416

Bronchitis

2149

9110

1.56

75.85

1.4

280.39

275.76

ug/g

0.44

1197

5245

Disorders of adult personality and behaviour

615

2774

2.27

75.74

1.4

302.95

285.59

ug/g

0.60

337

1510

Haemorrhage from respiratory passages

709

3128

2.15

75.32

1.4

268.48

258.25

ug/g

0.61

423

1878

Cervical disc disorders

778

3850

2.07

75.31

1.4

276.21

266.45

ug/g

0.63

441

2262

Secondary hypertension

230

612

3.91

74.76

1.6

1.4

247.84

293.91

ug/g

2.41

149

347

Other arrhythmias

1343

5977

1.75

74.68

1.5

1.4

283.87

275.96

ug/g

0.71

766

3421

Ulcerative colitis

550

2383

2.37

74.67

1.5

1.4

270.96

274.04

ug/g

0.12

334

1358

Crohn disease

327

1097

3.10

74.63

1.5

1.4

284.09

290.05

ug/g

0.18

179

608

Other diseases of hard tissues of teeth

1304

5599

1.76

74.48

1.4

288.31

274.74

ug/g

1.50

762

3208

Volume depletion

249

710

3.68

74.31

1.5

1.4

245.57

275.37

ug/g

1.31

151

419

Acute sinusitis

1049

5347

1.86

74.22

1.4

295.84

280.90

ug/g

1.42

586

3046

Nonalcoholic fatty liver disease

278

854

3.44

74.17

1.4

286.85

292.18

ug/g

0.14

159

482

Acute tubulo-interstitial nephritis

1252

6388

1.77

74.11

1.5

1.4

251.97

277.76

ug/g

4.24

735

3610

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1332

7256

1.73

73.63

1.5

1.4

274.07

265.93

ug/g

0.53

791

4258

Other external causes of accidental injury

1745

5336

1.66

73.59

1.4

278.41

281.32

ug/g

0.21

988

3034

Diseases of pulp and periapical tissues

740

3630

2.08

73.36

1.5

1.4

259.05

270.97

ug/g

0.81

429

2106

Persistent mood disorders

458

1845

2.56

73.22

1.5

1.4

282.17

272.31

ug/g

0.22

253

1039

Other diseases of upper respiratory tract

2277

7755

1.55

73.18

1.4

286.43

270.04

ug/g

2.93

1297

4468

Fissure and fistula of anal and rectal regions

465

1886

2.53

72.93

1.4

287.22

275.45

ug/g

0.50

255

1110

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

130

227

6.39

72.87

1.5

1.4

208.76

296.77

ug/g

4.92

129

Convulsions, not elsewhere classified

461

1837

2.53

72.82

1.5

1.4

250.62

280.19

ug/g

2.12

273

1042

Cholecystitis

308

1014

3.15

72.48

1.5

1.3

251.88

295.43

ug/g

1.13

194

599

Alcoholic liver disease

279

871

3.38

72.42

1.5

257.89

264.30

ug/g

0.15

152

530

Special screening examination for infectious and parasitic diseases

433

1231

2.67

72.15

1.4

288.74

280.28

ug/g

0.27

210

669

Asthma, including avohilmo

2352

9067

1.52

71.96

1.4

287.38

273.86

ug/g

2.26

1387

5143

Malignant neoplasm of other and unspecified parts of biliary tract

11.02

71.91

1.6

1.5

112.75

288.40

ug/g

9.07

Generalized anxiety disorder

332

1145

2.99

71.83

1.4

1.3

295.90

298.97

ug/g

0.08

153

612

Acute upper respiratory infections

2109

8598

1.55

71.66

1.4

283.07

274.86

ug/g

0.95

1171

4981

Personality disorders

585

2648

2.26

71.50

1.4

300.38

284.37

ug/g

0.51

317

1458

Malignant neoplasm

1820

6795

1.61

70.80

1.5

1.4

243.97

288.50

ug/g

15.01

1115

3856

Sleep apnoea, including avohilmo

1968

8225

1.57

70.68

1.5

1.4

284.82

270.94

ug/g

2.08

1109

4821

Symptoms and signs involving the skin and subcutaneous tissue

1395

8375

1.68

70.59

1.4

290.95

273.61

ug/g

2.31

781

4834

Glomerular diseases

443

1791

2.56

70.58

1.6

1.4

223.00

275.11

ug/g

6.76

318

1054

Alcohol dependence

598

2750

2.23

70.41

1.5

254.94

270.39

ug/g

0.81

322

1626

Alcohol abuse, main dg, excluding more controls

324

1116

3.00

70.34

1.5

1.4

255.48

274.96

ug/g

0.74

187

632

Diseases of the respiratory system

1341

3868

1.76

70.09

1.4

284.98

273.91

ug/g

1.01

763

2199

Kidney transplant status

181

433

4.51

69.86

1.5

256.11

289.93

ug/g

1.20

118

255

Arthropathies

1782

5645

1.62

69.85

1.4

288.76

274.38

ug/g

1.81

980

3153

Obesity related asthma

737

3698

2.04

68.92

1.5

1.4

289.10

274.47

ug/g

1.04

421

2122

Vitamin B12 deficiency anaemia

299

1002

3.12

68.67

1.6

1.4

243.93

272.59

ug/g

1.67

201

589

Polyuria

510

2224

2.36

68.51

1.4

284.87

266.46

ug/g

1.10

295

1345

Sleep apnoea

1860

8105

1.58

68.17

1.5

1.4

282.81

269.77

ug/g

1.83

1034

4784

Obesity and other hyperalimentation

1226

7141

1.73

68.09

1.4

283.18

280.06

ug/g

0.20

679

4048

Obesity

1219

7105

1.73

67.72

1.4

283.82

280.16

ug/g

0.24

673

4029

Abnormal findings on examination of blood, without diagnosis

958

4914

1.86

67.65

1.5

1.4

259.87

263.49

ug/g

0.20

556

2950

Disorders of choroid and retina

1640

7504

1.61

67.03

1.5

1.4

251.74

270.14

ug/g

3.25

1012

4380

Pain in thoracic spine

348

1280

2.81

66.97

1.5

1.3

282.79

277.57

ug/g

0.17

188

737

Accidents

1711

5336

1.62

66.82

1.4

275.59

281.32

ug/g

0.47

972

3034

Benign neoplasm: Rectum, anus and anal canal

442

1844

2.48

65.74

1.5

1.4

272.23

282.71

ug/g

0.44

269

1089

Acute upper respiratory infections of multiple and unspecified sites

1446

6638

1.65

65.61

1.4

285.85

279.20

ug/g

0.54

797

3820

Symptoms and signs involving the nervous and musculoskeletal systems

1170

6873

1.73

65.54

1.5

1.4

290.73

271.76

ug/g

2.33

706

3956

Benign neoplasm: Ascending colon

314

1110

2.95

65.54

1.5

1.4

266.69

288.35

ug/g

0.98

188

663

Poisoning by drugs, medicaments and biological substances

516

2307

2.29

65.09

1.5

1.4

290.37

287.75

ug/g

0.06

308

1257

Ulcerative colitis, NAS

330

1208

2.83

64.20

1.6

1.4

279.59

287.82

ug/g

0.30

206

683

L04AD Calcineurin inhibitors

290

997

3.05

63.78

1.4

266.19

285.74

ug/g

0.85

193

591

Type 1 diabetes, definitions combined

238

723

3.40

63.77

1.7

1.3

236.54

329.18

ug/g

9.08

158

366

Benign neoplasm: Sigmoid colon

409

1673

2.53

63.60

1.5

1.4

262.36

283.87

ug/g

1.25

249

987

External causes of morbidity and mortality

1359

4046

1.70

63.51

1.4

277.68

284.29

ug/g

0.49

765

2280

Substance use, excluding alcohol

425

1772

2.47

63.08

1.5

1.4

270.45

280.60

ug/g

0.42

240

1000

Benign neoplasm: Caecum

265

873

3.19

62.93

1.5

1.4

258.07

284.68

ug/g

1.29

161

520

Diseases of oral cavity, salivary glands and jaws

1824

6012

1.57

62.89

1.5

1.4

277.18

273.29

ug/g

0.31

1058

3452

Asthma, hospital admissions , main diagnosis only

1618

9306

1.58

62.13

1.4

287.43

276.56

ug/g

1.26

939

5290

Menorrhagia

724

1979

2.06

61.96

1.4

297.26

274.95

ug/g

1.95

385

1096

Heart failure and antihypertensive medication

531

1562

2.30

61.79

1.5

1.4

245.61

266.27

ug/g

1.47

349

920

Type 1 diabetes, strict (exclude DM2)

237

734

3.34

61.58

1.7

1.4

236.54

323.68

ug/g

8.15

158

373

Cervicalgia

447

1936

2.37

60.90

1.4

301.05

272.47

ug/g

2.16

254

1121

Coxibs

559

1328

2.28

60.70

1.5

1.4

283.29

256.41

ug/g

1.87

316

786

Specific personality disorders

496

2248

2.26

60.56

1.4

314.42

287.37

ug/g

0.87

268

1233

Benign neoplasm: Rectum

391

1606

2.52

60.29

1.5

1.4

266.01

284.47

ug/g

0.86

239

953

Dermatitis

1206

7306

1.68

60.21

1.4

278.33

273.92

ug/g

0.30

692

4224

Osteoporosis

592

2752

2.11

59.81

1.5

1.4

259.20

270.70

ug/g

0.74

359

1625

Obesity due to excess calories

912

5136

1.81

59.52

1.4

283.60

280.89

ug/g

0.14

499

2890

Other disorders of teeth and supporting structures

470

2101

2.30

59.50

1.5

1.4

255.59

264.94

ug/g

0.44

268

1218

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1907

8255

1.52

59.35

1.4

266.08

274.16

ug/g

0.71

1124

4774

5-aminosalicylic acid

461

2047

2.31

59.18

1.5

1.4

281.97

274.48

ug/g

0.31

272

1167

Other general symptoms and signs

148

339

4.57

59.02

1.4

315.61

318.12

ug/g

0.04

180

Hypothyroidism, other/unspecified

1746

7542

1.55

58.64

1.4

281.93

273.82

ug/g

0.81

971

4314

Temporomandibular joint disorders, including avohilmo

810

4413

1.87

58.63

1.4

295.90

289.88

ug/g

0.33

423

2420

Sleep disorders

460

2051

2.30

58.56

1.4

313.82

286.54

ug/g

0.83

259

1144

Excessive, frequent and irregular menstruation

757

2163

1.98

58.28

1.4

1.3

302.75

278.40

ug/g

2.24

408

1159

Deforming dorsopathies

565

2737

2.11

58.13

1.5

1.4

294.51

273.16

ug/g

1.65

331

1582

Dental caries 3 and operation codes

1778

5941

1.55

57.86

1.5

1.4

274.27

272.74

ug/g

0.10

1008

3466

Ventral hernia

527

2497

2.17

57.75

1.6

1.4

253.77

267.42

ug/g

0.80

315

1461

Bipolar affective disorders

382

1579

2.48

57.73

1.5

1.4

284.80

286.97

ug/g

0.07

212

862

Ovarian cyst

717

2106

2.00

57.62

1.4

1.3

298.19

277.22

ug/g

1.66

406

1138

Elevated blood glucose level

233

750

3.27

57.61

1.6

1.4

223.42

283.49

ug/g

3.60

125

434

Asthma-related pneumonia

727

3853

1.92

57.57

1.5

1.4

272.66

269.21

ug/g

0.17

449

2248

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

166

428

4.09

57.55

1.7

1.5

237.49

291.62

ug/g

3.23

131

259

Other arthrosis

1040

4320

1.75

57.51

1.4

289.23

263.05

ug/g

2.26

620

2500

Inflammatory diseases of female pelvic organs

1193

5433

1.68

57.51

1.4

1.3

299.45

289.58

ug/g

0.82

643

2996

IBD patients in KELA-register

470

2132

2.26

57.28

1.5

1.4

288.34

278.31

ug/g

0.46

269

1203

Asthma, hospital admissions 3, pneumonia

727

3863

1.92

57.10

1.5

1.4

272.66

269.23

ug/g

0.17

449

2252

Asthma-related pneumonia or sepsis

727

3863

1.92

57.10

1.5

1.4

272.66

269.23

ug/g

0.17

449

2252

Diseases of pulp and periapical tissues, including avohilmo

2121

7481

1.49

56.81

1.5

1.4

275.86

276.72

ug/g

0.06

1196

4280

Diseases of arteries, arterioles and capillaries

1332

6194

1.63

56.80

1.5

1.4

246.82

266.72

ug/g

3.06

840

3652

Disorders of the thyroid gland

1840

8011

1.52

56.75

1.4

281.89

272.65

ug/g

1.03

1039

4586

Dental pulpitis 4

2121

7488

1.49

56.53

1.5

1.4

275.83

276.89

ug/g

0.08

1198

4282

Gingivitis and periodontal diseases

1760

5937

1.55

56.51

1.5

1.4

278.16

272.73

ug/g

0.36

1007

3412

Coeliac disease

303

1136

2.77

56.49

1.5

1.4

258.04

295.33

ug/g

2.39

196

627

Dental pulpitis 1

2120

7490

1.48

56.35

1.5

1.4

275.83

276.83

ug/g

0.07

1198

4283

Cutaneous abscess, furuncle and carbuncle

531

2547

2.13

56.22

1.5

1.4

262.98

277.48

ug/g

0.87

333

1446

Hypothyreosis and Thyroxine purchase for inclusion criteria

1793

7864

1.52

56.08

1.4

282.57

274.54

ug/g

0.82

1002

4504

Chronic periapical parodontitis

448

2021

2.28

55.52

1.5

1.4

247.00

266.43

ug/g

1.18

259

1173

Vascular disorders of the intestines

155

390

4.16

55.39

1.6

1.4

246.06

273.16

ug/g

0.83

246

Dentofacial anomalies [including malocclusion]

545

2621

2.10

55.36

1.4

296.73

284.98

ug/g

0.65

301

1434

Polycystic ovarian syndrome, consortium definition

1383

5229

1.62

55.17

1.4

1.3

299.22

289.74

ug/g

0.86

759

2871

Crohn's disease of small intestine

185

530

3.66

55.00

1.5

1.4

290.76

298.75

ug/g

0.17

295

Chronic sinusitis

840

4734

1.80

54.57

1.4

307.81

272.51

ug/g

5.08

486

2713

Viral and other specified intestinal infections

384

1589

2.41

54.51

1.5

1.4

283.99

297.66

ug/g

0.60

229

816

Poisoning by medicine

447

2029

2.26

54.45

1.5

1.4

293.34

287.03

ug/g

0.14

266

1106

Dental caries 1 and operation codes

1696

5687

1.55

54.34

1.5

1.4

273.94

271.37

ug/g

0.18

986

3325

Dental pulpitis 1, only avohilmo

2161

7770

1.47

54.01

1.5

1.4

275.17

275.92

ug/g

0.05

1240

4457

Carpal tunnel syndrome

1193

6665

1.64

53.97

1.5

1.4

275.52

274.47

ug/g

0.05

699

3842

Atrial fibrillation and flutter

645

2131

2.01

53.95

1.4

278.05

279.79

ug/g

0.07

393

1212

Codes for special purposes

858

4884

1.79

53.95

1.5

1.4

277.71

281.96

ug/g

0.23

487

2753

Other diseases of oesophagus

226

741

3.17

53.86

1.5

1.4

258.81

274.49

ug/g

0.51

138

434

Oter anti-inflammatory and antirheumatic agents, non-steroids

460

1111

2.34

53.70

1.5

1.4

272.42

245.18

ug/g

1.90

286

670

Other CVD (FINNGEN)

274

765

2.92

53.57

1.5

1.4

278.42

274.44

ug/g

0.11

175

458

Benign neoplasm: Duodenum

172

6.24

53.49

1.6

1.4

208.91

305.47

ug/g

4.40

108

Intracranial injury

1086

6376

1.67

53.31

1.4

274.55

272.94

ug/g

0.08

616

3680

STROKE

1146

4832

1.67

53.29

1.4

267.78

274.54

ug/g

0.36

688

2768

Provisional assignment of new diseases of uncertain etiology

855

4881

1.78

53.23

1.5

1.4

278.17

282.04

ug/g

0.21

484

2752

Dental pulpitis 4, only avohilmo

2149

7740

1.46

53.21

1.5

1.4

274.97

276.11

ug/g

0.08

1232

4437

Early onset COPD, excluding more controls

422

1891

2.29

52.99

1.5

1.4

267.66

262.15

ug/g

0.21

255

1124

Cerebrovascular diseases (FINNGEN)

624

2266

2.01

52.87

1.5

1.4

263.07

283.85

ug/g

1.59

379

1270

L04AA Selective immunosuppressants

484

2300

2.16

52.75

1.5

1.4

278.35

276.77

ug/g

0.06

310

1307

Other symptoms and signs involving cognitive functions and awareness

863

4637

1.78

52.67

1.5

1.4

266.02

264.15

ug/g

0.09

472

2769

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

995

5814

1.70

52.52

1.4

293.62

267.40

ug/g

3.76

607

3361

Benign neoplasm: Small intestine

126

285

4.76

52.33

1.5

225.85

300.36

ug/g

3.80

167

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

562

2824

2.03

52.28

1.4

277.51

287.00

ug/g

0.46

316

1526

Disorders of lens

1363

5456

1.60

52.23

1.5

1.4

253.41

269.14

ug/g

1.95

809

3218

Arthrosis

1387

4822

1.60

52.18

1.4

294.06

265.58

ug/g

3.48

820

2777

Systemic connective tissue disorders

738

4065

1.85

52.14

1.4

297.83

273.85

ug/g

2.50

407

2359

Emotionally unstable personality disorder

267

977

2.82

51.99

1.4

311.25

312.75

ug/g

0.03

136

490

Injuries to the shoulder and upper arm

1594

8898

1.52

51.53

1.4

279.06

271.32

ug/g

0.58

954

5151

Diseases of the ear and mastoid process

2270

8047

1.44

51.46

1.4

284.05

275.47

ug/g

1.06

1276

4600

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

9.03

51.20

1.4

1.3

208.18

299.88

ug/g

3.08

Disorders of mineral metabolism

219

729

3.15

51.15

1.4

247.32

287.66

ug/g

1.95

139

413

ILD medications: azathioprine

329

1346

2.52

51.08

1.5

1.4

280.35

283.15

ug/g

0.08

185

781

Other systemic involvement of connective tissue (FG)

546

2723

2.04

51.04

1.4

297.49

267.31

ug/g

2.79

304

1557

Endometriosis

668

2061

1.96

51.03

1.4

1.3

311.75

276.36

ug/g

3.93

353

1121

Panic disorder

290

1118

2.66

50.83

1.4

1.3

302.14

295.80

ug/g

0.16

141

597

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

518

2560

2.08

50.80

1.4

290.81

280.08

ug/g

0.54

310

1469

Dental caries 3

1603

5371

1.54

50.72

1.4

274.75

275.05

ug/g

0.02

914

3121

Malignant neoplasm of small intestine

182

6.00

50.67

1.4

1.5

194.93

266.78

ug/g

3.13

106

Exposure to other specified factors

1380

8417

1.56

50.60

1.4

276.26

277.95

ug/g

0.10

788

4812

Any event in cancer register

1774

7103

1.50

50.44

1.4

253.02

288.17

ug/g

9.33

1070

3994

Ulcer of lower limb, not elsewhere classified

317

1287

2.55

50.28

1.6

1.4

234.41

268.06

ug/g

2.32

201

768

Acetic acid derivatives and related substances

534

1316

2.14

50.22

1.5

1.4

276.62

255.88

ug/g

1.22

305

781

Visual disturbances and blindness

989

5979

1.68

50.02

1.4

292.80

273.03

ug/g

1.33

553

3468

Suicide or other Intentional self-harm

497

2431

2.09

49.96

1.4

273.80

279.46

ug/g

0.22

285

1332

Dental operations

1266

4047

1.62

49.91

1.4

274.47

267.93

ug/g

0.49

751

2387

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

352

1502

2.41

49.76

1.4

278.71

289.85

ug/g

0.40

197

822

Problems related to lifestyle

230

796

2.99

49.76

1.5

1.4

264.55

285.51

ug/g

0.60

108

448

Benign neoplasm: Caecum

265

996

2.79

49.57

1.5

258.07

266.51

ug/g

0.28

161

595

Viral hepatitis, IBD co-morbidity

106

215

5.09

49.47

1.4

1.3

254.25

287.18

ug/g

0.84

138

Chronic rhinitis, nasopharyngitis and pharyngitis

624

3313

1.92

49.43

1.4

305.43

272.43

ug/g

3.44

355

1882

Other and unspecified dermatitis

978

5916

1.68

49.30

1.5

1.4

280.35

276.47

ug/g

0.22

559

3422

Dental caries, including avohilmo

1519

5068

1.55

49.06

1.4

276.05

273.43

ug/g

0.18

893

2944

Dental caries 1

1518

5071

1.55

48.71

1.4

276.10

273.41

ug/g

0.18

892

2947

Persons encountering health services for specific procedures, not carried out

187

586

3.33

48.22

1.4

259.36

299.32

ug/g

1.58

115

326

Azathioprine

329

1384

2.45

48.09

1.5

1.4

280.35

282.79

ug/g

0.07

185

801

Hypoglycaemia, other or unspecified

185

579

3.35

47.96

1.7

1.5

213.63

291.94

ug/g

4.66

117

330

Presence of other functional implants

1120

4935

1.63

47.74

1.6

1.4

264.24

266.24

ug/g

0.12

690

2911

Mycoses

543

2791

1.99

47.62

1.6

1.4

268.89

272.07

ug/g

0.13

342

1606

Injury, poisoning and certain other consequences of external causes

1065

3215

1.68

47.52

1.4

280.43

287.05

ug/g

0.42

597

1808

Polyarthrosis

435

1976

2.17

47.44

1.5

1.4

278.22

259.59

ug/g

1.17

238

1177

Benign neoplasm: Stomach

240

876

2.86

47.39

1.5

1.4

254.94

297.11

ug/g

2.59

139

528

Obesity, other/unspecified

646

3516

1.87

47.36

1.4

283.59

281.86

ug/g

0.07

363

1977

Eating disorder

190

606

3.24

47.26

1.3

318.76

325.79

ug/g

0.13

274

Benign neoplasm: Rectum, anus and anal canal

442

2119

2.15

47.25

1.5

1.4

272.23

266.29

ug/g

0.23

269

1278

Migraine with aura

444

2126

2.13

47.15

1.4

319.52

289.78

ug/g

1.99

221

1149

Hypothyroidism, strict autoimmune, 3 medication purchases required

1596

7344

1.50

46.80

1.4

281.97

276.85

ug/g

0.41

892

4194

Hernia of abdominal wall

885

5298

1.70

46.60

1.5

1.4

274.07

265.09

ug/g

0.40

530

3092

Disturbances of skin sensation

543

2811

1.97

46.54

1.4

312.87

279.59

ug/g

3.20

290

1570

Benign neoplasm: Ascending colon

314

1319

2.48

46.46

1.5

1.4

266.69

266.18

ug/g

0.01

188

794

Acute gastritis

186

595

3.26

46.37

1.5

1.4

264.58

279.38

ug/g

0.41

109

352

Cervicobrachial syndrome

436

2090

2.13

46.30

1.5

1.4

284.84

275.55

ug/g

0.43

266

1186

Other dialysis

111

252

4.81

46.14

1.7

1.5

237.99

285.22

ug/g

1.50

147

Injuries to the thorax

847

5026

1.71

46.01

1.5

1.4

254.67

268.45

ug/g

1.12

494

2951

Hyperlipidaemia, other/unspecified

737

3977

1.79

45.94

1.5

1.4

265.08

266.42

ug/g

0.06

440

2368

Other enthesopathies

572

3025

1.93

45.89

1.4

281.63

271.69

ug/g

0.53

323

1768

Erysipelas

1010

5708

1.64

45.68

1.4

241.40

273.46

ug/g

5.58

607

3366

Visual disturbances

912

5531

1.68

45.66

1.4

294.31

272.49

ug/g

1.43

517

3214

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

456

2238

2.09

45.65

1.4

213.98

284.06

ug/g

10.92

311

1324

Arthropathies in other diseases classified elsewhere

114

267

4.57

45.25

1.7

1.4

226.12

269.19

ug/g

1.35

154

Disorders of synovium and tendon

946

5202

1.66

45.18

1.4

297.70

269.89

ug/g

2.15

558

3007

Benign neoplasm: Sigmoid colon

409

1939

2.18

45.10

1.5

1.4

262.36

266.99

ug/g

0.18

249

1181

Hyperkalaemia

140

381

3.87

45.07

1.6

1.5

211.09

272.09

ug/g

2.64

231

Dental pulpitis 2, only avohilmo

1379

4596

1.55

45.04

1.4

279.85

272.66

ug/g

0.59

814

2682

Eating disorders

220

784

2.89

44.99

1.3

1.4

300.61

312.97

ug/g

0.29

101

377

Other diseases of lip and oral mucosa

351

1568

2.30

44.76

1.4

273.17

270.50

ug/g

0.09

207

907

Other cataract

856

3932

1.71

44.75

1.5

1.4

248.07

269.38

ug/g

2.28

509

2327

Nonorganic sleeping disorders

384

1781

2.21

44.52

1.4

320.13

289.07

ug/g

0.80

213

989

Asthma/COPD (KELA code 203)

1769

8675

1.45

44.47

1.4

276.94

276.10

ug/g

0.06

1051

4919

283

1155

2.52

44.27

1.4

277.05

290.17

ug/g

0.43

165

631

Gonarthrosis

1223

4491

1.58

44.25

1.4

283.64

263.27

ug/g

1.81

740

2593

Inflammatory bowel disease, strict (require KELA)

470

2356

2.04

44.25

1.5

1.4

288.34

279.18

ug/g

0.41

269

1331

Urticaria and erythema

703

4012

1.78

44.03

1.4

309.38

281.66

ug/g

2.81

370

2261

Dental operations, only avohilmo

1334

4441

1.55

44.02

1.4

274.63

267.18

ug/g

0.61

789

2626

Covid-19 confirmed case

551

2923

1.92

43.90

1.4

269.64

272.92

ug/g

0.14

309

1694

Insomnia

333

1467

2.33

43.85

1.4

319.05

290.67

ug/g

0.62

191

811

Charcot foot

116

6.90

43.81

1.8

1.5

198.04

295.71

ug/g

3.60

Other acute lower respiratory infections

987

5873

1.62

43.74

1.4

280.13

273.11

ug/g

0.48

557

3368

Soft tissue disorders related to use, overuse and pressure

514

2669

1.97

43.69

1.4

304.33

264.88

ug/g

4.13

295

1593

Acute bronchitis

780

4496

1.73

43.64

1.4

278.26

269.76

ug/g

0.53

429

2601

Acute alcohol intoxication, ICD10

398

1887

2.16

43.63

1.5

1.4

252.23

274.97

ug/g

1.09

223

1076

Benign neoplasm: Rectum

391

1846

2.18

43.61

1.5

1.4

266.01

263.83

ug/g

0.07

239

1113

Dental caries 3, only avohilmo

1597

5527

1.49

43.56

1.4

273.74

274.20

ug/g

0.03

914

3221

Dialysis

128

338

4.05

43.31

1.5

1.4

238.72

284.20

ug/g

1.66

204

Portal vein thrombosis

108

7.19

43.29

1.5

203.55

303.69

ug/g

3.42

Phobic anxiety disorders

243

930

2.67

43.24

1.5

1.4

285.58

301.81

ug/g

0.52

134

487

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

132

356

3.94

43.23

1.5

167.21

265.43

ug/g

5.42

217

Dental pulpitis 2

1339

4489

1.54

42.73

1.4

278.96

272.73

ug/g

0.48

790

2614

All influenza

488

2513

1.98

42.51

1.5

1.4

278.23

274.17

ug/g

0.15

269

1484

Pain associated with micturition

267

1084

2.55

42.43

1.4

309.59

285.03

ug/g

0.93

129

616

Oxicams

445

1205

2.13

42.38

1.4

275.89

249.39

ug/g

1.72

242

724

Alcohol abuse, main dg

324

1432

2.32

42.37

1.5

1.4

255.48

271.39

ug/g

0.58

187

828

Benign neoplasm: Transverse colon

222

828

2.79

42.05

1.4

258.46

286.48

ug/g

1.14

132

498

Disorders of vitreous body

957

5874

1.62

41.87

1.5

1.4

287.59

265.27

ug/g

1.75

596

3457

Undetermined asthma, excluding more controls

261

1052

2.55

41.83

1.4

311.53

281.54

ug/g

1.42

161

618

Colectomy operation

367

1719

2.20

41.75

1.5

1.4

243.92

271.91

ug/g

1.72

236

1032

Dental caries 1, only avohilmo

1515

5235

1.49

41.68

1.4

276.08

272.81

ug/g

0.23

884

3052

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

118

303

4.13

41.39

1.9

1.4

218.01

321.88

ug/g

7.23

160

Meniscus derangement

1048

4539

1.60

41.32

1.4

289.58

264.50

ug/g

2.09

613

2617

Disorders of vitreous body and globe

975

6007

1.61

41.32

1.5

1.4

287.94

265.54

ug/g

1.79

606

3539

Candidiasis

298

1287

2.39

41.27

1.5

1.4

280.79

288.20

ug/g

0.23

182

715

Disorders of conjunctiva

1498

8629

1.47

41.22

1.4

284.51

281.02

ug/g

0.26

878

4860

Migraine without aura

354

1639

2.20

41.09

1.3

328.11

302.19

ug/g

1.42

181

869

Other sleep disorders

241

947

2.63

40.96

1.5

1.4

302.97

276.68

ug/g

1.07

147

565

Mixed and other personality disorders

190

661

2.98

40.95

1.4

265.45

298.54

ug/g

1.15

101

333

Urticaria

574

3156

1.85

40.85

1.3

1.4

315.50

285.14

ug/g

2.73

302

1768

Acute alcohol intoxication

479

2485

1.96

40.83

1.5

1.4

252.29

274.08

ug/g

1.19

276

1455

Other systemic involvement of connective tissue

565

3099

1.86

40.67

1.4

296.29

274.45

ug/g

1.74

320

1790

Statin medication

1318

4901

1.52

40.52

1.5

1.4

273.33

278.77

ug/g

0.40

783

2791

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

491

2544

1.94

40.46

1.4

286.28

308.01

ug/g

1.43

271

1348

Gout

495

2362

1.95

40.45

1.5

1.4

253.19

248.66

ug/g

0.19

326

1438

Any operation in hilmo

9.18

40.43

1.4

1.2

283.25

422.56

ug/g

1.96

Exclusions for E4_PCOS_BROAD

355

1660

2.19

40.39

1.5

1.4

264.12

288.36

ug/g

1.40

208

931

Exclusions for E4_PCOS_CONSORTIUM

1350

5672

1.51

40.38

1.4

288.78

287.71

ug/g

0.06

746

3174

Undetermined asthma

261

1071

2.50

40.28

1.4

311.53

280.82

ug/g

1.47

161

633

Other symptoms and signs involving the nervous and musculoskeletal systems

795

4810

1.68

40.21

1.5

1.4

301.06

276.73

ug/g

2.38

461

2765

Other and unspecified effects of external causes

519

2785

1.90

39.94

1.5

1.4

290.69

281.09

ug/g

0.45

271

1550

Other abnormal uterine and vaginal bleeding

455

1632

2.03

39.85

1.4

295.68

273.21

ug/g

1.43

247

914

Venous thromboembolism

1018

6360

1.58

39.67

1.4

253.65

268.11

ug/g

1.41

613

3705

Injuries to the abdomen, lower back, lumbar spine and pelvis

726

4275

1.71

39.65

1.5

1.4

259.80

274.53

ug/g

1.10

410

2479

Lactose intolerance

101

239

4.51

39.61

1.4

304.83

305.39

ug/g

0.01

139

Ischaemic heart disease, wide definition

1504

6478

1.47

39.54

1.5

1.4

261.20

267.69

ug/g

0.57

912

3783

Unspecified haematuria

763

3907

1.70

39.51

1.5

1.4

254.72

262.69

ug/g

0.29

434

2350

Carcinoid syndrome

8.67

39.48

1.5

1.4

236.98

272.98

ug/g

0.55

Paroxysmal tachycardia

421

1772

2.05

39.15

1.4

284.97

286.01

ug/g

0.03

242

987

Gonarthrosis [arthrosis of knee](FG)

1446

5809

1.48

39.10

1.4

279.31

265.43

ug/g

1.21

876

3363

Assault

265

1113

2.44

38.96

1.4

274.43

289.67

ug/g

0.45

138

605

Diseases of peritoneum

241

973

2.57

38.88

1.6

1.4

239.63

280.68

ug/g

2.54

160

555

Disorders resulting from impaired renal tubular function

115

305

4.05

38.81

1.7

1.4

251.91

279.57

ug/g

0.70

181

Ischemic heart diseases

1515

6567

1.46

38.67

1.5

1.4

263.62

267.41

ug/g

0.29

917

3835

Enthesopathies of lower limb, excluding foot

410

2056

2.03

38.60

1.5

1.4

277.97

272.98

ug/g

0.20

233

1171

Other endocrine disorders

146

433

3.41

38.55

1.4

304.72

311.98

ug/g

0.15

232

Neuroendocrine tumor and carcinoma of small intestine

119

6.55

38.46

1.4

1.5

208.18

277.02

ug/g

2.27

Coxarthrosis

927

3934

1.62

38.38

1.4

266.79

258.68

ug/g

0.55

556

2307

Senile cataract

1203

4945

1.53

38.05

1.5

1.4

254.79

268.53

ug/g

1.45

706

2951

Symptoms and signs involving speech and voice

643

3739

1.75

37.92

1.4

272.68

273.13

ug/g

0.02

384

2155

Hyperkinetic disorders, excluding more controls

153

474

3.21

37.90

1.3

313.57

337.89

ug/g

0.57

236

Other inflammatory liver diseases

172

594

3.03

37.79

1.5

1.4

222.01

289.04

ug/g

3.51

111

348

Benign neoplasm: Duodenum

233

4.57

37.71

1.6

1.5

208.91

280.88

ug/g

2.87

143

Postprocedural disorders of digestive system, not elsewhere classified

108

280

4.15

37.62

1.6

1.4

254.06

298.18

ug/g

1.30

160

Immunodeficiencies

141

436

3.42

37.56

1.5

1.4

314.47

292.35

ug/g

0.58

247

Disorder of pancreatic internal secretion, other and/or unspecified

9.33

37.54

2.0

1.4

159.91

303.69

ug/g

3.63

Benign neoplasm: Small intestine

126

365

3.70

37.37

1.5

225.85

274.46

ug/g

2.04

223

Retention of urine

598

2867

1.79

37.36

1.5

1.4

248.72

256.39

ug/g

0.39

352

1736

Preparatory care for dialysis

127

370

3.66

37.26

1.5

1.4

221.85

278.53

ug/g

2.47

222

Disorders of calcium metabolism

162

546

3.11

37.21

1.4

240.43

289.74

ug/g

2.30

104

325

Fracture of rib(s), sternum and thoracic spine

558

3134

1.81

37.14

1.5

1.4

250.92

270.85

ug/g

1.41

322

1881

Atrial fibrillation and flutter with reimbursement

509

1734

1.91

37.09

1.4

275.38

274.63

ug/g

0.03

318

1000

Spondylolisthesis/Spondylolysis

358

1738

2.11

36.98

1.5

1.4

286.56

272.91

ug/g

0.62

207

1018

Subjective visual disturbances

483

2611

1.89

36.51

1.4

307.48

274.19

ug/g

1.23

271

1502

Benign neoplasm: Stomach

240

999

2.50

36.41

1.5

1.4

254.94

275.76

ug/g

0.89

139

581

Sequelae of external causes of morbidity and mortality

491

2672

1.88

36.34

1.4

265.16

273.86

ug/g

0.40

293

1571

Injuries to the ankle and foot

1205

7443

1.49

36.24

1.4

284.04

281.66

ug/g

0.14

669

4180

Diabetic neuropathy

309

1431

2.24

36.18

1.8

1.5

206.34

242.56

ug/g

2.82

213

846

Other disorders of ear

1710

8171

1.41

36.15

1.4

275.70

272.63

ug/g

0.24

979

4752

Peripheral artery disease

811

4048

1.64

36.08

1.5

1.4

239.03

261.32

ug/g

2.57

527

2444

Internal derangement of knee

675

4021

1.70

35.86

1.5

1.4

272.22

266.02

ug/g

0.31

366

2309

Pruritus

236

986

2.47

35.31

1.4

271.66

286.49

ug/g

0.42

132

544

Voice disturbances

523

2930

1.82

35.21

1.4

275.61

275.54

ug/g

0.00

309

1684

Malignant neoplasm of stomach

137

434

3.32

35.02

1.7

1.5

231.32

271.67

ug/g

1.84

109

266

Abnormal findings on diagnostic imaging of lung

869

5410

1.59

35.01

1.5

1.4

271.80

262.37

ug/g

0.43

518

3228

Injuries to the knee and lower leg

2162

9221

1.35

34.99

1.4

267.82

278.59

ug/g

1.53

1259

5259

Post-traumatic stress disorder

150

499

3.09

34.89

1.4

1.3

303.13

308.00

ug/g

0.08

245

Fibroblastic disorders

429

2264

1.93

34.85

1.4

274.03

258.60

ug/g

0.83

255

1365

Superficial injury of head

418

2193

1.94

34.56

1.4

283.45

275.38

ug/g

0.32

249

1282

Conjunctivitis

1324

8035

1.45

34.47

1.4

288.77

284.11

ug/g

0.34

775

4500

Paracetamol of NSAID medication

291

626

2.37

34.44

1.4

303.63

271.38

ug/g

1.42

162

350

Abnormal findings on diagnostic imaging of other body structures

286

1313

2.25

34.41

1.5

1.4

268.16

280.73

ug/g

0.48

174

760

Disorders of skin appendages

841

5360

1.59

34.31

1.4

286.73

280.83

ug/g

0.34

474

3012

Type 1 diabetes, strict definition, subgroup 1

146

482

3.10

34.25

1.7

1.2

250.96

354.53

ug/g

7.63

105

228

Unspecified fall

880

5627

1.57

34.24

1.5

1.4

275.54

272.24

ug/g

0.13

532

3239

Other disorders of kidney and ureter

275

1248

2.27

34.03

1.5

1.4

245.23

272.34

ug/g

1.34

166

740

Other shoulder lesions

195

759

2.65

33.88

1.5

1.4

283.42

283.11

ug/g

0.01

113

450

Fenamates

293

887

2.27

33.88

1.4

273.41

256.85

ug/g

0.65

167

530

Migraine without aura and triptan purchases

286

1317

2.22

33.83

1.3

1.4

330.09

306.89

ug/g

1.00

144

704

Mental and behavioural disorders due to sedatives or hypnotics

160

566

2.94

33.59

1.5

1.4

263.03

296.50

ug/g

1.01

308

Immunodeficiency with predominantly antibody defects

227

4.32

33.50

1.6

1.5

318.39

300.50

ug/g

0.33

139

Psychotic depression

127

393

3.34

33.45

1.5

1.4

269.79

279.40

ug/g

0.21

227

Irregular menses

806

4129

1.60

33.22

1.4

1.3

316.34

295.70

ug/g

1.91

428

2204

Other eating disorders

114

332

3.56

33.11

1.2

1.4

307.44

318.61

ug/g

0.18

154

Adhesive capsulitis of shoulder

335

1657

2.07

32.98

1.5

1.4

273.45

266.29

ug/g

0.24

204

991

Cellulitis

405

2143

1.93

32.74

1.5

1.4

255.24

276.07

ug/g

1.25

255

1225

Other protozoal intestinal diseases

6.55

32.71

1.6

1.3

303.57

310.07

ug/g

0.07

Cervicocranial syndrome

217

905

2.46

32.56

1.5

1.3

337.15

281.49

ug/g

1.06

137

529

Chronic periodontitis

297

1413

2.16

32.52

1.5

1.4

246.10

261.97

ug/g

0.69

186

835

Osteomyelitis

152

534

2.97

32.42

1.5

1.4

250.80

273.82

ug/g

0.72

100

322

Other CVD

364

1867

1.99

32.35

1.5

1.4

266.64

263.56

ug/g

0.11

230

1132

DVT of lower extremities and pulmonary embolism

763

4814

1.60

32.27

1.5

1.4

258.41

269.28

ug/g

0.74

456

2860

Direct fill therapy

277

1289

2.21

32.11

1.4

276.17

288.47

ug/g

0.43

161

731

Alcoholic gastritis

6.61

32.04

1.4

1.5

245.46

253.93

ug/g

0.08

Alcohol withdrawal state with delirium

165

610

2.82

31.98

1.4

250.67

269.97

ug/g

0.44

366

Open wound of head

897

5805

1.54

31.93

1.5

1.4

259.95

269.88

ug/g

0.70

523

3402

Diseases of male genital organs

885

2855

1.58

31.80

1.5

273.31

258.74

ug/g

1.10

539

1725

Other symptoms and signs involving the circulatory and respiratory systems

145

501

3.00

31.75

1.4

274.96

264.58

ug/g

0.22

286

Trochanteric bursitis

270

1250

2.22

31.71

1.4

307.24

275.00

ug/g

1.85

157

737

Adrenocortical insufficiency

109

320

3.63

31.67

1.6

1.5

247.57

292.13

ug/g

1.34

189

Chronic laryngitis and laryngotracheitis

286

1356

2.16

31.62

1.6

1.4

302.92

266.97

ug/g

2.28

163

792

Artrosis, including avohilmo

1548

6094

1.41

31.55

1.4

287.89

268.99

ug/g

2.84

890

3531

Noninflammatory disorders of female genital tract

722

2207

1.66

31.54

1.4

1.3

314.05

279.09

ug/g

3.75

374

1175

Infections with a predominantly sexual mode of transmission

519

2989

1.76

31.53

1.5

1.4

289.71

293.97

ug/g

0.17

308

1591

Duodenal ulcer

207

858

2.48

31.47

1.5

1.4

220.50

267.79

ug/g

2.44

124

515

Benign neoplasm: Endocrine pancreas

10.83

31.37

1.8

1.2

229.06

299.58

ug/g

0.87

Hypotension

314

1546

2.08

31.37

1.5

1.4

267.51

264.50

ug/g

0.10

203

947

Sequelae with surgical and medical care as external cause

393

2094

1.92

31.25

1.5

1.4

255.56

272.79

ug/g

0.88

234

1243

Certain disorders involving the immune mechanism

380

2002

1.94

31.25

1.5

1.4

296.84

272.83

ug/g

1.42

233

1157

Enlarged lymph nodes

279

1314

2.17

31.23

1.5

1.4

321.46

278.06

ug/g

2.80

165

763

Viral infections characterized by skin and mucous membrane lesions

745

4724

1.60

31.17

1.5

1.4

275.48

276.95

ug/g

0.07

431

2706

Diabetic retinopathy, excluding more controls

623

2084

1.73

31.08

1.6

1.5

211.90

250.20

ug/g

4.99

399

1208

Other neurological diseases

1298

7374

1.43

31.00

1.4

278.96

266.73

ug/g

0.91

763

4307

Non-allergic asthma (mode), excluding more controls

345

1745

1.99

30.88

1.5

1.4

276.98

274.40

ug/g

0.09

208

1015

Other disorders of bladder

238

1059

2.31

30.86

1.5

265.04

266.19

ug/g

0.03

155

640

Papulosquamous disorders

734

4657

1.60

30.82

1.4

272.57

273.12

ug/g

0.02

431

2690

Disorders of parathyroid gland

418

2252

1.87

30.76

1.5

1.4

263.33

274.08

ug/g

0.52

247

1333

Other and unspecified urticaria

375

1976

1.94

30.76

1.3

1.4

314.73

285.22

ug/g

1.80

190

1100

Dipeptidyl peptidase 4 (DPP-4) inhibitors

244

1100

2.29

30.73

1.4

262.09

273.45

ug/g

0.39

148

661

Type 1 diabetes, strict definition

153

552

2.84

30.62

1.7

1.3

249.34

337.58

ug/g

6.44

111

273

Crohn disease (strict definition, require KELA, min 2 HDR)

147

524

2.91

30.49

1.4

298.64

294.79

ug/g

0.07

292

Migraine with aura and triptan purchases

270

1268

2.17

30.48

1.4

324.56

303.28

ug/g

0.74

129

691

Adverse effects, not elsewhere classified

368

1936

1.94

30.33

1.4

299.39

288.03

ug/g

0.44

184

1067

Crohn disease (strict definition, require KELA)

149

537

2.88

30.27

1.4

300.03

295.14

ug/g

0.09

296

Second line medication for Crohn's disease

1013

6911

1.48

30.13

1.5

1.4

281.11

276.79

ug/g

0.27

590

3969

COPD (mode)

542

2518

1.73

30.10

1.4

260.53

259.71

ug/g

0.03

332

1516

Non-allergic asthma (mode)

345

1762

1.97

30.05

1.5

1.4

276.98

275.94

ug/g

0.03

208

1031

Crohn's disease NAS

144

513

2.91

29.86

1.5

1.4

309.37

299.17

ug/g

0.22

286

Volvulus

155

4.78

29.84

1.5

1.3

273.16

287.63

ug/g

0.21

Other disorders of eyelid

801

5039

1.56

29.83

1.4

283.46

264.62

ug/g

1.92

479

2981

Coronary atherosclerosis

1270

5770

1.43

29.81

1.5

1.4

257.50

263.94

ug/g

0.53

782

3384

Use of disulfiram, acamprosate or naltrexone

192

792

2.50

29.68

1.5

1.4

252.83

274.96

ug/g

0.68

107

466

Parodontitis or operation codes

1625

8824

1.37

29.64

1.5

1.4

260.04

273.92

ug/g

1.83

949

5146

Amenorrhoea

125

412

3.12

29.61

1.4

1.3

298.59

293.66

ug/g

0.08

196

Other extrapyramidal and movement disorders in other diseases

430

2402

1.83

29.39

1.4

280.67

271.37

ug/g

0.44

271

1416

Benign neoplasm: Transverse colon

222

983

2.34

29.33

1.4

258.46

267.62

ug/g

0.26

132

584

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

155

581

2.76

29.21

1.4

301.54

294.97

ug/g

0.13

317

Misadventures to patients during surgical and medical care

279

1352

2.12

29.19

1.5

1.4

239.52

284.61

ug/g

3.17

166

773

Acute peritonitis

150

554

2.82

29.17

1.6

1.5

230.44

274.48

ug/g

1.96

104

325

Parodontitis

1620

8825

1.36

29.12

1.5

1.4

260.32

273.86

ug/g

1.76

946

5149

Other diseases of blood and blood-forming organs, wide

422

2352

1.83

29.05

1.4

271.43

273.08

ug/g

0.06

267

1376

Other disorders of skin and subcutaneous tissue, not elsewhere classified

285

1396

2.09

28.96

1.5

1.4

263.74

279.50

ug/g

0.69

164

808

Lesion of ulnar nerve

272

1309

2.13

28.95

1.5

1.4

296.32

276.44

ug/g

0.29

148

755

Diseases of external ear

602

3698

1.65

28.94

1.5

1.4

280.18

273.96

ug/g

0.30

338

2149

Other metabolic disorders

259

1225

2.17

28.85

1.4

287.33

295.53

ug/g

0.24

152

684

Chronic periodontitis, including avohilmo

1613

8828

1.36

28.85

1.5

1.4

259.93

273.83

ug/g

1.83

939

5150

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

299

1495

2.04

28.59

1.4

1.3

297.37

297.43

ug/g

0.00

158

786

Anaemia in chronic diseases classified elsewhere

200

4.26

28.57

1.7

1.4

219.48

280.02

ug/g

1.74

120

Other disorders of adrenal gland

118

388

3.19

28.44

1.6

1.5

251.27

293.94

ug/g

1.35

230

Cluster headache, wide

282

3.60

28.44

1.5

1.3

308.26

305.24

ug/g

0.04

153

Oesophageal varices

110

348

3.34

28.35

1.4

269.99

284.33

ug/g

0.26

208

Other and unspecified mood [affective] disorders

131

455

2.96

28.34

1.4

275.13

292.53

ug/g

0.38

235

Impingement syndrome of shoulder

451

2581

1.78

28.29

1.4

282.63

261.68

ug/g

0.63

274

1531

Disorders of magnesium metabolism

9.88

28.28

1.7

1.4

205.22

222.61

ug/g

0.16

Crohn disease (strict definition, all UC cases excluded)

123

416

3.08

28.14

1.5

1.4

314.13

297.49

ug/g

0.31

235

Obsessive-compulsive disorder

118

388

3.13

28.12

1.4

1.3

300.79

307.66

ug/g

0.12

204

Fibrosis and cirrhosis of liver

168

670

2.61

28.04

1.4

284.72

283.46

ug/g

0.02

405

Monoamine oxidase A inhibitors

229

1044

2.25

27.99

1.4

291.06

269.60

ug/g

0.28

129

609

Transport accidents

746

4286

1.56

27.89

1.5

1.4

265.97

281.45

ug/g

1.16

416

2446

Missing teeth due to accident, extraction or parodontitis

238

1105

2.21

27.89

1.6

1.4

258.01

273.85

ug/g

0.58

142

651

Disorders of oesophagus in diseases classified elsewhere

136

4.98

27.86

1.4

1.3

253.64

283.20

ug/g

0.47

Benign neoplasm: Descending colon

141

517

2.84

27.81

1.5

1.4

235.68

282.47

ug/g

2.17

314

Benign neoplasm: Endocrine pancreas

9.22

27.76

1.8

1.5

229.06

296.59

ug/g

0.89

Special screening examination for other diseases and disorders

148

554

2.73

27.76

1.5

1.4

262.89

266.37

ug/g

0.07

305

Postmenopausal bleeding

509

1613

1.76

27.74

1.4

276.67

267.12

ug/g

0.44

281

939

Cluster headache, strict

263

3.67

27.70

1.5

1.3

308.86

310.20

ug/g

0.02

140

Diabetic nephropathy, excluding more controls

352

1566

1.93

27.42

1.7

1.5

210.08

243.45

ug/g

2.83

254

908

Brachial plexus disorders

183

765

2.46

27.42

1.4

307.48

310.53

ug/g

0.06

102

405

Injuries to the wrist and hand

1720

9388

1.34

27.15

1.4

279.89

276.77

ug/g

0.24

991

5370

Coxarthrosis [arthrosis of hip](FG)

981

4868

1.47

27.11

1.4

266.43

261.42

ug/g

0.31

585

2854

Triptan medication for migraine, single purchase ok

1335

6537

1.39

27.08

1.4

304.27

279.77

ug/g

3.87

726

3671

Migraine, single triptan purchase ok & required. ICD-code if available is included

1335

6537

1.39

27.08

1.4

304.27

279.77

ug/g

3.87

726

3671

Fungal Sepsis

303

3.45

26.93

1.7

1.4

240.25

292.14

ug/g

1.86

183

Other specified/unspecified arthritis

456

2655

1.74

26.87

1.4

285.15

265.32

ug/g

1.18

261

1525

Hypermobility syndrome

121

416

3.02

26.85

1.3

336.47

320.72

ug/g

0.30

199

Gout, FINNGEN

495

2953

1.70

26.75

1.5

1.4

253.19

256.88

ug/g

0.15

326

1782

Heart failure,strict

942

4643

1.48

26.68

1.4

257.44

263.28

ug/g

0.27

609

2756

Otitis externa

396

2222

1.81

26.64

1.5

1.4

291.14

277.97

ug/g

0.59

218

1272

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

170

4.34

26.55

1.7

1.3

251.63

292.67

ug/g

1.07

Vasomotor and allergic rhinitis

618

3841

1.60

26.49

1.4

300.26

280.50

ug/g

1.49

326

2117

Lactose intolerance, other/unspecified

211

3.96

26.37

1.4

300.86

305.38

ug/g

0.06

124

Female genital prolapse

526

1798

1.71

26.37

1.4

302.92

272.54

ug/g

2.73

295

1017

Gout, idiopatic and unspecified

430

2480

1.77

26.37

1.5

255.28

259.50

ug/g

0.16

284

1507

Radiculopathy

295

1512

1.99

26.34

1.4

280.87

270.61

ug/g

0.37

188

903

Colonic or urogenital fistula

495

2967

1.70

26.30

1.4

284.26

271.12

ug/g

0.68

275

1729

Propionic acid derivatives

484

1392

1.76

26.29

1.5

1.4

304.34

260.31

ug/g

4.15

277

816

Asthma and allergy

208

921

2.27

26.27

1.5

1.3

302.38

296.91

ug/g

0.14

117

486

Unspecified kidney failure

189

818

2.38

26.25

1.6

1.4

237.19

269.62

ug/g

1.54

134

497

Implicit fungal Sepsis

270

3.56

26.02

1.7

1.4

242.50

285.72

ug/g

1.27

167

Other noninflammatory disorders of vulva and perineum

173

722

2.46

26.02

1.5

1.3

296.52

279.67

ug/g

0.44

100

378

Oesophagitis

116

397

3.03

25.97

1.4

281.86

290.48

ug/g

0.17

234

Diseases of salivary glands

348

1897

1.87

25.75

1.5

1.4

277.93

273.22

ug/g

0.17

198

1091

Deposits [accretions] on teeth

154

590

2.60

25.74

1.4

280.49

297.61

ug/g

0.43

336

Asthma and allergy, excluding more controls

208

929

2.25

25.74

1.5

1.4

302.38

297.39

ug/g

0.12

117

492

Assault by bodily force

151

595

2.61

25.71

1.4

280.94

306.19

ug/g

0.62

315

Diabetic retinopathy, strict definition

424

2152

1.78

25.66

1.7

1.5

222.18

244.78

ug/g

1.67

292

1267

Nonhereditary hypogammaglobulinemia

5.86

25.61

1.6

1.4

333.54

289.15

ug/g

0.78

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

601

3809

1.60

25.49

1.4

287.82

280.05

ug/g

0.42

358

2167

Early onset COPD

422

2451

1.75

25.28

1.5

1.4

267.66

267.46

ug/g

0.01

255

1451

Other postsurgical states

143

555

2.67

25.25

1.5

249.02

281.75

ug/g

1.33

102

327

Superficial injury of abdomen, lower back and pelvis

271

1371

2.02

25.17

1.5

1.4

268.29

284.29

ug/g

0.57

154

764

Extrapyramidal and movement disorders

654

4241

1.56

25.09

1.4

283.80

268.02

ug/g

1.21

408

2510

Hyperparathyroidism

354

1935

1.85

25.05

1.4

263.19

273.44

ug/g

0.43

210

1152

Paralytic ileus

218

3.77

25.03

1.4

291.75

268.59

ug/g

0.45

140

L04AX Other immunosuppressants

965

6767

1.44

24.92

1.4

281.91

277.04

ug/g

0.30

561

3891

Parodontitis and operation codes

1505

8778

1.34

24.78

1.5

1.4

263.11

272.84

ug/g

1.01

880

5130

Iron deficiency anaemia secondary to blood loss (chronic)

300

1582

1.94

24.73

1.6

1.4

246.56

274.48

ug/g

1.53

174

935

Other diseases of gallbladder

303

3.30

24.72

1.4

1.3

305.75

311.61

ug/g

0.09

168

Unspecified/other endometriosis

156

636

2.51

24.64

1.4

1.3

344.12

295.57

ug/g

1.72

312

Adenomyosis (Endometriosis of uterus)

247

1219

2.07

24.63

1.3

313.01

274.79

ug/g

1.95

134

689

Other and unspecified disorders of vitreous body

746

4973

1.51

24.56

1.4

307.60

266.16

ug/g

3.52

457

2933

Pulmonary heart disease, diseases of pulmonary circulation

557

3504

1.61

24.38

1.5

1.4

251.71

271.62

ug/g

1.52

341

2098

Convalescence

122

446

2.84

24.25

1.6

1.4

324.37

295.34

ug/g

0.19

256

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

179

784

2.35

24.25

1.5

1.4

278.35

291.62

ug/g

0.35

104

430

Atypical facial pain

121

441

2.86

24.24

1.5

1.4

307.94

303.27

ug/g

0.08

234

Allergic asthma (mode), excluding more controls

359

1970

1.81

24.24

1.4

293.44

290.57

ug/g

0.09

195

1081

Gout, unspecified

356

1995

1.82

24.19

1.4

1.5

255.08

260.78

ug/g

0.20

235

1205

Coagulation defects, purpura and other haemorrhagic conditions

344

1907

1.84

24.19

1.5

1.4

284.31

276.79

ug/g

0.26

194

1094

Atherosclerosis, excluding cerebral and coronary sclerosis

710

3750

1.53

24.13

1.5

1.4

242.71

261.89

ug/g

1.82

454

2269

Atopic dermatitis

885

5219

1.46

24.12

1.4

300.89

289.01

ug/g

0.83

458

2879

Pulmonary heart disease

514

3181

1.64

24.10

1.5

1.4

250.54

269.66

ug/g

1.39

314

1908

Vitreous haemorrhage

202

933

2.23

24.10

1.7

1.4

221.08

269.69

ug/g

3.49

136

553

Pulmonary embolism

514

3182

1.64

24.07

1.5

1.4

250.54

269.54

ug/g

1.38

314

1907

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

907

6221

1.45

24.02

1.4

288.27

284.88

ug/g

0.19

526

3450

Gout, strict definition

316

1714

1.88

23.92

1.5

248.85

260.62

ug/g

0.46

213

1048

Personal history of other diseases and conditions

200

920

2.21

23.68

1.4

301.35

309.63

ug/g

0.18

461

Acidosis

138

4.58

23.67

1.6

1.5

260.65

269.50

ug/g

0.09

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

273

1279

1.97

23.60

1.3

314.47

325.65

ug/g

0.31

122

618

Amputation of toe

147

598

2.55

23.58

1.4

1.5

241.15

264.72

ug/g

0.79

361

Allergic conjunctivitis

948

6591

1.43

23.47

1.4

287.95

285.86

ug/g

0.11

550

3673

Allergic asthma (mode)

359

1991

1.79

23.42

1.4

293.44

288.24

ug/g

0.17

195

1098

Conductive and sensorineural hearing loss

1397

7225

1.35

23.37

1.5

1.4

274.33

267.71

ug/g

0.57

826

4245

Postprocedural endocrine and metabolic disorders, not elsewhere classified

227

1110

2.09

23.27

1.5

1.4

288.43

294.47

ug/g

0.16

134

622

Other problems related to primary support group, including family circumstances

207

952

2.16

23.16

1.4

270.52

318.20

ug/g

2.49

124

480

Peripheral arterial reconstruction

296

1590

1.90

23.08

1.5

244.22

258.25

ug/g

0.59

186

984

Fracture of shoulder and upper arm

612

3983

1.56

23.03

1.4

268.34

272.54

ug/g

0.20

364

2318

Gastrojejunal ulcer

6.35

23.01

1.8

1.4

230.81

279.77

ug/g

0.74

Combinations of oral blood glucose lowering drugs

490

3035

1.64

22.97

1.4

266.82

273.36

ug/g

0.28

295

1796

Peripheral artery operations in Hilmo

233

1155

2.06

22.96

1.4

242.42

268.53

ug/g

1.30

148

702

Gonarthrosis,primary

1597

7655

1.32

22.86

1.4

282.47

265.69

ug/g

1.82

959

4497

Sensorineural hearing loss

1333

6947

1.35

22.82

1.5

1.4

271.77

266.78

ug/g

0.38

795

4081

Hyperplasia of prostate

595

2152

1.60

22.82

1.4

1.5

266.38

246.18

ug/g

1.43

378

1309

Malnutrition

160

4.23

22.74

1.4

1.5

270.97

294.68

ug/g

0.32

102

Other benign neoplasms of skin

599

3817

1.56

22.73

1.5

1.4

263.06

287.62

ug/g

2.23

339

2157

Anti-inflammatory and antirheumatic products, non-steroids

468

1392

1.70

22.69

1.4

294.17

260.31

ug/g

2.60

272

816

Mucosal proctocolitis

216

1047

2.10

22.62

1.5

1.4

275.08

287.46

ug/g

0.35

131

587

Otalgia

162

702

2.38

22.57

1.4

281.18

286.83

ug/g

0.11

372

Other blood glucose lowering drugs, excl. Insulins

310

1703

1.86

22.54

1.5

1.4

244.25

270.19

ug/g

1.66

200

1016

Adjustment and management of implanted device

301

1638

1.87

22.49

1.5

1.4

248.36

269.99

ug/g

1.23

190

987

Vascular diseases of the intestine

306

3.18

22.45

1.6

1.4

246.85

282.39

ug/g

0.92

183

Neuromuscular dysfunction of bladder

175

786

2.29

22.36

1.5

1.4

272.40

271.44

ug/g

0.02

101

451

Purpura and other haemorrhagic conditions

246

1258

2.00

22.29

1.5

1.4

278.29

282.46

ug/g

0.11

138

714

Other Crohn's disease

134

535

2.58

22.29

1.5

1.4

267.22

302.13

ug/g

1.12

294

Hypertensive heart and/or renal disease

432

2002

1.70

22.28

1.4

240.81

265.28

ug/g

1.81

279

1202

Other diseases of pleura

749

4529

1.48

22.13

1.5

1.4

253.41

262.47

ug/g

0.57

464

2725

Inflammatory diseases of prostate (prostatitis)

220

1084

2.07

22.09

1.5

298.43

244.84

ug/g

2.86

127

664

Lichen ruber planus, wide definition including periferal and oral lichen planus

398

2364

1.72

22.09

1.4

274.67

277.55

ug/g

0.10

233

1380

Fall on same level involving ice and snow

964

6910

1.41

22.07

1.4

275.73

274.13

ug/g

0.08

555

3997

Abscess of anal and rectal regions

134

537

2.55

22.02

1.5

1.4

264.83

288.56

ug/g

0.62

320

Amputation

186

862

2.21

21.98

1.5

1.4

238.24

270.22

ug/g

1.50

121

525

Other complications of surgical and medical care, not elsewhere classified

187

869

2.21

21.97

1.5

1.4

264.86

289.92

ug/g

0.88

115

481

Anorexia (incl.atypical)

116

434

2.75

21.95

1.4

283.02

301.22

ug/g

0.32

219

ILD, hospital admission 2, with pulmonary infections

182

838

2.23

21.91

1.4

1.5

271.38

266.07

ug/g

0.13

106

526

Right hemicolectomy

131

524

2.60

21.85

1.5

237.05

277.17

ug/g

1.37

310

Other diseases of arteries and capillaries

180

827

2.24

21.79

1.4

254.35

280.67

ug/g

0.87

105

480

Neuralgia and neuritis, unspecified

107

388

2.86

21.62

1.6

1.4

304.10

290.17

ug/g

0.21

222

Diseases of the myoneural junction and muscle

224

1123

2.04

21.52

1.5

1.4

255.69

276.29

ug/g

0.79

125

666

Congenital malformations, deformations and chromosomal abnormalities

955

6566

1.40

21.52

1.4

300.00

284.31

ug/g

1.42

529

3645

Vitamin deficiency

112

418

2.79

21.49

1.5

267.73

286.09

ug/g

0.31

245

Vitamin deficiency, wide

112

418

2.79

21.49

1.5

267.73

286.09

ug/g

0.31

245

Other diseases of jaws

145

612

2.44

21.45

1.6

1.4

268.16

285.26

ug/g

0.44

353

Other specified/unspecified bacterial intestinal infections

140

583

2.48

21.40

1.5

1.4

287.75

283.67

ug/g

0.09

338

COPD

763

4331

1.47

21.37

1.5

1.4

257.09

263.16

ug/g

0.35

466

2594

Abnormal results of function studies

171

776

2.27

21.36

1.5

1.4

281.69

287.54

ug/g

0.13

436

Triptan medication for migraine, min. 3 purchases

884

4926

1.43

21.31

1.3

1.4

316.14

288.11

ug/g

3.27

470

2671

Deviated nasal septum

558

3625

1.56

21.21

1.4

274.26

260.26

ug/g

0.84

329

2115

Lateral epicondylitis

237

1217

1.99

21.19

1.4

293.01

267.76

ug/g

1.09

141

714

Ulcerative colitis (strict definition, require KELA)

293

1612

1.85

21.17

1.6

1.4

283.30

286.09

ug/g

0.08

177

909

Other arthritis (FG)

519

3324

1.58

21.10

1.4

280.17

265.55

ug/g

0.83

300

1895

Other ulcerative colitis

116

445

2.69

21.00

1.5

1.4

288.37

298.59

ug/g

0.20

241

Rheumatoid arthritis

541

3173

1.57

20.97

1.4

281.76

263.47

ug/g

1.30

314

1842

Total colectomy

351

2.94

20.97

1.6

1.4

256.78

291.34

ug/g

0.73

201

Total colectomy operation

351

2.94

20.97

1.6

1.4

256.78

291.34

ug/g

0.73

201

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

315

1777

1.80

20.94

1.6

1.4

281.47

283.02

ug/g

0.05

192

1012

Angina pectoris

1073

5290

1.38

20.85

1.5

1.4

261.94

262.95

ug/g

0.06

659

3109

Other viral diseases

469

2934

1.61

20.81

1.4

311.20

283.31

ug/g

2.14

278

1585

Recurring oral aphthae, including avohilmo

253

1338

1.93

20.80

1.4

283.56

281.73

ug/g

0.04

141

755

Hepatic failure, not elsewhere classified

311

3.07

20.66

1.5

217.20

293.44

ug/g

2.24

184

Other disorders of penis

167

762

2.24

20.53

1.6

1.5

277.09

252.81

ug/g

0.75

469

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

282

1549

1.85

20.51

1.6

1.4

280.15

286.83

ug/g

0.21

172

870

Unspecified privation

202

994

2.08

20.46

1.5

1.4

240.34

289.18

ug/g

2.63

124

561

Other disorders of patella

290

1607

1.83

20.44

1.4

303.19

274.21

ug/g

1.37

154

911

Lichen planus, including avohilmo

347

2031

1.74

20.40

1.4

272.04

275.97

ug/g

0.14

202

1177

Reimbursement for rheumatic diseases

998

7276

1.38

20.37

1.4

275.32

276.27

ug/g

0.05

584

4200

Benign neoplasm of other and unspecified endocrine glands

227

1166

1.99

20.37

1.5

1.4

239.85

294.00

ug/g

3.98

129

677

Chronic diseases of tonsils and adenoids

1327

6340

1.33

20.36

1.4

298.09

275.29

ug/g

3.30

721

3618

Seborrhoeic keratosis

398

2417

1.68

20.32

1.4

280.38

270.45

ug/g

0.50

232

1439

Endometriosis of pelvic peritoneum

246

1278

1.93

20.32

1.4

1.3

331.47

284.69

ug/g

2.67

122

672

Unspecified urinary incontinence

183

872

2.16

20.28

1.4

292.26

286.61

ug/g

0.12

502

Hallux valgus (acquired)

584

2774

1.54

20.25

1.4

288.88

268.23

ug/g

0.81

346

1615

Diabetic nephropathy

356

2080

1.73

20.24

1.7

1.5

210.60

240.15

ug/g

2.47

257

1244

Adenocarcinoma and papillary adenocarcinoma of stomach

207

3.55

20.16

1.7

1.4

251.63

271.65

ug/g

0.43

116

Disturbance of activity and attention

148

637

2.33

20.13

1.3

1.4

319.13

333.28

ug/g

0.29

311

Sequelae of injuries, of poisoning and of other consequences of external causes

406

2482

1.66

20.12

1.6

1.4

243.88

273.54

ug/g

2.00

230

1429

Ocular pain

163

744

2.25

20.12

1.4

322.00

297.79

ug/g

0.74

401

Localized swelling, mass and lump of skin and subcutaneous tissue

533

3474

1.55

20.10

1.4

284.81

272.94

ug/g

0.62

311

2027

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

15.93

20.10

1.6

1.3

126.36

315.00

ug/g

—

Kela reimbursement Agammaglobulinemia (D80-84)

6.26

19.97

1.4

1.5

382.00

270.18

ug/g

2.62

Hard cardiovascular diseases

1398

6851

1.32

19.92

1.4

257.44

269.26

ug/g

1.28

825

4014

Other/unspecified synovitis and tenosynovitis

202

1003

2.05

19.91

1.5

1.4

304.32

275.81

ug/g

0.38

124

599

Flatulence and related conditions

7.09

19.88

1.9

1.2

268.82

334.57

ug/g

0.69

Bulimia nervosa (incl. atypical)

218

3.42

19.87

1.3

313.74

326.61

ug/g

0.16

100

Other disorders of eye and adnexa

252

1351

1.90

19.87

1.4

298.35

292.68

ug/g

0.16

149

743

Other and unspecified tonsillitis

484

2608

1.59

19.83

1.4

305.94

285.46

ug/g

1.03

224

1453

Glomerulonephritis

192

939

2.10

19.82

1.5

1.4

242.34

287.03

ug/g

2.45

131

551

Palmar fascial fibromatosis [Dupuytren]

261

1416

1.88

19.77

1.4

262.68

253.05

ug/g

0.32

161

886

Disorders of ocular muscles, binocular movement, accommodation and refraction

756

5253

1.44

19.73

1.4

277.66

283.26

ug/g

0.30

411

2955

Other chronic obstructive pulmonary disease, including avohilmo

902

5404

1.40

19.68

1.5

1.4

256.73

264.03

ug/g

0.50

541

3257

Other/unspecified enthesopathies of lower limb, excluding foot

131

549

2.45

19.67

1.4

288.12

292.44

ug/g

0.07

307

Sulfonylureas

595

3161

1.52

19.65

1.5

1.4

240.36

268.52

ug/g

2.66

366

1905

Restless leg syndrome

232

1217

1.95

19.63

1.4

290.20

283.15

ug/g

0.21

152

694

Fracture of foot, except ankle

402

2467

1.65

19.62

1.4

261.97

273.49

ug/g

0.52

237

1387

Trigger finger

248

1328

1.90

19.60

1.5

1.4

285.88

269.29

ug/g

0.24

150

778

Fracture of skull and facial bones

348

2058

1.72

19.58

1.4

271.09

272.56

ug/g

0.04

188

1193

Other and unspecified drugs and medicaments

164

759

2.22

19.58

1.5

1.4

274.27

285.98

ug/g

0.29

424

Postmenopausal atrophic vaginitis

438

1620

1.65

19.49

1.4

307.93

268.71

ug/g

3.59

268

940

Mental and behavioural disorders due to opioids

257

3.19

19.41

1.6

1.4

252.05

318.92

ug/g

1.69

139

Excessive attrition of teeth

694

2557

1.49

19.40

1.4

282.27

276.73

ug/g

0.28

396

1421

Other chronic obstructive pulmonary disease

725

4188

1.45

19.40

1.5

1.4

258.36

262.47

ug/g

0.21

440

2507

All-cause Heart Failure

985

5183

1.38

19.37

1.4

258.65

259.22

ug/g

0.02

628

3106

Benign neoplasm: Descending colon

141

617

2.37

19.36

1.5

1.4

235.68

271.27

ug/g

1.46

367

Dislocation, sprain and strain of joints and ligaments at neck level

250

1347

1.89

19.36

1.3

1.4

293.07

291.52

ug/g

0.04

131

719

DVT of lower extremities

335

1972

1.73

19.25

1.4

271.52

274.92

ug/g

0.10

192

1178

Invasive ventilation

148

662

2.31

19.24

1.7

1.4

247.17

279.19

ug/g

0.95

391

Blepharochalasis

515

3369

1.55

19.20

1.4

280.90

269.05

ug/g

0.69

300

2034

Valvular heart disease excluding rheumatic fever

799

4121

1.43

19.20

1.4

253.83

268.07

ug/g

1.22

486

2411

Heart failure, strict

997

5258

1.38

19.19

1.4

258.97

259.59

ug/g

0.02

637

3155

Presence of cardiac and vascular implants and grafts

737

3887

1.45

19.13

1.5

1.4

252.19

261.75

ug/g

0.66

453

2344

Injuries to the neck

367

2216

1.68

19.10

1.4

274.96

278.08

ug/g

0.10

195

1242

Artificial opening status

111

438

2.63

19.10

1.6

1.5

222.43

268.90

ug/g

1.52

261

Mental and behavioural disorders due to tobacco

162

754

2.21

19.07

1.4

277.66

285.22

ug/g

0.18

439

Conduction disorders

487

2602

1.58

19.03

1.4

248.99

264.99

ug/g

1.08

286

1549

Other disorders of bone

340

2016

1.71

18.99

1.4

313.00

275.22

ug/g

0.94

191

1122

Non-rheumatic valve diseases

793

4089

1.43

18.98

1.4

253.94

267.42

ug/g

1.12

482

2397

Social phobias

126

527

2.44

18.93

1.4

1.3

297.18

303.72

ug/g

0.12

267

Superficial injury of lower leg

402

2495

1.63

18.76

1.5

1.4

266.28

280.01

ug/g

0.67

225

1404

Other and unspecified local infections of skin and subcutaneous tissue

173

831

2.13

18.75

1.4

245.76

289.19

ug/g

1.90

103

466

Smoking dependency

162

761

2.19

18.64

1.4

277.66

286.17

ug/g

0.20

444

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

147

664

2.28

18.64

1.4

1.5

246.18

282.35

ug/g

1.34

405

TMD related operations

292

1670

1.78

18.63

1.4

312.39

285.88

ug/g

1.41

175

932

Osteoporosis with pathological fracture (FG)

145

653

2.30

18.62

1.6

1.4

253.64

269.43

ug/g

0.43

385

Other disorders of veins

664

4596

1.46

18.58

1.4

272.36

276.25

ug/g

0.20

401

2665

Abnormal involuntary movements

238

1283

1.89

18.50

1.5

1.4

279.49

275.23

ug/g

0.11

146

743

Other local infections of skin and subcutaneous tissue

181

889

2.08

18.48

1.4

252.46

285.30

ug/g

1.21

106

504

Erosion of teeth, including avohilmo

337

1937

1.71

18.47

1.5

1.4

282.27

279.84

ug/g

0.07

190

1067

Phlebitis and thrombophlebitis (not including DVT)

386

2383

1.64

18.47

1.4

264.73

275.09

ug/g

0.42

226

1393

Barrett oesophagus

359

2.77

18.39

1.7

1.4

294.86

272.63

ug/g

0.48

218

Cluster headache, strict, including avohilmo

104

405

2.66

18.38

1.5

1.4

297.94

300.61

ug/g

0.04

214

Other and unspecified nerve root and plexus disorders, also in other diseases

314

1841

1.73

18.32

1.5

1.4

277.54

277.41

ug/g

0.00

174

1037

Disorder of lipoprotein metabolism, unspecified

238

1288

1.89

18.27

1.5

1.4

250.36

267.26

ug/g

0.62

141

777

Hyperkinetic disorders

155

710

2.19

18.19

1.3

1.4

319.15

333.28

ug/g

0.30

346

Cluster headache, wide,, including avohilmo

109

437

2.58

18.14

1.5

1.4

297.94

302.05

ug/g

0.06

230

Cirrhosis of liver, NAS

109

438

2.59

18.13

1.4

1.5

267.01

274.21

ug/g

0.11

267

Benign neoplasm: Adrenal gland

138

616

2.31

18.06

1.6

1.4

233.58

297.05

ug/g

3.08

356

Ulcerative colitis (strict definition, all Crohn cases excluded)

243

1329

1.86

18.00

1.6

1.4

286.98

286.77

ug/g

0.00

142

750

Disorders of sclera, cornea, iris and ciliary body

891

6531

1.38

17.93

1.5

1.4

271.25

275.77

ug/g

0.18

546

3758

Use of pramipexole

388

2419

1.63

17.91

1.5

1.4

275.99

271.13

ug/g

0.18

235

1439

Complications of internal orthopaedic prosthetic devices, implants and grafts

382

2373

1.64

17.87

1.5

1.4

267.71

269.93

ug/g

0.08

237

1414

Umbilical hernia

423

2693

1.59

17.78

1.5

1.4

298.88

263.87

ug/g

1.15

246

1579

Artificial joint operation, meniscal resection

1576

8266

1.28

17.71

1.4

281.26

266.81

ug/g

1.43

957

4830

Psoriasis

480

3147

1.55

17.71

1.4

273.75

274.86

ug/g

0.04

282

1811

Other specified and unspecified personality disorders

159

757

2.15

17.63

1.4

339.03

292.58

ug/g

0.48

397

All influenza (not pneumonia)

249

1381

1.83

17.60

1.5

1.4

283.18

274.79

ug/g

0.24

136

818

Unspecified mental disorder

661

4619

1.44

17.60

1.4

288.96

277.63

ug/g

0.75

385

2606

Other and unspecified visual disturbances

180

900

2.05

17.57

1.4

278.06

281.43

ug/g

0.08

103

508

Inflammatory disease of uterus

232

1261

1.87

17.54

1.4

329.31

299.30

ug/g

1.21

112

667

Drug-induced adrenocortical insufficiency

163

3.76

17.50

1.7

1.4

273.33

305.27

ug/g

0.49

Other noninflammatory disorders of uterus, except cervix

375

1565

1.66

17.50

1.4

281.71

268.62

ug/g

0.64

223

903

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

561

3799

1.49

17.47

1.4

301.51

284.13

ug/g

1.13

299

2072

Explicit bacterial Sepsis

171

841

2.08

17.37

1.4

252.62

282.21

ug/g

0.92

499

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

347

2.75

17.36

1.4

263.63

289.47

ug/g

0.57

212

Hyperhidrosis

182

3.47

17.28

1.3

343.57

310.70

ug/g

0.52

Abnormalities of gait and mobility

210

1114

1.93

17.23

1.5

1.4

283.94

272.46

ug/g

0.39

146

667

Urolithiasis

525

3530

1.50

17.18

1.5

1.4

265.42

265.72

ug/g

0.01

296

2095

Injuries to the hip and thigh

753

4943

1.41

17.13

1.4

268.28

269.29

ug/g

0.05

451

2895

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

447

2906

1.56

17.12

1.4

275.86

278.02

ug/g

0.07

266

1634

Disorders of breast

814

5487

1.39

17.08

1.4

293.88

288.21

ug/g

0.34

467

3041

Striking against or struck by other objects

498

3313

1.52

17.07

1.5

1.4

270.62

278.64

ug/g

0.36

284

1883

Lichen planus

247

1384

1.82

17.05

1.4

269.39

277.80

ug/g

0.27

146

820

Fracture of lumbar spine and pelvis

354

2184

1.64

16.94

1.5

1.4

244.85

271.26

ug/g

1.58

197

1303

Covid-19 suspected case

332

2017

1.67

16.94

1.5

1.4

293.71

289.49

ug/g

0.14

190

1109

Follow-up examination after treatment for malignant neoplasms

162

789

2.09

16.90

1.5

1.4

272.58

264.33

ug/g

0.19

101

481

Ptosis of eyelid

199

1045

1.95

16.88

1.5

1.4

276.81

270.94

ug/g

0.16

129

631

Kela-code for severe mental illness

597

4129

1.46

16.87

1.4

291.32

277.15

ug/g

0.95

347

2334

Diabetic retinopathy

710

3169

1.44

16.85

1.6

1.5

212.18

247.81

ug/g

5.32

451

1877

Degeneration of macula and posterior pole

770

4576

1.40

16.85

1.5

1.4

263.75

264.33

ug/g

0.03

454

2760

Disorders of vestibular function (Vertigo)

788

5687

1.39

16.83

1.4

278.11

269.25

ug/g

0.56

437

3322

Hypopituitarism

128

570

2.31

16.82

1.5

1.4

299.03

292.14

ug/g

0.13

330

Other female pelvic inflammatory diseases

296

1751

1.72

16.81

1.4

300.87

284.93

ug/g

0.61

154

977

COPD related to multimorbidity

636

3737

1.45

16.77

1.5

1.4

254.95

257.74

ug/g

0.12

385

2265

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

177

895

2.03

16.76

1.4

256.01

281.18

ug/g

0.83

110

521

Oral lichen ruber planus wide, hypothyreosis or thyroxin

123

542

2.36

16.74

1.5

1.4

257.05

293.09

ug/g

1.27

299

Plantar fascial fibromatosis

168

833

2.06

16.74

1.5

1.4

288.59

279.18

ug/g

0.24

504

Abnormal serum enzyme levels

472

3082

1.53

16.70

1.4

1.5

256.58

256.29

ug/g

0.01

290

1892

Benign neoplasm: Ill-defined sites within the digestive system

6.58

16.69

1.3

281.00

315.38

ug/g

0.28

Conjunctivitis (acute, non atopic)

444

2891

1.55

16.65

1.4

291.22

277.91

ug/g

0.72

268

1611

Dermatophytosis

225

1237

1.86

16.50

1.6

1.4

254.86

272.55

ug/g

0.66

144

723

Unknown and unspecified causes of morbidity

119

519

2.34

16.37

1.5

1.4

284.07

282.86

ug/g

0.02

284

Other viral diseases, not elsewhere classified

297

1766

1.70

16.32

1.4

315.38

289.32

ug/g

1.34

181

966

Other enthesopathy of foot (+metatarsalgia)

170

855

2.03

16.28

1.4

264.78

280.04

ug/g

0.40

499

Other respiratory diseases principally affecting the interstitium

298

1782

1.70

16.27

1.4

283.35

265.06

ug/g

0.34

181

1089

Transient ischemic attack

874

5359

1.36

16.26

1.4

270.27

263.94

ug/g

0.28

543

3177

Cerebral palsy and other paralytic syndromes

198

1050

1.92

16.25

1.5

1.4

271.71

285.92

ug/g

0.47

128

593

Other disorders of the musculoskeletal system and connective tissue

257

1478

1.77

16.20

1.5

1.4

250.90

274.85

ug/g

1.28

170

859

Diseases of inner ear

908

6641

1.35

16.19

1.4

283.14

268.43

ug/g

1.28

505

3882

Cytomegaloviral disease

191

3.37

16.19

1.5

286.53

292.97

ug/g

0.08

113

Cholangitis (primary sclerosing, PSC), with reimbursement 202

147

3.75

16.17

1.6

1.4

209.80

317.01

ug/g

2.47

Adenocarcinoma of small intestine

11.30

16.17

1.6

1.5

126.36

282.00

ug/g

1.90

Other/unspecified cytomegaloviral diseases

162

3.62

16.12

1.5

1.4

285.48

307.89

ug/g

0.35

Rash and other nonspecific skin eruption

180

929

1.98

16.07

1.3

1.4

267.93

286.21

ug/g

0.56

106

523

Polyp of the female genital tract

489

1879

1.53

15.94

1.4

273.39

273.64

ug/g

0.01

272

1043

Primary biliary cholangitis (PBC)

168

3.51

15.89

1.3

1.5

303.12

308.32

ug/g

0.06

Other and unspecified disorders of skin and subcutaneous tissue

130

599

2.23

15.82

1.4

284.00

286.83

ug/g

0.06

349

Benign lipomatous neoplasm

453

3009

1.52

15.77

1.4

297.99

287.20

ug/g

0.50

269

1739

Hypertensive Heart Disease

363

1864

1.61

15.76

1.4

232.74

266.73

ug/g

2.68

224

1120

Primary_lymphoid and hematopoietic malignant neoplasms

361

2282

1.60

15.70

1.5

1.4

262.71

285.99

ug/g

1.48

228

1347

Other symptoms and signs involving the urinary system

174

895

1.99

15.68

1.4

264.25

276.07

ug/g

0.28

542

Cytomegalovirus infection, IBD co-morbidity

185

3.37

15.64

1.5

1.4

278.50

296.73

ug/g

0.28

110

Other predominantly sexually transmitted diseases, not elsewhere classified

260

1514

1.74

15.60

1.4

320.28

308.45

ug/g

0.42

161

785

Zoster [herpes zoster]

302

1833

1.68

15.59

1.5

1.4

273.19

270.39

ug/g

0.08

173

1086

Type1 diabetes, definitions combined, early onset

115

505

2.32

15.46

1.7

1.4

258.32

331.27

ug/g

3.84

253

Mouth breathing

663

4747

1.41

15.45

1.4

293.99

269.31

ug/g

2.06

378

2756

Other specified/unspecified soft tissue disorders

404

2.50

15.42

1.6

1.4

261.59

287.56

ug/g

0.52

228

Other and unspecified myopathies

151

744

2.08

15.40

1.4

1.5

252.27

276.61

ug/g

0.75

440

Open wound of lower leg

243

1396

1.77

15.37

1.4

247.89

275.83

ug/g

1.37

151

804

Colorectal cancer, excluding all cancers (controls excluding all cancers)

418

2654

1.54

15.32

1.4

252.14

281.10

ug/g

2.12

265

1571

Bacterial pneumoniae

646

4075

1.42

15.28

1.5

1.4

253.87

269.85

ug/g

1.19

404

2406

ILD, hospital admissions 3, with pneumonia sepsis

142

686

2.12

15.27

1.4

1.5

275.02

268.38

ug/g

0.14

424

Calculus of kidney and ureter

480

3251

1.49

15.23

1.5

1.4

261.96

265.92

ug/g

0.15

273

1935

Cystic kidney disease

285

2.82

15.20

1.3

1.4

295.04

300.69

ug/g

0.08

173

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

149

735

2.08

15.18

1.4

280.91

273.55

ug/g

0.17

435

Cachexia

8.36

15.17

1.6

1.2

281.32

321.34

ug/g

0.28

Persons with potential health hazards related to communicable diseases

549

3782

1.45

15.17

1.4

285.39

291.17

ug/g

0.25

332

2022

ILD, hospital admissions

250

1458

1.75

15.04

1.4

1.5

290.17

264.69

ug/g

0.43

156

875

Decubitus ulcer and pressure area

105

453

2.38

14.95

1.5

1.4

256.85

270.38

ug/g

0.30

271

Chronic periodontitis, complicated

175

919

1.95

14.92

1.5

1.4

234.51

270.55

ug/g

1.52

108

552

Traumatic subdural haemorrhage

192

1018

1.88

14.91

1.4

257.71

257.40

ug/g

0.01

121

619

Gluteal tendinitis

276

2.82

14.91

1.5

1.4

296.83

298.93

ug/g

0.03

154

Vulvovaginal ulceration/inflammation in other diseases

404

2.46

14.88

1.5

1.3

322.14

312.83

ug/g

0.16

206

663

4495

1.40

14.87

1.4

281.60

261.53

ug/g

1.88

401

2713

Supplementary factors related to causes of morbidity and mortality classified elsewhere

475

3228

1.49

14.81

1.5

1.4

287.54

273.57

ug/g

0.72

265

1846

Acute suppurative otitis media

362

2163

1.58

14.76

1.3

1.4

304.16

301.81

ug/g

0.07

196

1109

Fracture at wrist and hand level

524

3631

1.46

14.69

1.4

266.59

272.71

ug/g

0.29

327

2087

Correction of physiology of bite - demanding therapy visit

127

598

2.18

14.63

1.5

1.4

309.99

300.02

ug/g

0.21

313

Diseases of tongue

124

579

2.20

14.62

1.5

1.4

297.60

278.47

ug/g

0.45

328

Diplopia

219

1242

1.80

14.54

1.5

1.4

278.77

276.58

ug/g

0.06

129

705

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

117

534

2.24

14.52

1.6

1.4

244.65

302.23

ug/g

1.76

283

Speech and linguistic disorders, excluding more controls

103

418

2.36

14.42

1.4

325.05

330.97

ug/g

0.10

224

Interstitial lung disease endpoints

250

1477

1.72

14.37

1.4

1.5

290.17

264.93

ug/g

0.43

156

890

Interstitial lung disease

250

1477

1.72

14.37

1.4

1.5

290.17

264.93

ug/g

0.43

156

890

Ulcer of oesophagus

115

524

2.25

14.37

1.4

276.60

274.07

ug/g

0.04

316

Other embolism and thrombosis

220

1254

1.79

14.36

1.4

278.80

280.15

ug/g

0.01

130

745

Other interstitial pulmonary diseases

250

1478

1.72

14.34

1.4

290.17

264.46

ug/g

0.44

156

892

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

855

4374

1.35

14.29

1.4

271.49

281.68

ug/g

0.81

536

2544

Injury of muscle and tendon at shoulder and upper arm level

579

4113

1.42

14.28

1.5

1.4

281.55

263.11

ug/g

0.75

367

2444

Chronic ulcer of skin, not elsewhere classified

125

591

2.17

14.28

1.7

1.5

234.43

274.54

ug/g

1.68

346

SLE (Finngen)

283

2.75

14.23

1.4

334.76

314.38

ug/g

0.34

157

Streptococcal septicaemia

141

698

2.06

14.22

1.4

254.85

287.16

ug/g

0.88

416

Metatarsalgia

158

814

1.98

14.21

1.4

271.00

279.69

ug/g

0.19

478

Injuries to the elbow and forearm

1123

7938

1.29

14.18

1.4

262.78

280.04

ug/g

2.00

631

4551

Crohn's disease of large intestine

408

2.42

14.15

1.5

1.4

270.56

301.03

ug/g

0.68

228

Appendectomy

1035

7727

1.30

14.14

1.4

285.19

279.17

ug/g

0.40

587

4376

Delirium, not induced by alcohol and other psychoactive substances

179

962

1.89

14.11

1.4

237.57

266.51

ug/g

0.96

585

Late syphilis

104

4.12

14.09

1.8

1.5

221.48

271.28

ug/g

0.85

Disorders of muscles

160

830

1.96

14.08

1.5

1.4

287.89

273.59

ug/g

0.34

491

Need for other prophylactic measures

111

504

2.27

14.08

1.6

1.5

225.72

281.99

ug/g

2.07

294

Anogenital herpesviral [herpes simplex] infection

106

471

2.30

14.07

1.4

285.01

310.31

ug/g

0.52

237

Cramp and spasm

398

2.44

14.03

1.6

1.4

263.45

290.03

ug/g

0.61

226

Skin changes due to chronic exposure to nonionizing radiation

621

4233

1.40

14.01

1.4

279.77

260.29

ug/g

1.74

375

2573

Atrophic disorders of skin

254

1518

1.70

14.01

1.4

292.83

288.84

ug/g

0.11

150

858

Sicca syndrome [Sjögren]

174

933

1.91

13.98

1.4

307.12

292.76

ug/g

0.40

530

Benign neoplasm of other and unspecified endocrine glands

227

1318

1.76

13.94

1.5

1.4

239.85

275.58

ug/g

2.04

129

762

Other disorders of nervous system

127

611

2.14

13.91

1.7

1.4

259.81

281.15

ug/g

0.52

363

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

284

1748

1.65

13.89

1.4

243.54

284.21

ug/g

2.65

186

1044

Disorders of continuity of bone

168

892

1.92

13.85

1.4

263.51

290.62

ug/g

0.90

103

488

Familial hypercholesterolemia

258

1552

1.69

13.85

1.4

246.21

270.27

ug/g

1.07

150

944

Chronic hepatitis, not elsewhere classified

282

2.73

13.81

1.4

1.5

266.15

306.60

ug/g

0.87

165

Benign neoplasm: Ill-defined sites within the digestive system

5.45

13.78

1.3

1.4

281.00

288.97

ug/g

0.06

COPD, early/later onset

729

4549

1.36

13.78

1.5

1.4

258.67

259.84

ug/g

0.05

443

2733

Stomatitis and related lesions

144

727

2.02

13.75

1.3

1.4

273.96

282.74

ug/g

0.19

404

TMD related pain

277

2.73

13.72

1.5

1.4

343.01

318.80

ug/g

0.38

148

Fitting and adjustment of other devices

529

3458

1.44

13.71

1.5

1.4

274.26

269.24

ug/g

0.23

319

2048

Selective deficiency of immunoglobulin G [IgG] subclasses

5.34

13.70

1.9

1.5

297.59

274.13

ug/g

0.24

Corns and callosities

130

635

2.10

13.66

1.5

1.4

252.47

284.33

ug/g

1.14

368

Sacrococcygeal disorders, not elsewhere classified

227

2.92

13.65

1.3

325.81

305.86

ug/g

0.32

128

Actinic keratosis

600

4104

1.40

13.57

1.4

280.02

260.77

ug/g

1.65

359

2502

Eosinophilic disease (BM)

4.19

13.56

1.6

1.3

274.30

308.97

ug/g

0.37

Unspecified misadventure during surgical and medical care

106

480

2.28

13.56

1.4

1.5

217.96

283.15

ug/g

2.77

282

Other otitis externa (chronic)

121

577

2.15

13.55

1.6

1.4

298.11

283.94

ug/g

0.28

326

Preparation and fitting of bite rail to mouth

228

1335

1.74

13.55

1.4

315.57

289.35

ug/g

1.17

140

740

Ethmoidectomy

217

1254

1.76

13.53

1.4

299.06

280.10

ug/g

0.63

115

719

Nephrotic syndrome

268

2.76

13.52

1.5

1.4

258.24

293.70

ug/g

0.90

162

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

448

3067

1.48

13.51

1.4

284.87

272.56

ug/g

0.56

258

1763

Other follicular disorders

122

584

2.14

13.49

1.5

1.4

294.50

297.02

ug/g

0.04

323

Viral pneumonia

202

1145

1.79

13.45

1.4

271.95

276.88

ug/g

0.11

109

661

COPD, hospital admissions

720

4514

1.36

13.44

1.5

1.4

258.83

259.96

ug/g

0.05

439

2711

Systemic sclerosis (FG)

208

3.02

13.43

1.5

1.4

292.61

299.64

ug/g

0.09

117

Agoraphobia

202

3.01

13.38

1.7

1.4

289.21

309.17

ug/g

0.24

108

Disorders of refraction and accommodation

399

2667

1.51

13.31

1.4

282.08

283.86

ug/g

0.06

218

1479

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

753

3852

1.36

13.30

1.4

268.27

282.96

ug/g

1.27

466

2263

Diagnoses used for exclusion with ILD

404

2720

1.50

13.29

1.4

254.61

269.03

ug/g

0.74

239

1621

Algoneurodystrophy

282

2.69

13.27

1.5

300.74

301.06

ug/g

0.00

156

Emotional disorders starting during childhood or adolecense, excluding more controls

187

3.04

13.26

1.4

264.20

357.74

ug/g

1.82

Deficiency of other B group vitamins

162

3.30

13.24

1.4

1.5

315.16

272.03

ug/g

0.63

Drug-induced cataract

210

3.00

13.23

1.5

1.4

257.75

295.82

ug/g

0.71

124

Thyroiditis, ILD-related definition

195

1100

1.80

13.23

1.4

292.37

289.07

ug/g

0.08

117

609

Abrasion of teeth

461

2324

1.47

13.22

1.5

1.4

287.95

271.80

ug/g

0.92

281

1306

Open wound of ankle and foot

163

870

1.91

13.22

1.4

265.72

276.49

ug/g

0.25

493

Amputation of foot

194

3.08

13.18

1.4

1.5

225.91

261.02

ug/g

0.66

113

Superficial injury of wrist and hand

293

1844

1.61

13.09

1.4

297.33

282.71

ug/g

0.48

155

1027

Disorders of phosphorus metabolism and phosphatases

7.44

13.06

1.6

1.3

251.32

293.72

ug/g

0.32

Superficial injury of thorax

236

1409

1.70

13.06

1.4

267.82

277.18

ug/g

0.27

139

827

Other and unspecified immunodeficiencies with predominantly antibody defects

115

3.83

13.03

1.6

1.4

363.38

319.09

ug/g

0.64

Benign neoplasm of mouth and pharynx

174

953

1.86

13.02

1.6

1.4

298.56

295.43

ug/g

0.03

108

562

Schizophrenia or delusion, excluding more controls

398

2658

1.50

13.01

1.4

281.84

278.85

ug/g

0.10

232

1542

Psoriatic and enteropathic arthropathies

193

1093

1.80

12.92

1.5

1.4

277.02

270.98

ug/g

0.16

116

632

Superficial injury of ankle and foot

179

992

1.83

12.86

1.5

1.4

293.03

294.10

ug/g

0.02

532

Allergic rhinitis

455

3123

1.46

12.84

1.4

306.61

289.75

ug/g

0.90

232

1704

Thrombocytopenia, unspecified

127

630

2.07

12.83

1.4

260.22

280.98

ug/g

0.48

370

Primary gonarthrosis, bilateral

835

5577

1.32

12.78

1.5

1.4

275.87

261.86

ug/g

1.26

519

3309

In situ neoplasms

521

3533

1.42

12.73

1.3

1.4

288.74

288.16

ug/g

0.02

294

2008

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

735

3785

1.35

12.67

1.4

266.59

282.70

ug/g

1.46

456

2224

Atopic dermatitis, strict definition with reimbursement

418

2770

1.48

12.64

1.4

306.24

296.30

ug/g

0.41

221

1483

Hypertrophic disorders of skin

103

474

2.23

12.64

1.5

1.4

294.09

306.68

ug/g

0.23

246

Varicose veins

1036

6138

1.28

12.63

1.4

270.97

271.28

ug/g

0.02

649

3596

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

139

717

1.98

12.57

1.5

1.4

251.35

291.56

ug/g

1.53

412

Congenital lactase deficiency

11.59

12.55

1.7

1.5

388.25

386.88

ug/g

—

Acute pharyngitis

202

1159

1.75

12.54

1.3

1.4

268.68

288.48

ug/g

0.60

110

642

Cerebrovascular diseases

1215

6959

1.26

12.50

1.5

1.4

256.82

266.19

ug/g

0.87

746

4084

Speech therapy

442

3068

1.46

12.49

1.4

275.63

274.27

ug/g

0.05

295

1777

Erosion of teeth

113

3.72

12.48

1.6

1.3

240.94

304.17

ug/g

0.97

Opening and dilatation of root channel of tooth

113

543

2.13

12.43

1.4

268.12

296.71

ug/g

0.61

298

Fracture of lower leg, including ankle

875

6733

1.30

12.42

1.5

1.4

259.85

275.49

ug/g

1.50

497

3904

Diseases of middle ear and mastoid

853

5361

1.31

12.40

1.4

290.02

285.20

ug/g

0.26

464

2988

Fall on and from stairs and steps

402

2747

1.48

12.33

1.4

267.31

270.69

ug/g

0.12

234

1595

FESS (DNB20)

206

1207

1.74

12.28

1.4

301.07

281.38

ug/g

0.63

109

685

Systemic sclerosis, icd10

219

2.87

12.27

1.5

1.4

292.61

304.23

ug/g

0.16

122

Common variable immunodeficiency

5.51

12.27

1.4

1.3

399.45

325.23

ug/g

1.15

Other inflammation of eyelid

212

1253

1.72

12.24

1.5

1.4

281.27

279.87

ug/g

0.03

129

736

6-mercaptopurine

213

2.86

12.21

1.7

1.4

252.76

307.42

ug/g

0.99

113

Other bursitis of hip

155

3.24

12.16

1.5

1.4

305.35

307.54

ug/g

0.02

Fracture of femur

401

2501

1.48

12.15

1.5

1.4

255.11

265.15

ug/g

0.46

231

1518

Congenital malformations of the urinary system

106

502

2.17

12.13

1.3

1.4

294.25

303.92

ug/g

0.18

286

Other benign neoplasms of skin

599

4402

1.37

12.12

1.5

1.4

263.06

273.94

ug/g

0.67

339

2585

Thyrotoxicosis, other and/or unspecified

311

2023

1.56

12.11

1.4

283.61

284.27

ug/g

0.02

195

1140

Endometriosis of ovary

241

1471

1.65

12.10

1.5

1.3

297.39

275.44

ug/g

0.79

116

800

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

758

3925

1.33

12.10

1.4

264.79

281.92

ug/g

1.59

467

2301

Benign neoplasm: Adrenal gland

138

721

1.96

12.08

1.6

1.4

233.58

283.22

ug/g

2.11

430

Pollen allergy

261

1612

1.62

12.08

1.4

313.42

312.87

ug/g

0.01

118

830

Systemic sclerosis

221

2.84

12.06

1.5

1.4

292.61

306.93

ug/g

0.21

122

Oesophageal obstruction

249

2.69

12.02

1.5

1.4

255.40

278.26

ug/g

0.46

148

Psoriasis vulgaris

298

1925

1.57

11.99

1.4

275.73

276.45

ug/g

0.02

171

1129

TMD muscular pain linked with fibromyalgia

4.15

11.97

1.6

1.3

392.65

323.63

ug/g

0.68

Benign neoplasm: Anus and anal canal

199

2.92

11.97

1.5

1.4

308.38

313.31

ug/g

0.06

121

Short stature, not elsewhere classified

145

3.22

11.95

1.4

1.3

380.47

386.94

ug/g

0.07

Other menopausal disorders

418

1640

1.48

11.93

1.4

294.95

272.24

ug/g

1.38

236

927

Bacterial pneumonia (organism specified)

683

4665

1.34

11.91

1.5

1.4

253.57

267.86

ug/g

1.05

423

2714

Other diseases of peritoneum

429

2.26

11.87

1.5

1.4

262.21

293.53

ug/g

0.81

246

CR(E)ST syndrome

143

3.34

11.80

1.5

1.3

277.61

313.86

ug/g

0.51

Glaucoma

898

6143

1.29

11.80

1.5

1.4

259.91

266.66

ug/g

0.47

553

3641

Intussusception

132

3.39

11.79

1.6

1.3

266.02

307.44

ug/g

0.59

Other maltreatment syndromes

229

2.75

11.74

1.3

1.4

304.30

314.99

ug/g

0.11

129

Protein-energy malnutrition of moderate and mild degree

4.75

11.73

1.4

282.46

289.62

ug/g

0.05

Other and unspecified injuries of head

109

529

2.11

11.72

1.3

1.5

261.80

288.46

ug/g

0.58

293

Colitis, primary sclerosing

3.84

11.72

1.6

1.4

199.98

313.20

ug/g

2.33

Disorder of the sleep-wake schedule

133

3.39

11.70

1.4

1.5

277.46

276.06

ug/g

0.01

Other pleural conditions

163

906

1.83

11.70

1.3

1.4

249.84

274.92

ug/g

0.85

102

540

Childhood asthma (age<16), excluding more controls

146

612

1.91

11.65

1.3

350.70

324.53

ug/g

0.65

300

Bacterial pneumonia, not elsewhere classified

592

3857

1.37

11.64

1.5

1.4

249.45

270.70

ug/g

1.77

378

2292

Pure hyperglyceridaemia

159

3.14

11.64

1.5

275.34

267.92

ug/g

0.09

Complications following infusion, transfusion and therapeutic injection

114

3.61

11.61

1.5

1.3

232.74

306.11

ug/g

1.16

Congenital malformations and deformations of the musculoskeletal system

140

739

1.92

11.61

1.4

322.73

314.95

ug/g

0.15

390

Drug-induced hypoglycaemia without coma

109

3.66

11.60

1.9

1.3

197.44

312.48

ug/g

2.05

Oligomenorrhoea

219

2.76

11.56

1.5

1.3

332.61

293.46

ug/g

0.73

102

Benign paroxysmal vertigo

463

3290

1.42

11.55

1.4

283.65

273.40

ug/g

0.50

252

1937

Dysplasia of cervi uteri

313

1582

1.54

11.44

1.3

330.72

281.01

ug/g

3.55

175

825

Vitamin D deficiency

135

3.34

11.43

1.7

1.5

229.77

292.87

ug/g

0.89

Other infectious diseases

135

713

1.93

11.42

1.3

1.4

271.26

284.53

ug/g

0.30

423

Childhood asthma (age<16)

146

617

1.89

11.40

1.3

350.70

324.16

ug/g

0.66

303

Type of accident

424

2977

1.44

11.28

1.5

1.4

288.14

273.98

ug/g

0.68

244

1716

Benign neoplasm: Skin of eyelid, including canthus

236

1467

1.63

11.24

1.5

1.4

244.95

296.12

ug/g

3.59

139

861

Maltreatment syndromes

386

2.28

11.24

1.6

1.4

248.48

310.12

ug/g

1.63

201

Early lumbar disc prolapse, operated

135

715

1.91

11.24

1.4

285.78

294.46

ug/g

0.16

394

Enteropathic arthropathies

168

3.03

11.19

1.7

1.4

285.39

297.43

ug/g

0.16

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

171

977

1.78

11.18

1.4

242.32

282.74

ug/g

1.93

109

588

Other hammer toe(s) (acquired)

285

1735

1.56

11.15

1.5

1.4

284.57

260.21

ug/g

1.25

176

1042

Other disorders of white blood cells

101

486

2.13

11.15

1.5

280.48

281.51

ug/g

0.02

292

ILD, hospital admissions 1, main diag only

214

1302

1.67

11.15

1.4

1.5

296.35

264.13

ug/g

0.48

129

785

Open wound of wrist and hand

631

4687

1.34

11.13

1.4

273.08

272.93

ug/g

0.01

350

2676

Diseases of spleen

134

3.29

10.91

1.5

1.4

285.83

282.83

ug/g

0.03

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

247

1511

1.60

10.90

1.4

289.94

293.30

ug/g

0.09

142

844

Spondyloarthritis

270

1743

1.57

10.90

1.4

253.54

276.23

ug/g

0.96

149

1025

Congenital malformations of the musculoskeletal system, not elsewhere classified

114

3.51

10.89

1.5

1.4

331.53

316.10

ug/g

0.14

Lichen simplex chronicus and prurigo

112

565

2.03

10.87

1.4

271.08

288.34

ug/g

0.39

325

Other/unspecified enthesopathies, not elsewhere classified

137

739

1.89

10.84

1.3

1.4

301.32

270.59

ug/g

0.95

445

Encephalopathy

4.40

10.84

1.4

320.00

287.16

ug/g

0.34

Tinnitus

375

2597

1.46

10.81

1.4

282.23

272.76

ug/g

0.38

208

1517

Suppurative and unspecified otitis media

492

3155

1.39

10.80

1.4

293.93

289.31

ug/g

0.18

269

1715

Nonsuppurative otitis media

307

1757

1.52

10.77

1.4

322.27

301.17

ug/g

0.95

163

901

Systemic lupus erythematosus

325

2.38

10.75

1.4

334.76

300.88

ug/g

0.67

187

Sequelae of injuries of lower limb

153

858

1.81

10.70

1.5

1.4

243.37

289.21

ug/g

1.93

486

Other necrotizing vasculopathies (FG)

105

521

2.06

10.68

1.5

287.95

264.23

ug/g

0.55

309

Dental caries 2 and operation codes

1168

7531

1.24

10.68

1.4

298.57

281.67

ug/g

1.22

656

4241

Other viral hepatitis

103

507

2.07

10.67

1.4

249.47

302.22

ug/g

1.96

278

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

154

866

1.81

10.67

1.4

246.44

283.95

ug/g

1.49

526

Benign neoplasm of urinary organs

326

2.36

10.62

1.5

236.76

302.70

ug/g

1.66

191

Medical abortion

1027

4441

1.26

10.61

1.4

1.3

295.33

287.65

ug/g

0.52

564

2467

Seronegative rheumatoid arthritis

196

1181

1.69

10.60

1.3

1.4

273.24

273.52

ug/g

0.01

109

685

Mixed connective tissue disease

119

619

1.97

10.60

1.4

312.52

296.20

ug/g

0.39

340

Other necrotizing vasculopathies

125

661

1.93

10.60

1.5

289.20

277.54

ug/g

0.25

380

COPD-related respiratory insufficiency

180

1061

1.72

10.58

1.5

1.4

284.43

262.08

ug/g

0.77

117

644

Ehlers-Danlos syndrome

3.99

10.55

1.6

1.4

321.14

320.20

ug/g

0.01

Follow-up care involving plastic surgery

322

2.37

10.49

1.4

299.97

315.11

ug/g

0.23

177

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

112

572

2.00

10.49

1.5

1.4

346.47

300.96

ug/g

0.38

298

Dental caries 2

1194

7648

1.23

10.47

1.4

298.69

281.57

ug/g

1.27

669

4326

Scoliosis

124

656

1.92

10.42

1.5

1.3

285.75

290.75

ug/g

0.09

356

Other disorders involving the immune mechanism, not elsewhere classified

262

2.53

10.42

1.5

273.32

286.38

ug/g

0.21

157

Reactive arthropathies

136

742

1.86

10.40

1.4

256.68

259.91

ug/g

0.06

447

Hallux rigidus

222

1388

1.62

10.37

1.4

288.69

257.87

ug/g

1.47

124

841

Chronic viral hepatitis

426

2.16

10.37

1.4

253.61

306.14

ug/g

1.66

229

Injury of eye and orbit

208

1279

1.65

10.36

1.5

1.4

263.45

271.01

ug/g

0.21

122

723

Benign neoplasm: Rectosigmoid junction

299

2.41

10.36

1.3

1.4

321.32

298.11

ug/g

0.39

176

Visual impairment including blindness (binocular or monocular)

112

576

1.99

10.30

1.5

1.4

285.93

288.54

ug/g

0.04

328

Degeneration of the brain due to alcohol

188

2.83

10.29

1.7

1.5

270.37

252.19

ug/g

0.19

109

Colitis due to radiation

4.45

10.28

1.7

1.4

297.15

288.09

ug/g

0.07

Other disorders starting during childhood or adolecense, excluding more controls

212

2.63

10.27

1.2

1.3

375.57

371.57

ug/g

0.04

103

Seborrhoeic dermatitis

148

833

1.81

10.25

1.6

1.4

261.41

278.56

ug/g

0.45

468

Epilepsy

439

3146

1.40

10.24

1.4

256.61

274.74

ug/g

1.09

262

1821

Keratitis

533

3954

1.36

10.23

1.5

1.4

281.05

276.65

ug/g

0.11

308

2261

Redundant prepuce, phimosis and paraphimosis

263

1705

1.55

10.22

1.5

255.87

260.63

ug/g

0.13

153

1026

Folate deficiency anaemia

4.34

10.21

1.3

1.6

195.07

258.95

ug/g

0.77

Acne

127

682

1.88

10.15

1.4

1.3

266.38

322.77

ug/g

1.76

332

Bronchiectasis

141

786

1.83

10.14

1.3

1.4

294.97

272.09

ug/g

0.71

460

Hypertensive Renal Disease

253

2.52

10.12

1.4

270.54

280.54

ug/g

0.16

158

Extreme obesity with alveolar hypoventilation

360

2.26

10.08

1.6

1.5

277.35

285.17

ug/g

0.12

219

Viral warts

156

896

1.77

10.08

1.5

1.4

274.74

293.59

ug/g

0.60

482

Impotence

392

2.19

10.05

1.6

240.99

243.38

ug/g

0.04

252

Postprocedural disorders of nervous system

111

574

1.97

10.02

1.5

1.3

333.96

308.00

ug/g

0.52

286

Allergic urticaria

132

724

1.86

9.97

1.3

1.4

311.61

291.45

ug/g

0.53

388

Tongue abnormality

112

584

1.97

9.95

1.5

1.4

307.51

286.48

ug/g

0.50

337

COPD, hospital admission 2, with asthma infections

477

2972

1.38

9.93

1.4

265.09

259.01

ug/g

0.26

289

1802

Oral leukoplakia and related diseases, including avohilmo

153

880

1.77

9.90

1.4

265.81

274.92

ug/g

0.24

519

Degeneration of nervous system due to alcohol

192

2.77

9.90

1.7

1.5

270.37

254.39

ug/g

0.17

111

SLE, strict definition

312

2.35

9.89

1.4

341.48

294.19

ug/g

1.12

182

SLE, ICD10

312

2.35

9.89

1.4

341.48

294.19

ug/g

1.12

182

Other strabismus

324

2214

1.47

9.89

1.5

1.4

285.22

287.99

ug/g

0.08

168

1237

Degenerative macular diseases

196

1204

1.65

9.89

1.4

256.79

272.69

ug/g

0.54

122

730

Flat foot [pes planus] (acquired)

149

850

1.78

9.87

1.4

289.27

270.97

ug/g

0.48

491

Unspecified protein-energy malnutrition

5.78

9.87

1.4

221.75

290.95

ug/g

0.72

Other disorders of conjunctiva

224

1422

1.60

9.86

1.5

1.4

260.69

273.39

ug/g

0.41

131

853

Emotional disorders and disorders of social functioning with onset specific to childhood

282

2.38

9.84

1.4

304.44

344.33

ug/g

0.52

133

Orchitis and epididymitis

125

676

1.88

9.84

1.5

245.99

249.71

ug/g

0.07

420

Other specified/unspecified systemic involvement of connective tissue

109

566

1.97

9.80

1.3

1.4

315.59

300.68

ug/g

0.32

309

Other degenerative diseases of the nervous system

370

1959

1.44

9.80

1.4

269.48

260.48

ug/g

0.34

188

1175

Leisure time condition

265

1748

1.53

9.79

1.5

1.4

297.62

280.37

ug/g

0.63

159

991

Memory loss

153

883

1.77

9.78

1.4

262.95

271.26

ug/g

0.18

532

Parodontitis, under 40 years

113

592

1.93

9.77

1.6

1.3

300.20

322.21

ug/g

0.52

278

Spinal instabilities

210

2.65

9.76

1.5

1.4

234.39

280.04

ug/g

1.06

115

Dermatographic urticaria

108

559

1.97

9.76

1.3

1.4

335.62

298.78

ug/g

0.96

300

Trigeminal neuralgia

102

518

2.01

9.76

1.3

1.4

276.99

294.57

ug/g

0.31

285

Superficial injury of shoulder and upper arm

166

979

1.72

9.76

1.4

275.26

285.21

ug/g

0.26

100

542

Female infertility

391

1693

1.44

9.76

1.4

1.3

313.94

280.29

ug/g

2.09

198

881

Car occupant injured in other and unspecified transport accidents

272

1805

1.52

9.75

1.5

1.4

288.97

286.56

ug/g

0.06

148

992

Parodontitis, under 40 years, or operation codes

113

593

1.93

9.73

1.6

1.3

300.20

322.21

ug/g

0.52

278

Hypertrophic scar

444

2.10

9.72

1.5

1.4

304.17

302.92

ug/g

0.02

232

Lung diseases due to external agents

200

1239

1.64

9.71

1.4

228.88

270.68

ug/g

2.47

122

741

Lesion of radial nerve

308

2.34

9.71

1.7

1.5

242.31

283.51

ug/g

0.82

167

Appendicitis, broad definition

1152

8646

1.22

9.67

1.4

285.05

276.64

ug/g

0.70

672

4918

Coxarthrosis, primary

941

6565

1.25

9.64

1.4

266.96

262.68

ug/g

0.26

557

3921

Hydronephrosis

171

1021

1.70

9.62

1.5

1.4

242.56

276.65

ug/g

1.20

107

589

Acute appendicitis, no complications

836

6623

1.27

9.62

1.4

285.42

278.24

ug/g

0.46

486

3725

Panniculitis affecting regions of neck and back

284

2.38

9.60

1.5

1.4

228.56

290.90

ug/g

1.52

161

Anosmia

3.48

9.60

1.6

1.4

293.62

306.78

ug/g

0.13

Anankastic personality disorder

297

2.35

9.58

1.3

1.4

306.51

305.92

ug/g

0.01

161

Diseases of appendix

1161

8700

1.22

9.57

1.4

283.69

276.58

ug/g

0.56

677

4956

Cerebral cysts

440

2.09

9.56

1.4

319.38

298.64

ug/g

0.37

236

Sequelae of injuries of neck and trunk

243

2.51

9.51

1.6

1.4

246.54

287.72

ug/g

0.76

143

Hemiplegia

442

2.08

9.46

1.5

282.32

288.21

ug/g

0.10

256

Lack of expected normal physiological development

3.45

9.45

1.3

339.32

396.73

ug/g

0.68

429

2756

1.39

9.43

1.5

1.4

252.94

262.22

ug/g

0.44

254

1677

Other specified/unspecified inflammatory spondylopathies

337

2.24

9.41

1.5

1.4

277.81

300.16

ug/g

0.37

190

Parodontitis, under 40 years and operation codes

108

565

1.94

9.40

1.6

1.3

298.76

324.86

ug/g

0.64

263

Parodontitis, operation under 40 years and operation codes

108

565

1.93

9.40

1.6

1.3

298.76

324.86

ug/g

0.64

263

AV-block

251

1495

1.54

9.39

1.5

1.4

230.51

261.99

ug/g

1.94

144

900

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

213

1352

1.60

9.38

1.4

256.11

292.88

ug/g

1.83

127

795

Acute bronchiolitis

359

2.14

9.38

1.5

1.3

344.25

338.22

ug/g

0.09

166

Salpingitis and oophoritis

290

1970

1.49

9.34

1.4

290.87

285.59

ug/g

0.16

169

1097

Viral hepatitis

116

625

1.89

9.30

1.4

252.28

299.47

ug/g

1.88

343

Effects of foreign body entering through natural orifice

354

2497

1.43

9.29

1.5

1.4

273.29

274.47

ug/g

0.04

201

1428

Benign neoplasm: Liver/bile ducts

175

2.78

9.29

1.5

1.4

303.56

309.65

ug/g

0.06

Other infective otitis externa

102

528

1.97

9.26

1.5

1.4

279.34

284.15

ug/g

0.08

305

Inguinal hernia

873

4692

1.26

9.26

1.5

1.4

268.77

263.33

ug/g

0.21

519

2764

308

2003

1.47

9.26

1.4

253.37

265.15

ug/g

0.49

188

1217

Disorders of psychological development

148

792

1.75

9.25

1.4

334.68

321.95

ug/g

0.32

401

Major coronary heart disease event excluding revascularizations

1061

5971

1.23

9.25

1.4

255.69

263.08

ug/g

0.57

650

3559

Disorders of plasma-protein metabolism, not elsewhere classified

5.09

9.24

1.2

1.4

293.50

283.69

ug/g

—

Pacemaker

481

3473

1.36

9.19

1.5

1.4

250.97

262.23

ug/g

0.64

291

2124

Other and unspecified rosacea

141

812

1.77

9.11

1.4

317.28

294.46

ug/g

0.59

454

Methotrexate

229

1489

1.56

9.09

1.4

289.80

277.37

ug/g

0.38

126

854

Agranulocytosis

180

1108

1.65

9.06

1.3

1.4

259.39

279.31

ug/g

0.68

119

631

Tonsillectomy and adenotomy

793

4368

1.27

9.05

1.4

315.15

293.56

ug/g

1.67

384

2413

Presence of other devices

328

2292

1.44

9.05

1.5

1.4

272.88

269.37

ug/g

0.11

206

1366

Ganglion

287

1956

1.48

9.05

1.4

303.66

272.89

ug/g

1.36

161

1132

Chondrocostal junction syndrome [Tietze]

331

2.24

9.04

1.5

1.4

286.12

299.17

ug/g

0.19

192

Haemangioma, any site

125

696

1.83

9.04

1.5

1.4

305.04

313.40

ug/g

0.19

392

Bruxism

161

2.85

9.03

1.2

1.4

370.97

304.50

ug/g

1.06

Strabismus

393

2832

1.40

9.03

1.5

1.4

281.69

283.28

ug/g

0.05

212

1602

Scar conditions and fibrosis of skin

344

2.21

9.02

1.4

301.64

302.40

ug/g

0.01

185

Heart failure and bmi 25plus

524

2708

1.35

8.99

1.4

264.57

256.69

ug/g

0.23

339

1593

Sulfasalazine

424

3102

1.38

8.97

1.5

1.4

265.75

270.38

ug/g

0.18

253

1789

Spondylopathies (FG)

202

1280

1.60

8.97

1.4

263.50

273.79

ug/g

0.28

112

740

Myocardial infarction, without ST-elevation

590

4177

1.31

8.94

1.4

250.44

257.76

ug/g

0.38

362

2535

Carcinoma in situ of skin of other and unspecified parts of face

111

598

1.89

8.94

1.4

279.56

283.78

ug/g

0.08

370

Postmenopausal osteoporosis with pathological fracture

114

622

1.88

8.90

1.5

1.4

251.30

282.60

ug/g

0.81

356

Dystonia

508

1.97

8.90

1.3

1.4

320.46

294.06

ug/g

0.64

282

Hypertrophy of breast in women and men

300

2071

1.46

8.90

1.4

286.80

285.41

ug/g

0.04

156

1123

Benign neoplasm: Liver

151

2.88

8.88

1.5

1.4

290.23

317.52

ug/g

0.32

Benign neoplasm: Other and unspecified parts of mouth

251

2.42

8.86

1.6

1.4

265.95

314.08

ug/g

0.98

149

Open wound of forearm

135

774

1.77

8.84

1.5

254.72

286.53

ug/g

1.00

442

Other disorders of gingiva or/and edentulous alveolar ridge

427

2.06

8.81

1.5

1.4

257.83

277.77

ug/g

0.32

247

Ulcerative enterocolitis

258

2.39

8.81

1.5

1.4

240.85

314.33

ug/g

2.17

148

Haemangioma and lymphangioma, any site

134

768

1.77

8.80

1.5

1.4

305.75

313.37

ug/g

0.18

430

Post-traumatic wound infection, not elsewhere classified

198

2.61

8.78

1.4

1.5

288.13

285.64

ug/g

0.03

118

Otitis externa, unspecified

163

986

1.68

8.77

1.4

306.69

290.58

ug/g

0.40

547

Atopic dermatitis, strict definition

398

2834

1.39

8.76

1.4

311.59

298.11

ug/g

0.59

211

1506

Heterophoria

124

696

1.81

8.74

1.4

293.18

300.32

ug/g

0.12

369

Emphysema

106

567

1.90

8.73

1.5

1.4

231.96

264.93

ug/g

0.84

336

Alcohol induced polyneuropathy

3.63

8.70

1.7

1.6

298.39

271.06

ug/g

0.27

Syphilis

223

2.51

8.70

1.8

1.5

214.62

284.77

ug/g

1.80

129

Necrobiosis lipoidica, not elsewhere classified

4.51

8.69

2.0

1.4

265.00

313.11

ug/g

0.48

Non-ischemic cardiomyopathy

461

2811

1.36

8.66

1.4

266.14

262.63

ug/g

0.08

283

1689

Carcinoma in situ of skin

117

648

1.84

8.65

1.3

1.4

296.82

283.02

ug/g

0.32

410

Medial epicondylitis

298

2.27

8.64

1.3

1.4

299.93

287.18

ug/g

0.15

176

Acute appendicitis

1071

8338

1.22

8.63

1.4

286.66

276.74

ug/g

0.85

627

4734

Oral leukoplakia and related diseases

521

1.95

8.62

1.5

1.4

273.57

280.53

ug/g

0.15

304

Pneumonitis due to solids and liquids

117

648

1.84

8.62

1.4

1.5

229.00

273.83

ug/g

1.69

396

Idiopathic gout

138

803

1.75

8.62

1.4

1.5

249.43

257.54

ug/g

0.20

490

Primary_lymphoid and hematopoietic malignant neoplasms

361

2593

1.41

8.61

1.5

1.4

262.71

270.77

ug/g

0.34

228

1555

Gonarthrosis, primary, with knee surgery

884

5837

1.24

8.60

1.4

280.90

260.66

ug/g

1.35

546

3483

Benign neoplasm: Skin of trunk

318

2.22

8.59

1.3

1.4

312.39

309.00

ug/g

0.05

179

Dislocation, sprain and strain of joints and ligaments of knee

900

6779

1.24

8.59

1.4

279.08

280.77

ug/g

0.08

516

3814

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

249

2.41

8.58

1.5

266.69

284.54

ug/g

0.29

150

Other disorders of Eustachian tube

249

2.41

8.58

1.5

1.4

292.44

293.46

ug/g

0.01

144

Chondropathies

231

1525

1.53

8.58

1.4

337.83

282.41

ug/g

1.00

128

850

Other diseases of the respiratory system

291

2012

1.46

8.57

1.5

1.4

269.96

267.20

ug/g

0.08

181

1209

Other respiratory disorders and diseases

291

2012

1.46

8.57

1.5

1.4

269.96

267.20

ug/g

0.08

181

1209

Other skin changes

257

1737

1.50

8.54

1.5

1.4

272.62

270.52

ug/g

0.06

140

1046

Glucosamine medication

813

5201

1.26

8.54

1.5

1.4

269.83

265.40

ug/g

0.27

504

3078

Somnolence, stupor and coma

345

2.16

8.53

1.5

223.74

277.42

ug/g

1.47

206

Nail disorders

132

761

1.76

8.52

1.6

1.4

261.84

295.15

ug/g

1.24

430

Cardiac murmurs and other cardiac sounds

125

700

1.79

8.49

1.4

275.20

283.36

ug/g

0.17

368

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

189

1196

1.60

8.49

1.5

1.4

264.58

288.01

ug/g

0.96

118

710

Assault by unspecified means

138

2.92

8.49

1.5

1.6

257.30

297.82

ug/g

0.43

Filling of root of tooth

263

2.35

8.47

1.4

1.5

220.20

288.16

ug/g

1.76

155

Procreative management

456

2863

1.35

8.46

1.4

283.41

285.37

ug/g

0.07

254

1615

Infective dermatitis

173

1073

1.63

8.45

1.4

277.33

277.85

ug/g

0.01

102

609

Granulomatous disorders of skin and subcutaneous tissue

214

2.51

8.44

1.5

1.4

291.23

310.26

ug/g

0.33

114

Ulcerative rectosigmoiditis

118

660

1.82

8.42

1.6

1.4

303.37

297.78

ug/g

0.11

365

Iron deficiency

150

2.83

8.40

1.3

1.4

398.45

334.18

ug/g

1.05

Disease of hard tissues of teeth, NOS

3.69

8.40

1.4

332.19

309.70

ug/g

0.19

Herpesviral [herpes simplex] infections

177

1106

1.62

8.40

1.5

1.4

260.98

289.30

ug/g

1.07

105

611

Hypoparathyroidism

335

2.19

8.40

1.8

1.4

258.19

297.40

ug/g

1.06

196

Problems related to social environment

202

2.54

8.40

1.4

263.59

298.31

ug/g

0.56

109

Endometriosis of rectovaginal septum and vagina

118

661

1.81

8.39

1.3

300.56

271.57

ug/g

0.76

360

Other (seronegative) rheumatoid arthritis, wide

304

2131

1.44

8.36

1.4

286.13

276.04

ug/g

0.39

177

1243

Follicular cysts of skin and subcutaneous tissue

269

1844

1.47

8.32

1.4

288.40

276.92

ug/g

0.39

155

1074

Other diseases of blood and blood-forming organs

110

606

1.85

8.30

1.5

1.4

286.84

280.99

ug/g

0.10

349

Failure and rejection of transplanted organs and tissues

108

3.21

8.30

1.9

1.3

280.91

321.32

ug/g

0.44

Postprocedural musculoskeletal disorders, not elsewhere classified

119

672

1.81

8.30

1.5

1.4

249.58

281.22

ug/g

1.11

391

Benign neoplasm of mouth and pharynx

174

1087

1.63

8.29

1.6

1.4

298.56

279.60

ug/g

0.20

108

625

Other peripheral vascular diseases

129

746

1.76

8.25

1.5

1.4

290.09

287.96

ug/g

0.04

413

Myocardial infarction

795

4575

1.26

8.22

1.4

250.38

261.03

ug/g

0.78

497

2718

Benign lipomatous neoplasm of other sites/unspecified

127

733

1.76

8.17

1.4

258.52

296.29

ug/g

1.37

439

Benign lipomatous neoplasm

453

3402

1.34

8.16

1.4

297.99

270.66

ug/g

2.03

269

1982

Eosinophilia

131

2.95

8.11

1.6

1.4

274.30

283.99

ug/g

0.09

Special screening examination for neoplasms

293

2.23

8.09

1.2

1.5

291.85

249.49

ug/g

0.74

173

conjunctival haemorrhage

120

685

1.79

8.06

1.5

1.4

243.96

280.91

ug/g

1.35

407

Superficial injury of hip and thigh

208

1361

1.55

8.06

1.5

1.4

281.87

278.83

ug/g

0.07

126

787

Ulcerative proctitis

469

1.95

8.05

1.6

1.4

280.04

302.04

ug/g

0.39

265

Leiomyoma of uterus

710

3158

1.27

8.04

1.4

1.3

300.96

303.08

ug/g

0.09

389

1735

Other noninflammatory disorders of vagina

112

626

1.82

8.03

1.2

1.3

329.03

274.66

ug/g

2.00

326

Systemic lupus erythematosus, unspecified

276

2.28

8.02

1.3

1.4

354.42

301.09

ug/g

1.21

159

Impacted cerumen

149

904

1.68

8.00

1.6

1.4

252.56

272.75

ug/g

0.55

529

All dysplastic lesions of the vulva

409

2.03

8.00

1.4

344.29

307.98

ug/g

0.67

229

Other bursopathies

189

1214

1.58

7.99

1.4

279.39

265.91

ug/g

0.39

738

Ischaemic Stroke, excluding all haemorrhages

864

5307

1.24

7.97

1.4

248.74

262.71

ug/g

1.27

528

3152

Lesion of lateral popliteal nerve

416

2.02

7.96

1.7

1.5

227.53

283.39

ug/g

1.44

233

Rheumatoid arthritis, including avohilmo

599

4688

1.29

7.96

1.4

285.28

270.18

ug/g

1.08

350

2733

Benign neoplasm: Other and unspecified parts of small intestine

116

3.06

7.95

1.4

279.83

309.76

ug/g

0.48

Biological medication for rheuma

223

1489

1.51

7.88

1.5

1.4

290.90

291.02

ug/g

0.00

123

836

Disorders of tooth development and eruption

346

2.09

7.85

1.6

1.3

296.51

319.52

ug/g

0.36

178

Other and unspecified aplastic anaemias

3.50

7.81

1.3

1.4

234.52

325.75

ug/g

1.13

Later onset COPD, excluding more controls

289

1575

1.44

7.80

1.4

247.46

253.68

ug/g

0.22

177

964

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

338

2.12

7.79

1.3

1.5

239.24

293.03

ug/g

1.43

203

Family history of malignant neoplasm

156

964

1.64

7.78

1.4

266.85

291.06

ug/g

0.69

517

Injury of intra-abdominal organs

186

2.55

7.76

1.3

1.5

312.57

298.79

ug/g

0.16

109

Stroke, excluding SAH

923

5626

1.23

7.75

1.4

247.63

263.91

ug/g

1.67

561

3328

Chronic nephritic syndrome

346

2.10

7.73

1.6

1.5

237.55

284.46

ug/g

1.21

204

Psoriatic arthropathies

148

905

1.66

7.70

1.5

1.4

273.29

261.58

ug/g

0.30

540

Endocarditis

274

2.25

7.69

1.4

289.80

266.62

ug/g

0.38

162

Toxic effects of substances chiefly nonmedicinal as to source

164

1029

1.61

7.68

1.4

265.64

288.13

ug/g

0.65

582

Moderate visual impairment, binocular

230

2.37

7.67

1.4

1.5

290.96

277.51

ug/g

0.16

128

Multiple myeloma, excluding all cancers (controls excluding all cancers)

340

2.11

7.67

1.4

1.5

221.28

292.15

ug/g

2.15

199

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

193

2.50

7.66

1.2

1.4

281.45

303.18

ug/g

0.35

117

Unspecified acute lower respiratory infection

209

1386

1.52

7.65

1.4

279.52

270.05

ug/g

0.28

122

792

Endocrine disorders, other/unspecified

170

2.62

7.64

1.3

1.4

276.12

302.74

ug/g

0.38

106

Acute and subacute iridocyclitis

283

1992

1.43

7.64

1.6

1.4

256.26

277.22

ug/g

0.96

182

1176

Other disorders of amino-acid metabolism

5.58

7.60

1.5

1.3

227.00

319.82

ug/g

—

Other specified/unspecified spondylopathies

188

2.52

7.60

1.5

1.4

235.00

305.25

ug/g

1.50

117

Mixed hyperlipidaemia

328

2.12

7.60

1.5

253.57

272.03

ug/g

0.34

201

Ingrowing nail

473

1.92

7.56

1.6

1.5

266.45

296.69

ug/g

0.83

271

Nummular dermatitis

121

706

1.74

7.54

1.4

292.70

276.65

ug/g

0.39

413

Congenital iodine-deficiency syndrome/hypothyroidism

245

2.31

7.51

1.4

261.31

306.61

ug/g

1.03

133

Campylobacter enteritis

220

2.39

7.50

1.5

1.4

248.08

290.13

ug/g

0.58

124

Iridocyclitis

333

2420

1.39

7.47

1.5

1.4

254.36

275.66

ug/g

1.15

216

1402

Other noninfective disorders of lymphatic vessels and lymph nodes

291

2.19

7.45

1.6

1.4

291.26

320.31

ug/g

0.53

168

therapeutic use

259

2.27

7.45

1.5

275.72

290.81

ug/g

0.21

161

Other fall from one level to another

309

2218

1.40

7.43

1.5

1.4

273.89

278.09

ug/g

0.12

164

1266

Small fibre neuropathy

234

2.34

7.42

1.7

1.5

295.00

285.94

ug/g

0.10

147

Other overlap syndromes

161

2.65

7.41

1.5

1.4

308.63

301.20

ug/g

0.07

Other disorders of breast

201

1334

1.53

7.38

1.4

296.51

288.21

ug/g

0.24

117

717

Corneal ulcer

261

1823

1.45

7.36

1.5

1.4

265.15

279.30

ug/g

0.51

148

1045

Benign neoplasm: Anus and anal canal

254

2.27

7.35

1.5

1.4

308.38

288.97

ug/g

0.31

155

Multiple myeloma and malignant plasma cell neoplasms

339

2.08

7.35

1.4

1.5

223.97

291.36

ug/g

1.95

198

Event of undetermined intent

506

1.87

7.34

1.4

296.13

295.15

ug/g

0.01

275

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

105

3.06

7.34

1.2

1.3

196.84

311.01

ug/g

2.41

Dissociative [conversion] disorders

260

2.24

7.32

1.4

361.54

293.33

ug/g

1.55

143

Reactive arthropathies, FINNGEN

108

616

1.78

7.29

1.4

264.90

279.75

ug/g

0.28

354

Injuries to unspecified part of trunk, limb or body region

147

911

1.64

7.29

1.4

261.96

287.67

ug/g

0.72

525

Pericarditis

274

2.20

7.27

1.4

232.34

266.68

ug/g

0.60

164

Amputation of ankle bones

163

2.60

7.21

1.4

1.5

245.32

270.79

ug/g

0.37

Excessive vomiting in pregnancy

115

670

1.74

7.20

1.2

1.4

331.44

308.94

ug/g

0.46

337

Hydrocele

150

936

1.62

7.20

1.7

1.5

231.26

249.78

ug/g

0.50

100

573

Acne vulgaris

530

1.83

7.19

1.5

1.3

256.62

320.41

ug/g

1.56

251

Cyst of kidney

110

635

1.77

7.17

1.4

231.20

272.06

ug/g

1.35

372

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.68

7.13

1.4

1.3

227.81

297.13

ug/g

0.99

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

253

1768

1.44

7.12

1.4

240.91

280.00

ug/g

2.28

160

1070

Other congenital malformations of the digestive system

375

2.00

7.12

1.6

1.4

271.60

321.44

ug/g

1.23

217

Major coronary heart disease event

1136

6388

1.19

7.09

1.4

255.73

263.74

ug/g

0.66

698

3790

Premenstrual syndrome

3.62

7.08

1.2

1.3

337.75

364.98

ug/g

0.20

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.33

7.07

1.3

214.79

316.67

ug/g

1.66

Pediculosis, acariasis and other infestations

491

1.87

7.07

1.6

1.5

267.91

289.02

ug/g

0.43

285

Simple and mucopurulent chronic bronchitis

351

2.03

7.06

1.6

1.4

295.45

268.56

ug/g

0.50

200

Melanocytic naevi

376

2811

1.35

7.04

1.4

285.35

296.49

ug/g

0.49

219

1561

Superficial injury of forearm

133

811

1.66

7.03

1.3

1.4

264.27

289.97

ug/g

0.68

442

Other/unspecified soft tissue disorders related to use, overuse and pressure

214

2.35

7.01

1.5

1.4

316.33

302.93

ug/g

0.15

121

Carcinoma in situ of skin of scalp and neck

136

2.73

7.00

1.5

1.4

283.50

281.42

ug/g

0.02

Secondary malignant neoplasm of respiratory and digestive organs

3.24

6.99

1.3

1.4

241.31

269.85

ug/g

0.26

Giant cell arteritis

367

2.01

6.98

1.4

292.06

278.99

ug/g

0.19

222

Ulcerative ileocolitis

339

2.05

6.98

1.5

1.4

284.71

304.20

ug/g

0.29

191

190

2.45

6.98

1.4

1.5

287.00

260.68

ug/g

0.39

113

Hypertrophy of breast

258

1819

1.43

6.96

1.4

290.48

290.46

ug/g

0.00

134

968

Shock, not elsewhere classified

3.94

6.91

1.5

1.2

250.29

261.51

ug/g

0.08

Stroke, including SAH

972

6002

1.20

6.91

1.4

252.05

263.66

ug/g

1.03

593

3545

Sacroiliitis, not elsewhere classified

313

2.08

6.89

1.4

1.3

295.09

307.93

ug/g

0.16

164

Need for immunization against other single viral diseases

167

2.54

6.88

1.5

239.90

294.60

ug/g

0.99

Drug-induced osteoporosis with pathological fracture

138

2.73

6.87

1.8

1.4

281.19

283.73

ug/g

0.03

Other and unspecified mononeuropathies, also in other diseases

255

2.22

6.85

1.4

1.5

273.03

276.25

ug/g

0.03

143

Benign neoplasm: Rectosigmoid junction

356

2.02

6.84

1.3

1.5

321.32

270.08

ug/g

1.19

220

Thyrotoxicosis

376

2827

1.34

6.82

1.4

283.11

279.51

ug/g

0.13

231

1593

UC patients in KELA-register (code 208), prior to 1994

412

1.94

6.81

1.7

1.4

255.88

284.74

ug/g

0.78

240

Achalasia of cardia

121

2.82

6.80

1.5

1.4

262.12

294.07

ug/g

0.38

Endometriosis ASRM stages 1,2

256

1811

1.43

6.78

1.4

332.17

294.69

ug/g

2.02

127

967

Pleural effusion

214

1465

1.48

6.77

1.4

1.5

240.50

266.18

ug/g

1.03

139

884

Idiopathic thrombocytopenic purpura

250

2.22

6.76

1.6

1.4

310.79

298.39

ug/g

0.16

156

Acute laryngitis and tracheitis

141

866

1.62

6.76

1.4

299.59

299.15

ug/g

0.01

460

Hypertension, portal

6.34

6.76

1.3

1.4

240.86

248.10

ug/g

—

Cushing syndrome

3.18

6.75

1.6

1.3

217.50

305.58

ug/g

1.12

Other abnormalities of plasma proteins

122

2.82

6.74

1.3

1.4

230.19

283.78

ug/g

0.60

Bursitis of shoulder

193

2.40

6.74

1.3

1.4

255.12

287.47

ug/g

0.48

115

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

180

1191

1.53

6.73

1.4

293.53

298.45

ug/g

0.11

100

681

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.46

6.73

1.7

1.4

313.06

324.91

ug/g

0.12

Radial styloid tenosynovitis [de Quervain]

427

1.90

6.73

1.2

1.3

423.49

306.48

ug/g

0.70

243

Arterial embolism and thrombosis

470

1.86

6.72

1.5

245.09

274.26

ug/g

0.63

288

Urethritis and urethral syndrome

181

2.45

6.72

1.3

1.5

404.28

274.72

ug/g

3.07

108

Acute nasopharyngitis (common cold)

166

1073

1.55

6.71

1.5

1.4

281.11

272.96

ug/g

0.21

653

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

144

904

1.61

6.71

1.5

223.40

273.85

ug/g

2.05

556

Haemorrhage, not elsewhere classified

251

2.20

6.67

1.5

259.09

272.20

ug/g

0.17

140

Achilles tendinitis

141

885

1.61

6.66

1.6

1.4

252.01

276.06

ug/g

0.83

523

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

105

610

1.74

6.66

1.3

1.4

314.35

286.69

ug/g

0.72

353

Dental caries 2, only avohilmo

1124

7520

1.18

6.66

1.4

301.87

281.20

ug/g

1.57

621

4240

Dependent personality disorder

182

2.44

6.66

1.4

443.34

306.13

ug/g

0.49

102

Hidradenitis suppurativa

291

2.11

6.66

1.3

1.4

302.81

317.06

ug/g

0.18

161

D07AA Corticosteroids, weak (group I)

210

1435

1.48

6.66

1.4

291.11

301.27

ug/g

0.26

124

774

Non-follicular lymphoma, hilmo, excluding all cancers

128

786

1.65

6.63

1.5

1.4

251.34

286.72

ug/g

1.21

475

Lichen simplex chronicus

292

2.11

6.62

1.5

1.4

313.31

287.30

ug/g

0.38

160

Other hearing loss

388

2893

1.33

6.60

1.5

1.4

275.79

265.41

ug/g

0.44

223

1744

Dermatitis due to substances taken internally

459

1.86

6.59

1.4

285.37

293.22

ug/g

0.11

247

Spondylopathies in diseases classified elsewhere

3.20

6.59

1.6

1.3

234.31

288.70

ug/g

0.57

Other erythematous conditions

313

2.07

6.58

1.4

1.5

301.50

289.27

ug/g

0.17

186

Osteonecrosis

540

1.79

6.58

1.5

1.4

269.86

276.09

ug/g

0.11

309

Female infertility, cervigal, vaginal, other or unspecified origin

333

1639

1.37

6.57

1.4

1.3

313.40

281.56

ug/g

1.77

178

851

L04AC Interleukin inhibitors

417

1.91

6.57

1.6

1.4

301.96

290.80

ug/g

0.18

227

Peptic ulcer

3.79

6.56

1.5

1.4

260.62

271.75

ug/g

0.07

Secondary thrombocytopenia

3.05

6.56

1.4

276.63

271.99

ug/g

0.04

Benign neoplasm of bone and articular cartilage

111

659

1.71

6.54

1.4

248.71

311.27

ug/g

2.13

365

Other prurigo

3.11

6.51

1.3

280.11

328.27

ug/g

0.59

Other and unspecified glaucoma

108

639

1.72

6.48

1.4

1.5

247.50

274.66

ug/g

0.69

379

Scabies

356

1.98

6.46

1.6

1.5

265.88

290.81

ug/g

0.47

207

Tubulo-interstitial nephritis, not specified as acute or chronic

102

594

1.74

6.46

1.4

267.19

285.52

ug/g

0.35

343

Other and unspecified erythematous conditions

275

2.13

6.45

1.4

297.60

291.08

ug/g

0.08

163

Allergic colitis

124

2.72

6.45

1.2

1.3

353.14

360.33

ug/g

0.06

Varicose veins of other sites

565

1.76

6.44

1.6

1.4

272.77

290.90

ug/g

0.37

333

Maternal care for other conditions predominantly related to pregnancy

254

1786

1.41

6.43

1.3

315.25

314.10

ug/g

0.02

127

904

Acute generalized exanthematous pustulosis

399

1.92

6.43

1.3

1.5

254.45

292.64

ug/g

0.88

229

Somnolence

3.00

6.43

1.5

1.4

252.67

298.31

ug/g

0.53

Speech disturbances, not elsewhere classified

124

762

1.65

6.42

1.5

1.4

260.56

274.96

ug/g

0.31

443

Leiomyoma of uterus

985

4697

1.20

6.42

1.4

290.74

285.67

ug/g

0.31

543

2665

Parodontitis or/and operation codes

1094

5508

1.19

6.41

1.5

1.4

264.36

281.60

ug/g

1.82

646

3147

Benign neoplasm: Kidney

249

2.18

6.41

1.5

1.4

241.00

298.40

ug/g

0.92

152

Malignant neoplasm of kidney, except renal pelvis

133

833

1.62

6.39

1.4

1.5

249.43

268.81

ug/g

0.54

508

Injury of other and unspecified intrathoracic organs

537

1.78

6.38

1.6

1.4

237.85

278.13

ug/g

1.10

329

Other peripheral vertigo

143

912

1.59

6.37

1.5

1.4

267.22

276.02

ug/g

0.19

524

Chronic tubulo-interstitial nephritis

358

1.97

6.37

1.4

283.58

297.41

ug/g

0.24

210

Other and unspecified intracranial injuries

217

2.26

6.37

1.3

1.5

269.15

284.27

ug/g

0.20

131

Foreign body in alimentary tract

472

1.83

6.36

1.6

1.4

276.51

290.34

ug/g

0.26

273

In situ neoplasms

521

4130

1.27

6.35

1.3

1.4

288.74

271.49

ug/g

1.09

294

2400

Rosacea

168

1111

1.53

6.35

1.4

319.41

290.89

ug/g

0.98

621

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

161

2.48

6.34

1.2

1.4

328.86

282.15

ug/g

0.75

Benign neoplasm: Skin of other and unspecified parts of face

147

944

1.58

6.33

1.6

1.4

246.38

295.67

ug/g

2.37

562

Astigmatism

523

1.79

6.33

1.4

297.71

303.33

ug/g

0.10

297

Anterior Iridocyclitis

291

2130

1.38

6.33

1.5

1.4

257.77

276.35

ug/g

0.84

189

1240

Other epidermal thickening

366

1.95

6.32

1.3

1.4

225.89

281.96

ug/g

1.43

210

Fracture of forearm

828

6451

1.21

6.30

1.4

262.00

277.98

ug/g

1.46

460

3719

Other and unspecified follicular disorders

325

2.01

6.29

1.6

1.5

299.98

301.72

ug/g

0.02

184

Unspecified renal colic

4.20

6.29

1.2

1.4

274.00

269.29

ug/g

—

Benign neoplasm: Skin of eyelid, including canthus

236

1671

1.43

6.29

1.5

1.4

244.95

274.83

ug/g

1.53

139

995

Other and unspecified abdominal hernia

339

1.99

6.29

1.7

1.4

265.70

272.16

ug/g

0.10

201

Labour and delivery complicated by fetal stress [distress]

138

1434

0.64

6.28

1.3

345.57

319.58

ug/g

0.66

715

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

147

945

1.57

6.28

1.4

245.05

278.65

ug/g

1.40

577

Other specified disorders of muscle

225

2.23

6.27

1.4

290.37

286.86

ug/g

0.04

132

Deep bite

146

817

1.58

6.26

1.3

1.4

302.06

306.60

ug/g

0.10

429

Viral infections of the central nervous system

108

646

1.70

6.22

1.4

286.74

299.85

ug/g

0.28

357

226

2.23

6.22

1.6

1.4

270.98

297.11

ug/g

0.33

129

Other symptoms and signs involving general sensations and perceptions

299

2.05

6.21

1.3

1.4

275.93

287.13

ug/g

0.14

169

Other and unspecified injuries of lower leg

104

616

1.71

6.21

1.5

1.4

277.43

295.85

ug/g

0.37

332

Haemorrhage in early pregnancy

384

2867

1.32

6.16

1.3

1.4

302.26

297.62

ug/g

0.16

205

1499

Pregnancy with abortive outcome

1017

4484

1.19

6.14

1.4

1.3

298.17

287.55

ug/g

0.79

554

2483

Myeloid leukaemia

170

2.41

6.13

1.4

245.42

305.69

ug/g

1.04

Colorectal cancer

330

2476

1.34

6.13

1.4

245.77

263.41

ug/g

0.87

211

1506

Gout due to impairment of renal function

3.39

6.11

1.8

1.5

266.12

264.10

ug/g

0.02

Unstable angina pectoris

572

3807

1.25

6.11

1.4

261.21

258.78

ug/g

0.10

342

2315

Other coagulation defects

105

627

1.70

6.10

1.5

1.4

304.73

296.48

ug/g

0.14

346

Parkinson's disease, excluding more controls

166

1075

1.52

6.09

1.4

274.56

252.00

ug/g

0.77

104

664

Torticollis

117

2.73

6.07

1.7

1.4

387.91

298.25

ug/g

1.38

Other salmonella infections

295

2.04

6.06

1.5

1.4

442.46

287.78

ug/g

0.49

171

Tobacco use

458

1.82

6.05

1.4

1.5

274.68

293.84

ug/g

0.32

262

Benign neoplasm: Liver/bile ducts

216

2.24

6.05

1.5

1.4

303.56

295.08

ug/g

0.09

124

Kyphosis

2.95

6.04

1.5

1.3

288.38

307.18

ug/g

0.17

LSIL lesion of the vulva

269

2.10

6.03

1.5

1.4

323.40

312.13

ug/g

0.14

151

Foreign body entering into or through eye or natural orifice

115

706

1.65

6.01

1.4

300.32

286.12

ug/g

0.30

410

Sequelae of injuries of upper limb

140

901

1.57

6.01

1.6

1.4

253.73

287.42

ug/g

1.04

517

Female infertility, tubal origin

358

1.93

6.00

1.4

1.3

321.04

290.73

ug/g

0.35

189

Sequelae of intentional self-harm, assault and events of undetermined intent

4.21

6.00

1.3

1.4

366.22

317.92

ug/g

—

Primary coxarthrosis, bilateral

426

3323

1.29

5.97

1.4

267.11

263.03

ug/g

0.15

252

2022

Speech and linguistic disorders

107

618

1.68

5.97

1.3

1.4

326.62

325.23

ug/g

0.02

315

Other neurotic disorders

438

1.84

5.97

1.5

1.4

252.32

273.60

ug/g

0.40

256

Personal history of certain other diseases

118

2.70

5.97

1.6

1.3

276.14

320.97

ug/g

0.36

Malignant neoplasm of colon

211

1479

1.44

5.96

1.4

244.46

267.31

ug/g

0.87

137

900

Emotional disorders starting during childhood or adolescence

287

2.03

5.95

1.4

1.3

271.95

349.55

ug/g

1.45

131

Carcinoma in situ of skin of upper limb, including shoulder

142

2.54

5.95

1.5

1.4

264.96

285.98

ug/g

0.27

Autoimmune hyperthyroidism

504

1.77

5.94

1.4

291.67

305.57

ug/g

0.27

267

Other and unspecified papulosquamous disorders

4.02

5.94

1.5

1.4

282.11

284.18

ug/g

—

Gingival hyperplasia

257

2.11

5.93

1.4

1.5

260.52

270.36

ug/g

0.09

158

Parkinson's disease, strict definition, excluding more controls

155

1002

1.53

5.93

1.4

274.19

252.32

ug/g

0.69

621

Temporal arteritis

319

1.99

5.92

1.3

1.4

299.90

278.22

ug/g

0.32

192

Arthropathy in Crohn disease

3.14

5.92

1.7

1.3

308.00

302.32

ug/g

0.05

Tumor necrosis factor alpha inhibitors

193

1332

1.46

5.91

1.4

294.64

295.59

ug/g

0.02

106

752

Other inflammation of vagina/vulva

257

2.10

5.91

1.5

1.3

291.04

324.23

ug/g

0.38

134

Haemangioma, any site

125

787

1.61

5.91

1.5

1.4

305.04

290.31

ug/g

0.38

440

Other papulosquamous disorders

3.13

5.91

1.5

1.3

260.54

305.07

ug/g

0.43

Left ventricular outflow tract obstruction (LVOTO), broad definition

144

937

1.56

5.89

1.4

237.80

273.93

ug/g

1.39

556

Left hemicolectomy

199

2.28

5.89

1.8

1.4

207.42

269.33

ug/g

1.34

113

Allergic contact dermatitis

190

1309

1.47

5.88

1.3

1.4

304.48

293.15

ug/g

0.30

102

722

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

258

2.10

5.87

1.4

1.5

270.94

281.23

ug/g

0.15

157

Open wound of shoulder and upper arm

131

2.59

5.86

1.6

1.5

295.44

290.56

ug/g

0.04

Benign neoplasm of urinary organs

412

1.86

5.86

1.5

236.76

278.49

ug/g

0.87

248

Social disorders starting during childhood or adolecense, excluding more controls

5.67

5.85

1.1

1.4

407.00

349.86

ug/g

—

Benign neoplasm: Liver

187

2.32

5.84

1.5

1.4

290.23

304.52

ug/g

0.15

109

Carcinoma in situ of skin of trunk

193

2.28

5.84

1.3

1.4

258.88

281.45

ug/g

0.31

117

Other congenital malformations

118

734

1.63

5.83

1.4

303.14

315.38

ug/g

0.26

392

Bicipital tendinitis

377

1.89

5.80

1.4

263.28

280.68

ug/g

0.26

232

Superficial injuries involving multiple body regions

200

2.26

5.80

1.5

292.60

300.40

ug/g

0.09

120

Residual foreign body in soft tissue

377

1.89

5.79

1.5

225.09

274.04

ug/g

1.03

221

Other immunodeficiencies

2.95

5.79

1.5

1.3

323.08

319.99

ug/g

0.02

Benign neoplasm: Other and unspecified parts of mouth

301

2.01

5.77

1.6

1.5

265.95

277.23

ug/g

0.16

182

Wide developmental disorders, excluding more controls

130

2.55

5.77

1.5

1.4

359.33

346.44

ug/g

0.10

Erythema intertrigo

188

2.30

5.76

1.4

247.14

291.47

ug/g

0.79

113

Suppurative and necrotic conditions of lower respiratory tract

458

1.80

5.75

1.5

1.4

210.10

269.27

ug/g

1.85

280

Rheumatic fever with heart involvement

4.33

5.75

1.4

1.3

357.11

299.36

ug/g

—

Protozoal diseases

234

2.15

5.74

1.5

1.4

242.96

290.97

ug/g

0.85

135

Left bundle-branch block

105

638

1.67

5.74

1.5

1.4

250.92

269.45

ug/g

0.48

360

Seminoma of testis, excluding all cancers (controls excluding all cancers)

3.83

5.71

1.6

1.4

285.38

324.86

ug/g

—

Aortic valve malfunction, age under 60 years

133

857

1.57

5.71

1.4

235.51

270.71

ug/g

1.27

508

Ankylosing spondylitis

112

692

1.64

5.70

1.4

260.13

282.92

ug/g

0.51

412

severe traumatic brain injury, does not include concussion

292

2176

1.35

5.70

1.5

1.4

262.26

261.85

ug/g

0.01

174

1310

Single delivery by forceps and vacuum extractor

867

0.58

5.70

1.3

1.4

356.45

308.82

ug/g

1.06

433

Isolated proteinuria

228

2.16

5.69

1.6

1.5

253.34

282.41

ug/g

0.47

130

Chronic hepatitis NAS

110

2.74

5.68

1.3

1.4

238.45

318.12

ug/g

1.07

Recurrent dislocation and subluxation of joint

518

1.74

5.68

1.3

1.4

315.36

298.79

ug/g

0.31

295

Benign neoplasm of eye and adnexa

133

858

1.57

5.67

1.4

295.53

298.05

ug/g

0.05

504

Arthropathic psoriasis

162

1091

1.50

5.66

1.5

1.4

278.06

288.26

ug/g

0.27

623

Complications of other internal prosthetic devices, implants and grafts

324

1.95

5.66

1.4

216.25

292.37

ug/g

2.24

189

Respiratory insufficiency

104

631

1.67

5.66

1.4

287.28

277.54

ug/g

0.18

375

Use of antiglaucoma preparations and miotics

119

749

1.61

5.66

1.4

264.54

276.57

ug/g

0.30

444

Benign neoplasm: Skin of trunk

374

1.88

5.64

1.3

1.5

312.39

292.62

ug/g

0.35

216

Haemangioma and lymphangioma, any site

134

868

1.56

5.63

1.5

1.4

305.75

290.89

ug/g

0.41

488

Other and unspecified disorders of white blood cells

353

1.91

5.62

1.5

283.49

277.31

ug/g

0.08

208

Nasal polyp

262

1925

1.37

5.62

1.4

290.64

260.59

ug/g

1.62

145

1127

Benign neoplasm: Tongue

203

2.22

5.61

1.5

1.4

253.58

311.99

ug/g

1.14

122

Benign neoplasm: Skin of ear and external auricular canal

249

2.09

5.60

1.5

1.4

260.68

303.44

ug/g

0.72

155

Contusion of other and unspecified parts of foot

396

1.85

5.60

1.4

305.00

307.48

ug/g

0.03

213

Acute posthaemorrhagic anaemia

291

2.00

5.57

1.4

209.28

288.24

ug/g

2.42

174

Pneumonia due to Streptococcus pneumoniae

354

1.90

5.56

1.5

308.79

282.13

ug/g

0.43

209

Adalimumab

122

776

1.59

5.54

1.4

308.87

297.08

ug/g

0.25

413

Giant cell arteritis with polymyalgia rheumatica

327

1.94

5.53

1.3

1.5

299.90

277.39

ug/g

0.34

196

Benign intracranial hypertension

3.46

5.52

1.6

1.4

273.27

328.04

ug/g

0.41

Mixed disorders of conduct and emotions, excluding more controls

3.10

5.52

1.2

1.3

243.41

377.71

ug/g

—

Morphin

100

2.78

5.50

1.3

253.59

329.53

ug/g

1.18

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

159

1073

1.50

5.50

1.3

1.4

257.61

284.32

ug/g

0.95

652

Myocardial infarction, strict

710

4297

1.21

5.49

1.4

249.90

260.92

ug/g

0.76

452

2569

Stenosis and insufficiency of lacrimal passages

137

897

1.55

5.49

1.5

1.4

294.16

278.68

ug/g

0.44

523

Certain conditions originating in the perinatal period

100

535

1.67

5.49

1.5

1.3

302.17

340.58

ug/g

0.83

266

Assault by blunt object

2.90

5.48

1.3

1.6

292.33

303.57

ug/g

0.07

Anorexia

130

2.55

5.47

1.3

1.4

302.05

320.15

ug/g

0.22

Other/unspecified rheumatoid arthritis

191

1338

1.44

5.47

1.5

1.4

286.03

276.47

ug/g

0.28

115

799

Exposure to other and unspecified inanimate mechanical forces

593

1.68

5.46

1.6

1.5

290.37

293.52

ug/g

0.06

341

Other acquired deformities of musculoskeletal system and connective tissue

429

1.81

5.46

1.4

292.81

287.65

ug/g

0.09

250

Glaucoma suspect

532

4308

1.24

5.46

1.5

1.4

259.15

270.97

ug/g

0.69

329

2564

Melanocytic naevi, other sites/unspecified

593

1.67

5.45

1.4

292.13

308.53

ug/g

0.33

314

Autoimmune thyroiditis

136

2.50

5.45

1.5

1.4

311.73

323.75

ug/g

0.12

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

136

2.50

5.45

1.6

1.4

217.77

297.71

ug/g

1.22

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

810

5559

1.19

5.45

1.3

1.4

307.42

283.41

ug/g

2.50

472

3086

Early complications of trauma

364

1.88

5.45

1.3

1.5

285.63

283.73

ug/g

0.03

211

!Aliquae complicationes praecoces traumatis

364

1.88

5.45

1.3

1.5

285.63

283.73

ug/g

0.03

211

Vasomotor rhinitis (mode)

110

687

1.63

5.42

1.7

1.4

284.43

288.60

ug/g

0.08

387

Unspecified chronic bronchitis

294

1.97

5.40

1.6

1.4

295.81

277.46

ug/g

0.21

173

Other and unspecified paralytic syndromes

113

2.66

5.39

1.4

246.89

307.50

ug/g

0.79

Malignant neoplasm of urinary organs

139

917

1.54

5.39

1.4

1.5

246.18

266.70

ug/g

0.63

555

Habit and impulse disorders

113

2.64

5.37

1.7

1.5

251.53

293.68

ug/g

0.36

Selective deficiency of immunoglobulin A [IgA]y

4.92

5.36

1.4

387.43

327.48

ug/g

—

Generalized skin eruption due to drugs and medicaments

345

1.89

5.34

1.3

1.4

264.65

289.68

ug/g

0.44

199

COPD, hospital admissions 3, with asthma pneumonia sepsis

363

2389

1.30

5.34

1.4

1.5

254.78

259.12

ug/g

0.15

213

1460

Anomalies of dental arch relationship, including avohilmo

245

1610

1.38

5.33

1.4

308.96

304.23

ug/g

0.14

124

881

Cardiomyopathy

236

1721

1.38

5.33

1.3

1.4

257.29

263.01

ug/g

0.17

158

1040

Other specified/unspecified dorsopathies

261

2.03

5.33

1.5

1.4

305.20

294.54

ug/g

0.15

143

Olecranon bursitis

477

1.74

5.30

1.4

1.5

319.57

260.46

ug/g

1.35

294

Explicit fungal Sepsis

3.68

5.29

1.5

1.4

171.58

301.69

ug/g

2.34

Sleep disorders, other/unspecified

269

2.01

5.28

1.4

1.5

326.57

298.90

ug/g

0.34

148

Hyphaema and other vascular disorders of iris and ciliary body

151

2.39

5.25

1.7

1.5

207.34

279.21

ug/g

1.38

Laparoscopic right hemicolectomy

525

1.71

5.23

1.3

1.5

253.79

275.52

ug/g

0.45

311

Lichen sclerosus et atrophicus

156

1062

1.49

5.22

1.4

284.03

286.21

ug/g

0.05

620

Contraceptive management

579

3325

1.23

5.21

1.3

1.4

315.93

281.54

ug/g

1.47

299

1883

Inflammatory diseases of the central nervous system

119

765

1.58

5.20

1.5

1.4

250.89

291.06

ug/g

1.30

435

Carcinoma in situ of skin of other and unspecified parts of face

111

703

1.60

5.19

1.4

1.5

279.56

261.94

ug/g

0.42

432

Injuries involving multiple body regions

313

1.92

5.18

1.5

1.4

256.70

290.56

ug/g

0.56

181

Evidence of alcohol involvement determined by level of intoxication

2.95

5.17

1.3

1.5

261.56

284.63

ug/g

—

Nontoxic goitre/thyroid nodule

453

3628

1.26

5.17

1.4

301.88

272.79

ug/g

2.68

273

2105

Perineal laceration during delivery

1237

0.60

5.16

1.2

1.3

313.45

317.58

ug/g

0.06

610

Abnormal findings in nipple discharge synovial fluid wound secretions

128

2.51

5.14

1.5

1.3

268.26

287.38

ug/g

0.18

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

110

2.62

5.12

1.5

1.4

233.42

314.38

ug/g

0.97

Hepatomegaly and splenomegaly, not elsewhere classified

3.68

5.10

1.6

1.3

262.18

284.89

ug/g

0.15

Pleural plaque

127

832

1.54

5.10

1.4

1.5

271.89

251.26

ug/g

0.58

523

Carcinoma in situ of skin

117

754

1.58

5.09

1.3

1.5

296.82

265.96

ug/g

0.94

447

Seropositive rheumatoid arthritis

362

2821

1.29

5.08

1.4

282.82

265.57

ug/g

0.93

215

1632

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

123

801

1.55

5.07

1.3

1.4

247.31

284.81

ug/g

1.35

493

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

2.75

5.05

1.6

1.5

276.40

310.25

ug/g

0.26

Other and unspecified mononeuropathies of upper limb

253

2.02

5.05

1.5

258.17

283.04

ug/g

0.41

140

Unspecified nephritic syndrome

193

2.18

5.03

1.3

1.5

230.02

275.94

ug/g

0.81

113

Sequelae of other external causes

470

1.73

5.02

1.4

1.5

283.40

283.73

ug/g

0.00

273

Abnormal findings on examination of urine, without diagnosis

374

1.82

5.02

1.7

1.4

257.89

292.15

ug/g

0.70

219

Colitis, primary sclerosing, strict definition

3.14

5.02

1.4

246.75

290.67

ug/g

0.37

Basal cell carcinoma, including avohilmo

845

5660

1.18

5.02

1.4

266.94

263.62

ug/g

0.20

530

3361

Other and unspecified psoriasis

592

1.65

5.02

1.4

274.79

287.31

ug/g

0.26

346

Early lumbar disc prolapse operation

137

916

1.51

5.00

1.4

287.24

300.00

ug/g

0.26

484

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

108

686

1.60

4.99

1.5

1.4

332.30

301.83

ug/g

0.85

391

Benign neoplasm: Other and unspecified parts of small intestine

149

2.37

4.97

1.4

1.5

279.83

276.55

ug/g

0.04

Spirochaetal infections, other/unspecified

124

814

1.54

4.97

1.3

1.4

309.21

285.63

ug/g

0.76

472

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

124

2.49

4.95

1.4

216.45

301.40

ug/g

1.29

Secondary polycythaemia

181

2.21

4.95

1.7

1.5

292.91

272.57

ug/g

0.21

109

Right bundle-branch block

283

1.95

4.93

1.5

1.4

245.18

269.92

ug/g

0.38

160

IgA nephropathy (IgA glomerulonephritis)

208

2.12

4.92

1.6

1.5

273.38

285.14

ug/g

0.15

122

Polyarthritis, unspecified

283

1.94

4.92

1.3

1.5

293.55

269.31

ug/g

0.41

167

Basal cell carcinoma

821

5562

1.18

4.92

1.4

266.10

263.35

ug/g

0.16

515

3311

Correction of physiology of bite - very demanding therapy visit

242

2.03

4.91

1.7

1.4

324.67

309.35

ug/g

0.18

135

Injury of unspecified body region

108

689

1.59

4.91

1.4

263.41

288.23

ug/g

0.54

398

IBD (strict) with PSC

3.10

4.91

1.6

1.3

222.93

323.73

ug/g

1.13

Other and unspecified injuries of ankle and foot

326

1.87

4.90

1.4

290.82

305.07

ug/g

0.20

179

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

341

1710

1.30

4.90

1.3

337.37

330.07

ug/g

0.22

154

817

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.72

4.90

1.4

1.3

313.02

315.70

ug/g

0.02

Focal brain injury

473

1.71

4.88

1.5

1.3

297.35

261.26

ug/g

0.69

281

Carcinoma in situ of other and unspecified digestive organs

169

2.24

4.88

1.2

1.3

254.31

294.39

ug/g

0.50

Dermatitis due to ingested food

226

2.03

4.87

1.4

1.3

370.50

359.28

ug/g

0.12

104

Dislocation, sprain and strain of joint and ligaments of hip

313

1.89

4.87

1.5

244.86

278.04

ug/g

0.70

192

Familial hypercholesterolemia, with ischemic heart disease

138

931

1.50

4.86

1.4

1.5

259.31

259.62

ug/g

0.01

565

Carcinoma in situ of colon

2.83

4.85

1.2

1.3

220.48

298.40

ug/g

—

Other obstructive and reflux uropathy

356

1.83

4.85

1.3

1.4

245.11

300.06

ug/g

1.31

195

Scleritis and episcleritis

528

1.67

4.85

1.5

1.4

283.22

299.01

ug/g

0.31

293

Oral lichen ruber planus, including avohilmo

592

1.63

4.80

1.3

1.4

287.03

287.64

ug/g

0.01

335

Xerosis cutis

114

2.54

4.80

1.3

1.4

238.29

281.36

ug/g

0.48

Intentional self-harm by unspecified means

2.87

4.78

2.0

1.3

283.29

301.53

ug/g

0.16

Attention to artificial openings

279

1.93

4.78

1.2

1.4

261.58

285.41

ug/g

0.33

175

Mental disorders, not otherwise specified

104

662

1.59

4.76

1.4

275.70

298.16

ug/g

0.51

343

Nontoxic multinodular goitre

292

2241

1.31

4.75

1.4

301.84

277.57

ug/g

1.35

181

1310

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

125

830

1.52

4.74

1.3

1.4

249.84

286.01

ug/g

1.29

508

Other specified and unspecified disorders of eye and adnexa

352

1.83

4.74

1.4

1.5

276.16

289.17

ug/g

0.20

205

Biomechanical lesions, not elsewhere classified

441

1.73

4.73

1.5

242.65

277.02

ug/g

0.78

253

Other diseases of pericardium

352

1.82

4.73

1.3

1.4

238.13

275.00

ug/g

0.75

210

Calcific tendinitis of shoulder

486

1.69

4.72

1.5

1.4

266.03

282.94

ug/g

0.27

292

Hypermetropia

617

1.61

4.72

1.3

1.4

289.47

305.53

ug/g

0.31

353

Procedures for purposes other than remedying health state

205

2.10

4.70

1.4

1.3

322.90

311.52

ug/g

0.13

113

Other lack of coordination

140

2.36

4.70

1.6

1.4

254.65

293.02

ug/g

0.44

Carbimazole or st.post thyroidectomy, condition for graves disease

292

2245

1.31

4.68

1.4

290.30

284.12

ug/g

0.20

175

1245

Other/unspecified reactive arthropathies

603

1.61

4.68

1.4

278.18

288.02

ug/g

0.15

337

Secondary parkinsonism, excluding more controls

146

2.30

4.68

1.3

1.4

232.94

254.28

ug/g

0.24

Pyogenic arthritis

533

1.65

4.67

1.6

1.4

261.53

259.64

ug/g

0.03

330

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

310

1.87

4.67

1.4

315.71

301.48

ug/g

0.20

179

Retinal haemorrhage

199

2.11

4.67

1.5

254.70

284.23

ug/g

0.42

118

Abnormal findings in peritoneal fluid saliva

4.13

4.66

1.5

1.4

365.71

245.49

ug/g

—

LSIL lesion of the cervix uteri, vagina or vulva

181

1295

1.41

4.65

1.4

324.59

304.06

ug/g

0.71

116

675

Bronchitis, not specified as acute or chronic

119

786

1.53

4.64

1.5

1.4

218.60

280.06

ug/g

3.29

437

Entropion and trichiasis of eyelid

114

747

1.54

4.62

1.4

298.93

268.76

ug/g

0.93

469

Recurring oral aphthae

414

1.75

4.62

1.3

1.4

294.96

292.21

ug/g

0.03

241

Tetraplegia

3.21

4.61

1.3

252.27

307.12

ug/g

0.57

Retinal detachments and breaks

493

4038

1.23

4.61

1.4

256.27

268.31

ug/g

0.69

293

2409

Causalgia

135

2.36

4.59

1.5

1.4

275.93

324.02

ug/g

0.49

Melanocytic naevi of trunk

140

958

1.47

4.59

1.4

276.89

303.07

ug/g

0.78

526

Habitual aborter

2.60

4.58

1.4

1.2

270.91

352.71

ug/g

0.77

Hordeolum and other deep inflammation of eyelid

460

1.70

4.58

1.7

1.4

261.18

287.42

ug/g

0.53

260

Amyloidosis

148

2.29

4.57

1.4

230.99

284.65

ug/g

0.84

Other specified/unspecified deforming dorsopathies

148

2.29

4.57

1.2

1.3

246.76

305.16

ug/g

0.95

ILD-related respiratory insufficiency

270

1.93

4.57

1.4

1.5

257.77

274.44

ug/g

0.21

164

Macular pucker

207

1521

1.38

4.56

1.5

1.4

281.80

268.96

ug/g

0.49

119

927

Asthma and opportunity respiratory infection

431

1.73

4.56

1.3

1.4

300.54

278.62

ug/g

0.44

238

Blood alcohol or alcohol intoxication level

194

2.11

4.56

1.5

241.00

290.01

ug/g

0.67

107

Other mental disorders due to brain damage and dysfunction and to physical disease

152

1060

1.45

4.54

1.4

262.74

268.84

ug/g

0.13

653

Malignant neoplasm of respiratory system and intrathoracic organs

153

1994

0.70

4.54

1.3

1.4

272.68

259.06

ug/g

0.36

1225

Alcohol abuse counselling and surveillance

136

2.35

4.52

1.6

1.4

250.71

281.98

ug/g

0.30

Benign neoplasm: Pituitary gland, craniopharyngeal duct

379

1.77

4.52

1.4

247.86

313.53

ug/g

2.57

215

Sudden idiopathic hearing loss

143

987

1.47

4.52

1.5

1.4

278.27

268.21

ug/g

0.25

592

Retinal detachment with retinal break

173

1236

1.41

4.51

1.3

1.4

262.85

270.99

ug/g

0.19

102

739

Rare circulating lymphoid malignancy

243

1.98

4.50

1.2

1.4

281.45

284.57

ug/g

0.04

142

Preterm labour and delivery

358

2839

1.27

4.50

1.3

1.4

311.77

292.21

ug/g

1.07

189

1559

Other aneurysm

440

1.71

4.49

1.5

245.31

269.51

ug/g

0.47

271

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

343

1.80

4.48

1.3

1.4

294.38

283.88

ug/g

0.14

197

Combined immunodeficiencies

2.65

4.47

1.8

1.3

296.47

300.63

ug/g

0.04

Benign neoplasm: Choroid

471

1.68

4.47

1.4

301.16

296.36

ug/g

0.07

276

Poisoning by medicine, drug-induced

112

2.49

4.47

1.5

251.00

309.37

ug/g

0.61

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

182

2.13

4.46

1.3

340.79

299.77

ug/g

0.61

Benign neoplasm: Other/unspecified site

106

2.52

4.44

1.4

1.3

268.32

326.04

ug/g

0.89

Recurrent dislocation of patella

330

1.81

4.41

1.3

299.94

302.90

ug/g

0.03

164

Burns and corrosions

178

1283

1.40

4.41

1.5

1.4

286.80

285.17

ug/g

0.03

111

724

Injury of nerves at wrist and hand level

309

1.84

4.40

1.6

1.5

282.76

280.38

ug/g

0.02

180

Lesion of sciatic nerve

375

1.76

4.40

1.5

1.4

252.04

273.57

ug/g

0.37

219

Behçet disease

4.90

4.40

1.1

1.5

413.80

241.92

ug/g

—

Anxious personality disorder

144

2.28

4.40

1.7

1.4

528.11

314.87

ug/g

0.40

Traumatic subarachnoid haemorrhage

231

1.98

4.39

1.4

213.37

255.30

ug/g

0.60

143

Complications of cardiac and vascular prosthetic devices, implants and grafts

138

2.30

4.37

1.6

1.5

250.12

304.04

ug/g

0.89

Otitis media, unspecified

132

829

1.48

4.36

1.5

1.4

300.17

310.64

ug/g

0.21

419

Manic episode

218

2.01

4.35

1.4

1.5

328.57

287.31

ug/g

0.64

123

Abnormal findings on diagnostic imaging of central nervous system

384

1.75

4.35

1.5

316.59

292.83

ug/g

0.47

217

Disorders of porphyrin and bilirubin metabolism

2.87

4.35

1.5

315.74

264.96

ug/g

—

Hypersomnia

114

2.44

4.31

1.5

301.60

290.62

ug/g

0.08

Testicular hypofunction

233

1.97

4.30

1.3

1.5

350.45

265.26

ug/g

2.25

135

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

219

2.00

4.30

1.4

238.58

284.90

ug/g

0.74

127

Alkalosis

7.63

4.29

1.6

1.5

210.78

170.80

ug/g

—

All dysplastic lesions of the cervix uteri, vagina or vulva

358

2838

1.26

4.28

1.3

1.4

333.47

302.97

ug/g

1.80

211

1465

Endometriosis ASRM stages 3,4

330

2610

1.27

4.28

1.4

303.94

290.75

ug/g

0.51

163

1453

Synovial cyst of popliteal space [Baker]

617

1.57

4.27

1.4

281.73

274.66

ug/g

0.14

376

Nontoxic single thyroid nodule

106

697

1.54

4.27

1.2

1.4

319.98

289.78

ug/g

0.97

386

Postviral fatigue syndrome

3.26

4.27

1.4

1.5

405.56

353.38

ug/g

—

Multiple myeloma and malignant plasma cell neoplasms

409

1.72

4.27

1.4

1.5

223.97

273.53

ug/g

1.27

247

Other obstetric conditions, not elsewhere classified

347

1780

1.27

4.26

1.3

336.41

327.54

ug/g

0.28

157

859

Inflammatory disease of cervix uteri

100

650

1.56

4.26

1.3

284.71

292.77

ug/g

0.15

357

Fracture of neck

501

1.64

4.25

1.3

1.5

244.79

271.90

ug/g

0.60

302

Cardiomyopathy, other and unspecified

110

730

1.52

4.24

1.3

1.4

277.53

265.16

ug/g

0.25

410

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

118

794

1.50

4.24

1.5

266.13

284.34

ug/g

0.49

473

Eustachian salpingitis and obstruction

642

1.56

4.23

1.3

1.4

293.70

300.08

ug/g

0.09

326

Specific development disorders of scholastic skills

259

1.89

4.23

1.2

1.4

373.64

335.57

ug/g

0.48

123

Abscess of Bartholin gland

200

2.04

4.22

1.2

1.3

317.72

322.25

ug/g

0.04

108

Other disorders starting during childhood or adolescence

332

1.78

4.22

1.2

1.4

374.04

354.73

ug/g

0.25

154

Testicular dysfunction

263

1.90

4.21

1.3

1.5

345.72

264.16

ug/g

2.21

156

Benign neoplasm: Long bones of lower limb

221

1.98

4.20

1.5

1.4

248.22

320.62

ug/g

1.43

127

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

141

985

1.44

4.19

1.4

237.12

283.47

ug/g

1.88

599

Diabetes mellitus in pregnancy

360

1856

1.26

4.18

1.4

1.3

297.56

320.76

ug/g

1.21

202

922

Myopia

149

1052

1.43

4.17

1.5

1.4

261.21

304.89

ug/g

1.53

546

Other disorders of iris and ciliary body

215

2.00

4.17

1.7

1.4

229.88

287.93

ug/g

0.89

132

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

3.97

4.17

1.3

1.2

274.43

319.08

ug/g

—

Infective bursitis

208

2.01

4.16

1.3

1.5

251.51

271.89

ug/g

0.21

127

Benign neoplasm of other and unspecified sites

243

1.93

4.16

1.5

1.4

249.76

307.25

ug/g

1.32

147

Other specified/unspecified disorders of bone/cartilage

258

1.90

4.14

1.4

1.5

280.69

278.16

ug/g

0.03

154

Benign lipomatous neoplasm of other sites/unspecified

127

873

1.47

4.14

1.4

258.52

275.89

ug/g

0.47

499

Viral pneumonia (unknown virus, not influenza)

575

1.58

4.13

1.4

268.40

286.96

ug/g

0.38

326

Liposarcoma, excluding all cancers (controls excluding all cancers)

2.96

4.13

1.3

221.10

320.29

ug/g

—

Tooth eruption problems

145

1010

1.43

4.12

1.2

1.3

294.86

321.46

ug/g

0.69

484

Nonalcoholic steatohepatitis

2.89

4.11

1.2

1.3

327.25

310.81

ug/g

—

Symptoms and signs involving emotional state

230

1.95

4.11

1.6

1.4

283.68

297.36

ug/g

0.16

125

Sarcoidosis

189

1396

1.37

4.07

1.4

285.36

275.41

ug/g

0.25

110

801

Other keratitis

141

991

1.44

4.07

1.4

303.11

292.91

ug/g

0.07

559

Carcinoma in situ of skin of scalp and neck

176

2.10

4.07

1.5

283.50

258.12

ug/g

0.37

106

Acute lymphadenitis

499

1.62

4.06

1.4

295.86

304.02

ug/g

0.12

264

Congenital malformations of the circulatory system

184

1310

1.37

4.06

1.5

1.4

293.27

296.56

ug/g

0.07

108

727

Clear cell adenocarcinoma of kidney

423

1.69

4.06

1.3

1.5

239.24

266.70

ug/g

0.57

253

Pustulosis palmaris et plantaris

385

1.72

4.05

1.7

1.4

227.89

299.80

ug/g

2.14

217

Intermittent heterotropia

484

1.63

4.04

1.4

299.64

323.65

ug/g

0.43

262

Acquired absence of organs, not elsewhere classified

2.67

4.03

1.6

1.4

221.08

286.20

ug/g

0.71

Impetigo

355

1.74

4.03

1.5

1.4

283.39

315.00

ug/g

0.49

194

Assault by sharp object

124

2.32

4.02

1.4

198.93

308.86

ug/g

1.64

Disorders of puberty, all

2.48

4.01

1.4

1.3

290.54

365.96

ug/g

—

Arterial embolism and thrombosis of lower extremity artery

275

1.85

4.00

1.5

1.4

234.49

278.04

ug/g

0.72

172

Lymphoid leukaemia

386

1.71

3.99

1.4

274.90

302.13

ug/g

0.57

233

Benign neoplasm of major salivary glands

121

830

1.47

3.99

1.4

262.28

291.00

ug/g

0.86

489

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

157

2.15

3.99

1.4

257.63

305.23

ug/g

0.53

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

388

1.70

3.98

1.2

1.4

344.97

341.90

ug/g

0.03

197

Impaction of intestines

3.77

3.97

1.5

1.3

230.71

308.67

ug/g

—

Malignant neoplasm of bronchus and lung

128

1704

0.70

3.97

1.3

1.5

274.80

258.93

ug/g

0.37

1036

Progressive vascular leukoencephalopathy

269

1.86

3.97

1.4

209.73

273.74

ug/g

1.40

165

Convergent concomitant strabismus

479

1.63

3.96

1.5

1.4

285.13

310.85

ug/g

0.41

260

Organic, including symptomatic, mental disorders

697

4301

1.17

3.96

1.4

262.25

261.29

ug/g

0.04

383

2643

Other disorders of the genitourinary system

192

1430

1.36

3.95

1.4

292.13

279.18

ug/g

0.40

105

836

Fall on and from ladder

103

686

1.52

3.94

1.5

1.4

259.46

264.02

ug/g

0.08

427

Amyloidosis, other/unspecified

119

2.33

3.93

1.4

1.5

241.00

277.81

ug/g

0.49

Multiple myeloma

199

2.01

3.93

1.4

233.68

265.88

ug/g

0.50

115

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

199

2.01

3.93

1.4

233.68

265.88

ug/g

0.50

115

Alzheimer disease, excluding more controls

212

1060

1.34

3.93

1.3

1.4

269.40

257.38

ug/g

0.36

103

655

Background retinopathy and retinal vascular changes

165

2.11

3.92

1.7

1.4

298.09

297.70

ug/g

0.00

Disorders of puberty

2.62

3.92

1.4

1.3

300.55

364.04

ug/g

—

Polymyalgia rheumatica

179

1320

1.37

3.92

1.5

1.4

254.16

264.63

ug/g

0.35

104

793

Carcinoma in situ of skin of upper limb, including shoulder

172

2.09

3.91

1.5

1.4

264.96

267.91

ug/g

0.03

Nonspecific lymphadenitis

512

1.60

3.91

1.8

1.4

268.43

299.76

ug/g

0.72

290

Status epilepticus

263

1.85

3.89

1.2

1.3

254.11

291.10

ug/g

0.59

153

Psoriasis (vulgaris), strict definition

249

1.88

3.89

1.3

1.4

244.97

291.53

ug/g

0.99

137

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

2.69

3.87

1.5

1.2

260.10

306.47

ug/g

—

Toxic liver disease

120

2.32

3.87

1.6

1.4

351.83

328.98

ug/g

0.21

Calcaneal spur

2.50

3.87

1.4

238.80

305.74

ug/g

0.99

Other and unspecified injuries of shoulder and upper arm

221

1.94

3.86

1.5

317.07

289.91

ug/g

0.32

123

L01XE Protein kinase inhibitors

546

1.58

3.86

1.3

1.5

239.57

277.46

ug/g

0.92

328

Microscopic polyangiitis

3.36

3.86

1.6

1.5

234.50

266.63

ug/g

—

Amoebiasis

3.34

3.85

2.0

1.4

230.63

342.84

ug/g

—

Toxic effect of other and unspecified substances

2.60

3.85

1.4

265.45

275.18

ug/g

0.06

Contact with and exposure to communicable diseases

366

2955

1.24

3.84

1.3

1.4

319.32

297.97

ug/g

1.05

206

1544

Hyperfunction of pituitary gland

406

1.67

3.84

1.4

260.21

301.53

ug/g

0.97

209

Other specified disorders of kidney and ureter

294

1.80

3.84

1.7

1.5

234.84

280.24

ug/g

0.86

175

Meningitis

437

1.65

3.83

1.4

1.5

265.99

289.41

ug/g

0.48

244

ILD medications: nintedanib

3.50

3.83

1.5

230.63

280.13

ug/g

—

Examination and encounter for administrative purposes

279

1.82

3.82

1.5

261.00

248.92

ug/g

0.13

167

Contact with heat and hot substances

445

1.64

3.82

1.4

1.5

283.30

290.46

ug/g

0.10

250

Behavioural disorders, excluding more controls

2.45

3.81

1.6

1.5

278.17

337.52

ug/g

0.56

Psoriatic arthropathies, ICD10

145

1038

1.41

3.81

1.5

1.4

272.56

283.99

ug/g

0.30

591

Assault by other specified means

2.82

3.81

1.5

1.4

179.17

284.98

ug/g

—

Additional codes for the location of defect, injury or illness

508

1.60

3.81

1.4

1.5

324.89

277.88

ug/g

1.14

289

Pneumocystosis

134

2.23

3.81

1.2

1.4

245.47

294.60

ug/g

0.54

Carcinoma in situ of skin, other sites/unspecified

2.81

3.81

1.3

1.2

329.33

316.50

ug/g

—

Pilonidal cyst

104

699

1.50

3.80

1.5

1.4

283.02

296.24

ug/g

0.26

394

Oral lichen ruber planus

223

1.93

3.80

1.4

1.5

277.82

296.78

ug/g

0.25

134

Spontaneous rupture of synovium and tendon

105

708

1.50

3.79

1.5

1.4

290.62

265.96

ug/g

0.70

438

Personality and behavioural disorders due to brain disease, damage and dysfunction

121

2.29

3.79

2.2

1.5

234.21

287.37

ug/g

0.55

Exposure to other and unspecified animate mechanical forces

230

1.90

3.78

1.2

1.4

341.96

314.20

ug/g

0.46

129

Benign leiomyoma with endometriosis

224

1718

1.31

3.76

1.5

1.4

286.27

294.82

ug/g

0.29

128

981

Diffuse brain injury

237

1.88

3.76

1.6

1.4

262.33

272.00

ug/g

0.09

141

Personal history of risk-factors, not elsewhere classified

2.57

3.76

1.6

1.3

298.14

289.71

ug/g

0.05

Other and unspecified coagulation defects

401

1.67

3.76

1.5

1.4

261.52

302.39

ug/g

0.78

219

Acute alcohol intoxication ICD-9

281

1.81

3.76

1.6

1.5

271.19

269.76

ug/g

0.01

174

Thyrotoxicosis with diffuse goitre

183

1364

1.35

3.74

1.5

1.4

279.01

286.36

ug/g

0.19

115

745

Calculus of lower urinary tract

409

1.66

3.74

1.4

1.5

262.46

261.76

ug/g

0.01

267

Abnormality of white blood cells, not elsewhere classified

2.80

3.73

1.3

1.5

172.88

295.23

ug/g

—

HSIL lesion of the vulva

162

2.10

3.73

1.2

1.4

376.60

306.50

ug/g

0.82

Disorder of external ear, unspecified

260

1.84

3.73

1.6

1.5

240.96

281.70

ug/g

0.61

155

Inguinal or femoral hernia, bilateral

130

918

1.43

3.70

1.4

1.5

293.01

250.25

ug/g

0.34

580

Drug-induced osteoporosis

110

2.36

3.70

1.6

1.3

221.00

289.25

ug/g

0.87

Dyshidrosis [pompholyx]

116

2.30

3.69

1.6

1.3

197.92

334.97

ug/g

2.29

Peritonsillar abscess

249

1940

1.29

3.69

1.4

294.12

275.52

ug/g

0.60

135

1089

conjunctival degenerations and deposits

190

1.99

3.69

1.6

1.5

250.03

292.30

ug/g

0.51

116

2.54

3.69

1.4

265.31

292.50

ug/g

0.21

Infection of intervertebral disc (pyogenic)

2.61

3.68

1.5

1.4

189.02

294.08

ug/g

—

Other juvenile arthritis

268

1.81

3.67

1.4

273.05

313.82

ug/g

0.46

136

Malignant neoplasm of liver and intrahepatic bile ducts

247

1.85

3.66

1.2

1.5

267.41

252.65

ug/g

0.16

150

Poisoning by narcotics and psychodysleptics [hallucinogens]

110

2.33

3.66

1.4

291.92

306.92

ug/g

0.16

Benign neoplasm: Skin of other and unspecified parts of face

147

1063

1.40

3.66

1.6

1.4

246.38

274.70

ug/g

1.02

620

COPD, hospital admissions 1, only main diagnosis

470

3340

1.20

3.66

1.4

1.5

265.65

260.41

ug/g

0.22

287

2039

Visual field defects

112

772

1.47

3.65

1.3

1.4

281.81

276.66

ug/g

0.10

452

Other contact dermatitis

106

723

1.48

3.63

1.4

295.30

296.39

ug/g

0.02

393

Benign neoplasm of middle ear and respiratory system

626

1.52

3.62

1.6

1.4

277.87

297.13

ug/g

0.43

371

Pathological resorption of teeth

248

1.85

3.62

1.5

1.4

268.10

281.94

ug/g

0.14

139

Inguinal hernia, bilateral

127

897

1.43

3.62

1.4

1.5

293.01

250.20

ug/g

0.34

568

Ectopic pregnancy

233

1807

1.30

3.61

1.4

288.71

292.37

ug/g

0.09

115

962

Open wound of hip and thigh

241

1.86

3.60

1.5

281.52

305.38

ug/g

0.35

136

Ménière disease

136

974

1.41

3.60

1.4

286.89

276.37

ug/g

0.22

557

Hyperosmolality and hypernatraemia

2.57

3.59

1.5

1.4

172.00

295.20

ug/g

2.36

Benign neoplasm: Kidney

308

1.75

3.59

1.5

241.00

282.82

ug/g

0.60

184

Haemolytic anaemias

293

1.77

3.58

1.4

1.5

258.71

293.38

ug/g

0.70

169

Autism spe, excluding more controls

2.42

3.58

1.7

1.3

339.70

349.99

ug/g

—

Other and unspecified medical devices associated with adverse incidents

3.35

3.58

1.4

1.5

351.38

269.58

ug/g

—

Benign neoplasm of bone and articular cartilage

111

767

1.46

3.57

1.4

248.71

294.51

ug/g

1.34

427

Cardiac arrest

456

1.56

3.57

1.5

1.4

245.52

278.16

ug/g

0.75

269

Pyothorax

346

1.70

3.56

1.4

1.5

223.53

272.31

ug/g

0.99

209

Other interventions on the root canals of the tooth

158

2.08

3.56

1.3

1.4

268.00

290.16

ug/g

0.28

Other disorders of optic [2nd] nerve and visual pathways

565

1.54

3.55

1.5

1.4

269.72

287.76

ug/g

0.27

324

Neuroendocrine tumor and carcinoma of stomach

3.52

3.55

1.3

1.4

274.43

290.20

ug/g

—

Prolonged pregnancy

1143

0.66

3.55

1.2

1.3

363.19

318.03

ug/g

1.06

570

Malignant melanoma, excluding all cancers (controls excluding all cancers)

208

1593

1.31

3.55

1.4

284.29

289.95

ug/g

0.17

134

959

Other noninflammatory disorders of cervix uteri

431

1.62

3.54

1.4

278.52

277.15

ug/g

0.02

241

Other maternal disorders predominantly related to pregnancy

790

4320

1.15

3.54

1.3

1.4

294.80

295.76

ug/g

0.04

439

2307

Non-follicular lymphoma

128

910

1.42

3.54

1.5

1.4

251.34

273.01

ug/g

0.61

553

Muscle strain

228

1.87

3.54

1.3

1.4

270.64

303.89

ug/g

0.32

135

Other and unspecified vaccines and biological substances

3.01

3.53

1.4

1.3

327.25

304.44

ug/g

—

Disorders of optic nerve and visual pathways

122

860

1.43

3.53

1.4

291.18

293.70

ug/g

0.04

464

Abnormal blood-pressure reading, without diagnosis

347

1.69

3.52

1.4

291.41

282.93

ug/g

0.12

199

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

132

2.18

3.51

1.5

1.3

209.70

314.90

ug/g

1.76

Benign neoplasm: Skin, unspecified

295

1.75

3.50

1.4

353.23

317.33

ug/g

0.62

171

Prurigo nodularis

208

1.92

3.49

1.3

1.4

201.19

304.59

ug/g

3.30

115

Bitten or struck by other mammals

134

964

1.40

3.45

1.4

284.50

302.62

ug/g

0.50

513

Pneumonia due to other infectious organisms, not elsewhere classified

252

1.82

3.45

1.3

1.4

256.27

292.16

ug/g

0.41

150

Crystalline deposits in vitreous body

2.67

3.45

1.7

1.5

219.87

278.96

ug/g

0.63

Seminoma of testis

2.74

3.44

1.6

285.38

294.26

ug/g

—

100

682

1.48

3.44

1.3

341.81

330.21

ug/g

0.19

318

Benign neoplasm of other and unspecified intrathoracic organs

2.58

3.43

1.5

1.3

252.23

321.98

ug/g

0.63

Artificial joint re-operation

100

684

1.48

3.43

1.4

1.5

327.21

269.83

ug/g

1.91

400

Suggestive for eosinophilic asthma

121

857

1.43

3.43

1.3

1.4

294.44

281.22

ug/g

0.28

490

Dental pulpitis 3

113

563

1.45

3.42

1.4

1.3

337.87

357.50

ug/g

0.34

236

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

238

1.83

3.42

1.3

1.4

247.63

308.39

ug/g

1.02

144

Autoimmune hepatitis

2.94

3.41

1.3

297.22

319.07

ug/g

—

Episcleritis

459

1.59

3.41

1.4

290.05

300.61

ug/g

0.17

254

Femoral hernia

358

1.67

3.41

1.5

1.4

273.80

268.32

ug/g

0.08

214

Other psoriatic arthropathies

139

1010

1.39

3.40

1.5

1.4

277.53

285.66

ug/g

0.20

572

Other vitreous opacities

336

1.69

3.39

1.4

1.5

283.73

284.89

ug/g

0.01

197

Persons encountering health services in circumstances related to reproduction

807

4784

1.15

3.39

1.4

296.58

281.30

ug/g

0.69

439

2718

Personal history of allergy to drugs, medicaments and biological substances

2.43

3.38

1.4

1.2

312.26

334.01

ug/g

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

180

1363

1.33

3.36

1.4

293.53

280.40

ug/g

0.35

100

780

Malignant neoplasm of skin

899

5973

1.14

3.36

1.4

265.97

263.14

ug/g

0.17

569

3539

Coronary angioplasty

530

3457

1.18

3.36

1.5

1.4

261.82

259.33

ug/g

0.10

338

2085

False labour

348

1780

1.23

3.35

1.3

336.96

306.90

ug/g

1.55

154

918

Acute otitis externa, noninfective

128

2.16

3.35

1.4

1.5

213.08

283.50

ug/g

1.05

Disorders of iron metabolism

102

2.31

3.34

1.3

1.4

315.62

282.29

ug/g

0.31

Bell's palsy

149

1098

1.37

3.33

1.3

1.4

287.04

282.90

ug/g

0.10

612

Benign neoplasm: Tongue

248

1.81

3.33

1.5

253.58

284.85

ug/g

0.49

147

Deep endometriosis

133

963

1.39

3.33

1.3

1.4

322.52

289.80

ug/g

0.90

503

Myeloid leukaemia

219

1.86

3.32

1.4

1.5

245.42

288.96

ug/g

0.68

125

Carcinoma in situ of skin of trunk

241

1.82

3.31

1.3

1.4

258.88

267.87

ug/g

0.11

145

Perforation of tympanic membrane

129

930

1.40

3.31

1.3

1.4

253.77

287.17

ug/g

1.08

519

Other and unspecified epidermal thickening

212

1.87

3.31

1.4

1.5

213.30

292.41

ug/g

1.44

121

Sequelae of injuries of head

455

1.58

3.30

1.6

1.4

219.26

285.66

ug/g

1.74

260

Benign neoplasm: Parotid gland

648

1.48

3.30

1.4

263.21

294.64

ug/g

0.78

374

Other and unspecified trigeminal disorders

129

2.15

3.29

1.5

1.4

222.69

318.13

ug/g

1.66

Lung transplant status

2.69

3.29

1.0

1.5

257.12

288.98

ug/g

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.75

3.28

1.6

1.3

237.11

323.90

ug/g

—

Malignant neoplasm of breast, HER-positive

368

4371

0.83

3.27

1.4

277.68

280.60

ug/g

0.10

229

2500

Secondary uncertain malignant neoplasm

164

1231

1.34

3.27

1.4

259.18

269.41

ug/g

0.28

103

744

Spontaneous abortion

621

3638

1.17

3.26

1.3

300.31

293.04

ug/g

0.35

336

1996

Other sexually transmitted chlamydial diseases

440

1.58

3.26

1.3

241.97

326.45

ug/g

1.81

205

3.51

3.26

1.2

1.5

365.00

274.26

ug/g

—

Neovascular glaucoma

340

1.67

3.25

1.4

257.18

294.37

ug/g

0.77

204

Spinal enthesopathy

170

1.96

3.24

1.5

1.4

228.66

262.47

ug/g

0.42

100

Nontoxic diffuse goitre

273

1.75

3.22

1.6

1.4

272.93

303.87

ug/g

0.53

151

Abnormal findings in secretions and smears from cervix uteri vagina vulva

638

4338

1.16

3.21

1.3

1.4

313.54

294.65

ug/g

1.41

371

2309

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

207

1.87

3.21

1.3

1.4

308.39

309.51

ug/g

0.01

113

Lung transplantation

2.65

3.20

1.0

1.5

257.13

288.98

ug/g

—

Burns and corrosions of multiple body regions

2.81

3.20

1.4

1.7

158.22

251.54

ug/g

—

Motorcycle rider injured in noncollision transport accidents

229

1.82

3.19

1.5

239.91

296.77

ug/g

0.78

129

Idiopathic pulmonary fibrosis

645

1.47

3.19

1.4

1.5

256.51

271.59

ug/g

0.34

391

Symptoms and signs involving appearance and behaviour

2.71

3.18

1.4

1.5

355.67

266.37

ug/g

—

Hereditary motor and sensory neuropathy

2.63

3.18

1.3

277.65

292.35

ug/g

0.10

Mental and behavioural disorders due to use of other stimulants, including caffeine

193

1.89

3.18

1.4

251.22

312.77

ug/g

0.97

Tic and related disorders

2.78

3.18

1.8

1.3

309.33

358.89

ug/g

—

Congenital malformations of gallbladder, bile ducts and liver

2.37

3.17

1.6

1.3

240.57

308.02

ug/g

0.70

Unspecified lump in breast

226

1780

1.28

3.17

1.5

1.4

271.78

288.02

ug/g

0.58

142

980

Burns and corrosions of external body surface, specified by site

134

980

1.38

3.17

1.4

289.27

286.54

ug/g

0.05

542

Malignant neoplasm of breast

588

4912

0.86

3.16

1.3

1.4

278.64

284.34

ug/g

0.28

347

2798

Pustular psoriasis

437

1.58

3.15

1.7

1.4

235.68

293.76

ug/g

1.68

253

Other disorders of bone density and structure

223

1.83

3.15

1.6

1.4

252.63

296.56

ug/g

0.64

134

Juvenile arthritis (FINNGEN)

343

1.65

3.14

1.4

276.79

310.69

ug/g

0.45

179

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

517

1.53

3.13

1.4

311.05

295.33

ug/g

0.21

305

Contusion of toe(s) without damage to nail

180

1.92

3.13

1.3

1.4

335.12

323.70

ug/g

0.09

103

Coxarthrosis, primary, with hip surgery

659

5442

1.15

3.12

1.4

266.18

262.46

ug/g

0.18

395

3277

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

112

2.20

3.12

1.5

1.3

241.62

325.22

ug/g

1.02

Peroneal tendinitis

112

2.19

3.10

1.3

1.4

246.00

290.89

ug/g

0.47

Other and unspecified nail disorders

174

1.94

3.09

1.5

1.4

235.66

299.85

ug/g

1.00

103

Hereditary deficiency of other clotting factors

2.58

3.09

1.7

1.4

338.35

322.13

ug/g

0.09

Carcinoma in situ of other and unspecified sites

217

1.82

3.08

1.4

1.5

216.38

277.48

ug/g

1.12

135

Presbyopia

568

1.50

3.08

1.5

1.4

282.99

289.88

ug/g

0.12

323

Juvenile rheumatoid arthirtis

146

2.02

3.08

1.3

1.4

300.87

315.78

ug/g

0.11

Foreign body in respiratory tract

448

1.56

3.06

1.5

287.77

292.64

ug/g

0.07

260

Overexertion and strenuous or repetitive movements

125

910

1.39

3.05

1.3

1.4

281.40

289.25

ug/g

0.17

512

Other disorders of male genital organs

247

1.76

3.05

1.5

249.33

261.40

ug/g

0.13

151

Benign neoplasm of breast

164

1245

1.33

3.05

1.4

266.52

302.27

ug/g

1.53

688

Other other unspecified disorders of the circulatory system

331

1.66

3.05

1.6

1.4

251.66

276.06

ug/g

0.42

191

Acquired haemolytic anaemia

211

1.84

3.05

1.3

1.5

254.29

287.85

ug/g

0.54

124

Chloasma

3.16

3.04

1.3

300.17

307.01

ug/g

—

Other bacterial agents as the cause of diseases classified to other chapters

2.42

3.04

1.3

1.5

222.80

263.07

ug/g

—

Malignant neoplasm of breast, HER-negative

205

2600

0.78

3.04

1.3

1.4

284.48

282.36

ug/g

0.05

110

1499

Malignant neoplasm of breast, HER2-negative

573

4867

0.86

3.03

1.3

1.4

279.89

284.17

ug/g

0.20

339

2773

Endometriosis of intestine

2.34

3.03

1.4

1.2

479.38

340.26

ug/g

—

Benign neoplasm of meninges

129

946

1.38

3.03

1.5

1.4

296.98

296.79

ug/g

0.00

547

Sequelae of cerebrovascular disease

467

3485

1.18

3.03

1.4

241.34

265.16

ug/g

1.88

295

2110

Dependence on enabling machines and devices, not elsewhere classified

2.35

3.02

1.5

1.4

339.87

303.92

ug/g

0.28

Hypoplasia of dental enamel, including avohilmo

2.55

3.02

1.2

1.4

372.00

361.82

ug/g

—

Synovial hypertrophy, not elsewhere classified

2.53

3.00

1.4

1.3

391.50

360.14

ug/g

0.26

Fall involving bed

249

1.76

3.00

1.4

223.97

279.43

ug/g

1.00

147

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

105

746

1.42

2.97

1.4

321.06

308.26

ug/g

0.30

405

Disorders of orbit

388

1.59

2.97

1.3

1.4

259.09

299.72

ug/g

0.78

214

Bacterial, viral and other infectious agents

111

797

1.41

2.96

1.4

295.25

281.85

ug/g

0.27

453

Orthopaedic devices associated with adverse incidents

163

1.95

2.96

1.4

1.6

264.11

270.21

ug/g

0.06

Ovarian dysfunction

548

1.49

2.96

1.5

1.3

326.73

325.47

ug/g

0.01

251

2.46

2.95

1.7

1.3

338.18

331.17

ug/g

0.06

Carcinoma in situ of skin of lower limb, including hip

135

2.04

2.95

1.1

1.4

287.67

292.31

ug/g

0.04

Helminthiases

142

2.02

2.94

1.4

294.61

292.49

ug/g

0.02

Benign neoplasm: Conjunctiva

228

1.78

2.94

1.5

299.11

308.35

ug/g

0.11

128

Drug-induced polyneuropathy

2.52

2.94

1.4

254.56

292.68

ug/g

0.33

Injury of nerves at shoulder and upper arm level

2.43

2.94

1.8

1.3

187.60

303.56

ug/g

—

Other complications of labour and delivery, not elsewhere classified

845

0.63

2.93

1.2

1.3

391.80

324.66

ug/g

1.03

401

Glaucoma secondary to other eye disorders

350

1.62

2.93

1.4

1.5

257.18

285.54

ug/g

0.54

210

Ulcer of vagina/vulva

199

1.84

2.93

1.5

1.4

287.07

312.39

ug/g

0.20

115

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

281

1.70

2.93

1.4

284.21

302.19

ug/g

0.25

168

Other specified and unspecified retinal disorders

304

1.67

2.93

1.4

1.5

219.90

285.04

ug/g

1.57

173

Pneumonia derived septicemia

281

1.70

2.93

1.4

302.96

282.35

ug/g

0.23

160

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

311

1.66

2.92

1.3

1.5

231.45

286.80

ug/g

1.08

189

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

3.06

2.92

1.5

158.86

238.36

ug/g

—

Acute epiglottitis

122

2.10

2.91

1.6

1.4

265.24

276.74

ug/g

0.12

Injury of muscle and tendon at wrist and hand level

169

1298

1.31

2.90

1.4

316.70

265.83

ug/g

2.34

768

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

185

1.87

2.90

1.3

1.4

234.94

299.42

ug/g

0.94

109

Open wound of abdomen, lower back and pelvis

229

1.77

2.90

1.7

1.5

283.67

289.05

ug/g

0.05

130

Primary open-angle glaucoma, strict

353

2941

1.20

2.89

1.5

1.4

251.84

267.62

ug/g

0.81

207

1774

Chronic conjunctivitis

267

1.71

2.89

1.3

1.5

292.14

294.95

ug/g

0.03

161

Non-allergic asthma

116

843

1.39

2.89

1.4

272.79

280.03

ug/g

0.15

484

Aortic aneurysm

272

2175

1.23

2.88

1.5

256.08

258.78

ug/g

0.08

162

1326

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.24

2.87

1.6

1.5

229.07

304.52

ug/g

0.89

Wet age-related macular degeneration

212

1648

1.27

2.87

1.5

1.4

251.34

267.45

ug/g

0.54

117

1021

Erythema multiforme

179

1.88

2.86

1.3

1.5

341.73

297.06

ug/g

0.63

103

Colorectal adenocarcinoma

253

2046

1.24

2.86

1.4

240.91

263.21

ug/g

1.02

160

1254

Diastasis of muscle

2.85

2.86

1.8

1.3

311.00

312.93

ug/g

—

Mantle cell lymphoma

2.55

2.84

1.0

1.5

284.00

247.58

ug/g

—

Collapsed vertebra, not elsewhere classified

2.73

2.84

1.6

1.4

246.22

309.89

ug/g

—

Delayed puberty

3.13

2.83

1.5

1.3

286.48

403.57

ug/g

—

Hypothyroidism, autoimmune, DX-based

3.40

2.83

1.2

306.20

329.36

ug/g

—

Benign neoplasm of eye and adnexa

133

992

1.35

2.83

1.4

295.53

278.75

ug/g

0.46

577

Carrier of infectious disease

187

1.85

2.82

1.5

1.4

243.26

297.40

ug/g

0.69

Palindromic rheumatism

2.33

2.82

1.6

1.4

301.00

295.85

ug/g

—

Tibial collateral bursitis [Pellegrini-Stieda]

2.32

2.81

1.4

242.13

295.18

ug/g

—

Separation of retinal layers (serosa)

362

1.60

2.81

1.4

1.5

246.89

283.28

ug/g

0.80

209

Contracture of joint

2.22

2.81

1.9

1.4

238.87

283.30

ug/g

—

Amiodarone users

127

942

1.36

2.80

1.4

1.5

248.21

263.50

ug/g

0.42

570

Melanocytic naevi of lower limb, including hip

323

1.63

2.80

1.6

1.4

247.54

313.31

ug/g

1.46

178

Intentional self-harm by sharp object

173

1.88

2.79

1.3

1.4

297.25

305.13

ug/g

0.06

Hyperprolactinaemia

285

1.67

2.79

1.4

252.62

305.68

ug/g

1.03

148

Melanocytic naevi

376

3169

1.19

2.78

1.4

285.35

280.16

ug/g

0.20

219

1788

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

168

1298

1.30

2.78

1.4

287.36

286.07

ug/g

0.03

113

776

Contact with other sharp object(s)

532

1.48

2.77

1.4

285.68

302.48

ug/g

0.32

293

Primary open-angle glaucoma

430

3574

1.18

2.76

1.5

1.4

248.12

264.03

ug/g

0.96

257

2161

Acquired absence of limb

2.50

2.75

1.5

1.6

280.11

272.04

ug/g

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

286

1.66

2.75

1.4

241.06

303.72

ug/g

1.36

171

Meralgia paraesthetica

271

1.69

2.75

1.5

314.46

293.06

ug/g

0.34

147

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.57

2.74

1.5

1.3

324.00

323.17

ug/g

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

302

1.64

2.73

1.6

1.4

262.78

302.05

ug/g

0.72

176

Other surgical follow-up care

241

1.72

2.73

1.6

1.5

226.26

307.20

ug/g

1.89

134

Torsion of ovary, ovarian pedicle and fallopian tube

132

2.00

2.72

1.5

1.3

363.00

319.27

ug/g

0.44

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

559

1.46

2.72

1.4

329.31

313.55

ug/g

0.34

302

Other specified and unspecified strabismus

2.23

2.71

1.7

1.4

328.03

307.36

ug/g

—

Congenital malformations of genital organs

108

780

1.39

2.71

1.5

1.3

333.69

321.31

ug/g

0.26

386

Bullous disorders

519

1.48

2.70

1.5

1.4

260.54

283.01

ug/g

0.35

311

Infection due to other mycobacteria

119

2.06

2.70

1.5

1.4

217.33

303.28

ug/g

1.01

Severe visual impairment, monocular

2.46

2.68

1.6

1.4

320.01

314.89

ug/g

—

Dislocation, sprain and strain of joints and ligaments of head

335

1.60

2.68

1.4

322.86

308.73

ug/g

0.15

185

Defects in the complement system

2.55

2.67

1.6

1.3

336.86

299.56

ug/g

—

Viral meningitis

312

1.62

2.67

1.5

1.4

260.76

308.60

ug/g

0.91

182

Viral encephalitis, not elsewhere classified/unspecified

169

1.87

2.67

1.2

1.4

316.50

301.92

ug/g

0.13

101

Long labour

187

2062

0.79

2.66

1.3

1.4

362.85

305.29

ug/g

2.96

1089

Medicines for HER+ breast cancer

395

4511

0.85

2.65

1.4

280.91

281.68

ug/g

0.03

242

2572

Coronary revascularization (ANGIO or CABG)

656

4028

1.14

2.63

1.5

1.4

259.18

259.31

ug/g

0.01

422

2422

Melanocytic naevi, other sites/unspecified

705

1.40

2.63

1.4

292.13

289.54

ug/g

0.04

396

Thoracic aortic aneurysm

169

1319

1.29

2.62

1.5

1.4

260.36

270.31

ug/g

0.24

103

818

Disorders of speech understanding and production

315

1.61

2.62

1.5

1.4

304.47

339.10

ug/g

0.65

161

Galactorrhea

2.25

2.62

1.2

1.3

305.56

316.44

ug/g

—

Myositis

192

1.80

2.61

1.4

1.5

334.23

297.76

ug/g

0.42

107

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.35

2.61

1.8

1.2

269.83

302.51

ug/g

0.32

Pyoderma gangrenosum

2.51

2.59

1.2

1.5

266.29

289.11

ug/g

—

Epileptic seizures related to alcohol

2.83

2.59

1.3

1.6

138.67

286.51

ug/g

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

773

5438

1.13

2.59

1.4

261.61

262.58

ug/g

0.05

484

3232

Benign neoplasm: Cerebral meninges

115

852

1.36

2.59

1.4

299.46

302.00

ug/g

0.04

489

Other disorders of peripheral nervous system

2.70

2.58

1.6

1.5

306.25

296.51

ug/g

—

135

1.96

2.58

1.8

1.4

309.76

306.96

ug/g

0.03

Atypical mycobacterium lung infection

101

2.14

2.57

1.4

247.78

275.05

ug/g

—

Squamous cell neoplasms and carcinomas of the skin

147

1129

1.31

2.57

1.4

1.5

245.05

263.24

ug/g

0.59

704

L02BG Aromatase inhibitors

313

3729

0.84

2.57

1.4

278.88

277.57

ug/g

0.04

187

2161

Carcinoma in situ of other and unspecified digestive organs

216

1.75

2.56

1.2

1.5

254.31

260.86

ug/g

0.06

132

Pedestrian injured in collision with pedal cycle

269

1.66

2.56

1.4

300.73

290.71

ug/g

0.13

165

Myasthenia gravis

150

1.91

2.56

1.5

263.33

282.51

ug/g

0.21

Molar incisor enamel hypoplasia, with caries

2.57

2.55

1.4

367.00

374.34

ug/g

—

Idiopathic urticaria

157

1.88

2.55

1.6

1.4

318.48

313.65

ug/g

0.03

Foreign body on external eye

178

1403

1.28

2.55

1.5

254.54

265.28

ug/g

0.28

103

826

Vertigo of central origin

129

1.98

2.54

1.5

223.39

275.83

ug/g

0.73

Other/unspecified disorders of vestibular function

340

1.58

2.54

1.6

1.4

262.67

283.86

ug/g

0.28

194

Other and unspecified diseases of blood and blood-forming organs

224

1.73

2.54

1.4

1.5

264.86

289.58

ug/g

0.28

133

Dissocial personality disorder

115

2.04

2.54

1.2

1.6

285.31

267.45

ug/g

0.15

Enteritis due to Yersinia enterocolitica

2.93

2.52

1.7

1.5

153.40

294.29

ug/g

—

Unspecified event, undetermined intent

202

1.76

2.51

1.5

255.30

299.60

ug/g

0.63

118

Other and/or unspecified nontoxic goitre

114

848

1.36

2.51

1.4

308.68

280.72

ug/g

0.87

486

Contusion of toe(s) with damage to nail

2.25

2.51

1.9

1.4

285.64

301.63

ug/g

0.13

Childhood allergy (age < 16)

131

815

1.33

2.50

1.4

1.3

352.37

340.92

ug/g

0.19

347

Thiamine deficiency

2.78

2.50

1.7

1.6

307.80

260.11

ug/g

—

Respiratory conditions due to other external agents

173

1.83

2.50

1.1

1.5

285.20

275.15

ug/g

0.09

102

Colorectal neuroendocrine tumor and carcinoma

123

2.00

2.50

1.5

1.3

241.62

307.93

ug/g

0.74

Mixed specific developmental disorders

140

1.89

2.49

1.1

1.4

403.47

383.58

ug/g

0.20

Malignant neoplasm of testis

109

2.06

2.49

1.5

1.6

245.58

287.46

ug/g

0.29

Lesion of plantar nerve

612

1.42

2.49

1.5

1.4

290.08

285.08

ug/g

0.08

339

Effects of other external causes

210

1.74

2.49

1.4

327.17

301.72

ug/g

0.31

120

Fistulae involving female genital tract

116

2.02

2.49

1.5

1.4

311.00

284.46

ug/g

0.24

Other specified congenital malformation syndromes affecting multiple systems

130

1.96

2.48

1.3

1.4

355.50

313.58

ug/g

0.56

Heart failure and coronary heart disease

428

2740

1.17

2.48

1.4

261.19

258.40

ug/g

0.10

272

1685

Toxic effect of ethanol

342

1.57

2.48

1.5

1.4

215.04

302.02

ug/g

1.76

195

Pedestrian injured in transport accident

629

1.41

2.48

1.4

277.03

293.77

ug/g

0.34

363

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

520

0.57

2.47

1.4

1.5

290.81

294.00

ug/g

0.03

303

Wide developmental disorders

188

1.78

2.46

1.5

1.4

359.33

355.05

ug/g

0.03

100

Crushed, pushed or stepped on by crowd or human stampede

571

1.43

2.46

1.4

296.78

310.65

ug/g

0.23

295

Retinal vascular disorders

146

1129

1.30

2.45

1.4

237.79

270.04

ug/g

1.29

680

Disorders of purine and pyrimidine metabolism

3.05

2.45

1.5

364.80

256.96

ug/g

—

Previous suicide attempt

2.34

2.45

1.7

1.4

277.30

299.73

ug/g

—

Other articular cartilage disorders

189

1.77

2.44

1.5

1.4

168.31

275.58

ug/g

1.67

116

Discitis, unspecified

117

2.01

2.44

1.5

1.4

238.31

285.83

ug/g

0.50

Other orthopaedic follow-up care

473

1.47

2.43

1.6

1.4

285.81

289.68

ug/g

0.05

267

Autonomic disorders

182

1.79

2.43

1.4

333.71

300.78

ug/g

0.27

107

Systemic sclerosis,strict definition

2.13

2.43

1.9

1.4

229.18

307.37

ug/g

—

Conductive hearing loss, unspecified

107

794

1.36

2.41

1.4

287.47

277.81

ug/g

0.16

453

Contact with lifting and transmission devices, not elsewhere classified

146

1.89

2.41

1.8

1.5

201.47

278.67

ug/g

1.09

Benign neoplasm: Pituitary gland, craniopharyngeal duct

450

1.48

2.40

1.4

1.5

247.86

291.99

ug/g

1.45

258

Benign neoplasm: Skin of ear and external auricular canal

329

1.57

2.40

1.5

1.4

260.68

281.54

ug/g

0.29

201

Follicular lymphoma

329

1.57

2.40

1.4

282.73

302.42

ug/g

0.39

193

Obstructed labour due to malposition and malpresentation of fetus

169

2005

0.79

2.40

1.2

1.4

340.07

304.84

ug/g

1.31

1058

Injury of muscle and tendon at lower leg level

183

1460

1.26

2.40

1.5

1.4

297.42

269.83

ug/g

1.08

118

846

Undescended testicle

2.26

2.39

1.3

1.4

386.55

354.16

ug/g

0.27

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

337

1.56

2.39

1.5

1.4

256.54

301.65

ug/g

1.01

198

Endometriosis of fallopian tube

2.57

2.39

1.2

1.3

324.83

306.38

ug/g

—

Dermatopolymyositis

125

1.96

2.39

1.3

300.94

297.47

ug/g

0.03

Abscess of lung

111

2.02

2.39

1.8

1.5

169.15

264.06

ug/g

1.37

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.32

2.38

1.6

1.4

237.11

316.91

ug/g

—

Presbycusis

160

1251

1.28

2.37

1.4

283.02

256.87

ug/g

0.81

786

Diffuse large B-cell lymphoma, helper endpoint

322

1.57

2.37

1.7

1.5

205.08

297.94

ug/g

2.93

188

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

322

1.57

2.37

1.7

1.5

205.08

297.94

ug/g

2.93

188

Congenital malformations of heart and great arteries

154

1166

1.29

2.37

1.5

1.4

278.82

301.91

ug/g

0.72

650

Major anomalies of jaw size

221

1.70

2.37

1.4

1.5

301.35

305.06

ug/g

0.04

127

Anisometropia and aniseikonia

283

1.61

2.37

1.5

1.4

284.94

299.77

ug/g

0.21

171

Dronedarone medication

252

1.65

2.37

1.7

1.4

246.10

262.83

ug/g

0.30

138

Retinal vascular occlusion

143

1109

1.30

2.37

1.5

1.4

240.09

269.55

ug/g

1.13

664

Other pulmonary heart/vessel disease

411

1.50

2.36

1.5

1.4

249.84

285.53

ug/g

0.80

253

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

108

806

1.35

2.36

1.5

1.4

332.30

284.39

ug/g

1.67

455

Varicella [chickenpox]

395

1.51

2.35

1.5

1.4

258.17

285.53

ug/g

0.42

231

Benign neoplasm: Choroid

552

1.43

2.35

1.4

301.16

282.05

ug/g

0.34

329

Optic atrophy

162

1.83

2.35

1.4

330.77

304.82

ug/g

0.22

Multifocal fibrosclerosis

2.46

2.34

1.9

1.5

235.49

275.51

ug/g

—

Epiphora

207

1.72

2.34

1.5

1.4

278.06

297.21

ug/g

0.23

129

Dermatopolymyositis (FG)

119

1.98

2.34

1.3

1.5

295.13

282.08

ug/g

0.11

Granuloma annulare

119

1.97

2.34

1.1

1.4

320.85

325.86

ug/g

0.05

Dental pulpitis 3, only avohilmo

522

1.38

2.34

1.3

336.77

352.04

ug/g

0.22

217

Cardiomyopathies, Primary/intrinsic

149

1164

1.29

2.33

1.5

1.4

251.68

263.17

ug/g

0.29

696

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

662

1.39

2.33

1.4

323.71

313.55

ug/g

0.21

359

Patellar tendinitis

105

2.03

2.33

1.7

1.4

242.48

301.83

ug/g

0.69

Exclusion endpoint for clefts

155

1.84

2.32

1.4

364.52

323.53

ug/g

0.62

Other and unspecified hypertrophic disorders of skin

2.54

2.32

1.4

1.3

242.71

316.40

ug/g

—

Exposure to other and unspecified forces of nature

2.78

2.32

1.5

1.3

234.83

335.15

ug/g

—

Melanoma in situ of trunk

2.17

2.32

1.4

1.3

271.75

314.89

ug/g

0.51

Other and unspecified mononeuropathies of lower limb

238

1.66

2.32

1.2

1.5

273.26

299.79

ug/g

0.24

133

Schizophrenia, schizotypal and delusional disorders

403

3477

1.16

2.30

1.4

281.97

277.08

ug/g

0.18

234

1952

Other abnormal findings of blood chemistry

381

1.51

2.30

1.5

1.4

284.93

285.06

ug/g

0.00

224

Social disorders starting during childhood or adolescence

2.75

2.30

1.1

1.4

407.00

379.60

ug/g

—

Delayed milestone in childhood

147

1.82

2.29

1.3

1.4

345.46

390.47

ug/g

0.59

Other disorders of cornea

120

914

1.32

2.28

1.4

282.54

288.04

ug/g

0.11

520

Cholera

390

1.51

2.28

1.5

1.4

245.88

279.63

ug/g

0.61

220

Osteomalacia

2.16

2.27

1.4

314.30

284.86

ug/g

—

Atopic conjunctivitis

382

1.51

2.27

1.6

1.4

291.04

301.68

ug/g

0.15

217

Other nonscarring hair loss

2.15

2.27

1.6

1.4

293.54

341.53

ug/g

0.45

Adenocarcinoma and papilloma adenocarcinoma of rectum

114

863

1.33

2.27

1.3

1.5

249.18

270.55

ug/g

0.58

524

Carcinoma in situ of skin, other sites/unspecified

2.15

2.26

1.3

1.4

329.33

255.18

ug/g

—

Benign neoplasm: Tonsil

2.14

2.26

1.3

305.18

323.27

ug/g

0.13

Specific development disorders of speech and language

423

1.47

2.25

1.4

293.66

319.59

ug/g

0.58

215

Malignant neoplasm of bladder

548

1.42

2.24

1.5

231.03

257.25

ug/g

0.56

347

Other arterial embolism and thrombosis

217

1.68

2.24

1.4

1.5

268.75

280.89

ug/g

0.12

135

Pulmonary eosinophilia, not elsewhere classified

107

2.01

2.24

1.6

1.4

243.40

294.51

ug/g

—

Hypertrophy of tongue papillae

107

2.01

2.24

2.2

1.4

361.69

309.04

ug/g

0.46

Unspecified visual impairment (binocular)

121

1.94

2.24

1.3

1.4

313.00

286.60

ug/g

0.21

Vasculitis limited to skin, not elsewhere classified

225

1.67

2.24

1.4

1.5

277.70

299.03

ug/g

0.27

137

Benign neoplasm of other and unspecified sites

296

1.58

2.22

1.5

1.4

249.76

285.34

ug/g

0.68

178

Other acute skin changes due to ultraviolet radiation

304

1.57

2.21

1.4

1.5

297.07

287.22

ug/g

0.11

177

Cardiomyopathy (excluding other)

155

1226

1.27

2.21

1.5

1.4

247.95

263.78

ug/g

0.45

103

719

Single delivery by caesarean section

145

1069

0.78

2.21

1.3

312.13

302.75

ug/g

0.20

539

Glaucoma-related operations

534

1.42

2.21

1.5

1.4

246.58

274.63

ug/g

0.68

314

Herpesviral keratitis and keratoconjunctivitis

385

1.50

2.20

1.6

1.4

208.00

288.32

ug/g

2.53

228

Other specific arthropathies, wide

173

1.76

2.19

1.5

302.41

292.22

ug/g

0.08

104

Generalized epilepsy, strict definition

188

1.73

2.19

1.3

300.72

321.43

ug/g

0.21

105

Inflammatory disorders of male genital organs, not elsewhere classified

2.11

2.19

1.9

1.6

260.46

264.20

ug/g

0.03

Adult respiratory distress syndrome

2.07

2.19

1.6

1.5

244.00

271.99

ug/g

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

592

1.39

2.19

1.5

265.62

281.89

ug/g

0.31

357

Other forms of systemic lupus erythematosus

2.23

2.19

1.6

1.4

387.82

316.72

ug/g

1.00

Benign neoplasm: Other/unspecified site

144

1.84

2.18

1.4

268.32

294.46

ug/g

0.32

Other condition

164

1309

1.26

2.18

1.5

1.4

283.10

284.01

ug/g

0.02

733

Pneumococcal septicemia

274

1.59

2.17

1.4

1.5

315.75

286.20

ug/g

0.31

163

Drug-induced systemic lupus erythematosus

2.29

2.16

1.1

1.4

353.78

317.51

ug/g

—

Myocarditis

370

1.50

2.16

1.6

1.3

220.49

297.16

ug/g

2.05

218

Other lesions of median nerve

251

1.62

2.15

1.5

1.4

252.64

283.32

ug/g

0.36

138

Use of rasagiline

228

1.65

2.15

1.2

1.5

285.80

273.07

ug/g

0.15

138

Polymyositis

2.27

2.15

1.2

1.4

324.89

252.51

ug/g

—

Other abnormal immunological findings in serum

152

1.81

2.15

1.4

381.20

310.84

ug/g

1.04

Benign neoplasm of other and unspecified intrathoracic organs

2.05

2.14

1.5

1.4

252.23

306.01

ug/g

0.45

Fasciculation

2.05

2.14

1.5

1.4

330.65

313.76

ug/g

0.13

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.66

2.14

2.0

1.3

222.33

305.06

ug/g

—

Schizophrenia or delusion

398

3454

1.16

2.13

1.4

281.84

277.05

ug/g

0.17

232

1934

Malignant neoplasm of rectum

113

863

1.32

2.13

1.3

1.4

249.32

271.49

ug/g

0.58

529

Allergic contact dermatitis due to drugs in contact with skin

190

1.71

2.13

1.3

1.4

269.30

296.08

ug/g

0.27

115

Melanocytic naevi of trunk

140

1100

1.28

2.13

1.4

276.89

285.59

ug/g

0.19

620

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

529

1.41

2.13

1.3

1.4

238.90

288.13

ug/g

1.47

315

Pyoderma

160

1.78

2.12

1.3

1.4

189.95

307.84

ug/g

1.86

Allergic purpura

252

1.61

2.12

1.4

307.00

309.91

ug/g

0.03

143

Other and unspecified vasculitis limited to skin

198

1.69

2.11

1.4

1.5

274.29

298.33

ug/g

0.28

124

Right ventricular outflow tract obstruction

2.32

2.11

1.4

1.5

232.67

324.38

ug/g

—

Supervision of normal pregnancy

169

1202

0.80

2.10

1.3

1.4

347.52

304.71

ug/g

1.49

615

Uterine polyps

114

874

1.31

2.09

1.4

269.80

272.89

ug/g

0.06

484

Other and unspecified nonscarring hair loss

2.39

2.08

1.3

327.25

330.33

ug/g

—

Femoral hernia, unilateral

222

1.65

2.08

1.6

1.4

278.40

284.12

ug/g

0.07

135

Inguinal hernia, unilateral

222

1.65

2.08

1.6

1.4

278.40

284.12

ug/g

0.07

135

Inguinal of femoral hernia, unilateral

222

1.65

2.08

1.6

1.4

278.40

284.12

ug/g

0.07

135

Macular hole

507

1.42

2.07

1.5

275.64

278.52

ug/g

0.04

297

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

309

1.54

2.07

1.5

1.4

325.73

351.01

ug/g

0.35

160

Inflammation of lacrimal passages (acute and unspecified)

154

1.79

2.07

1.6

1.4

318.11

310.29

ug/g

0.08

Carcinoma in situ of colon

125

1.89

2.06

1.2

1.4

220.48

281.58

ug/g

—

Congenital deformities of feet

192

1.69

2.05

1.3

1.5

256.47

303.62

ug/g

0.61

115

Ectropion of eyelid

286

1.55

2.05

1.5

301.25

264.05

ug/g

0.64

183

Melanocytic naevi of scalp and neck

162

1.75

2.04

1.4

257.89

325.60

ug/g

0.60

Retained placenta and membranes, without haemorrhage

160

1286

1.25

2.03

1.3

1.4

284.38

291.03

ug/g

0.16

708

Family history of other specific disorders

2.04

2.03

1.6

1.3

214.44

314.83

ug/g

—

Endometriosis diagnosis and infertility diagnosis occurring together

121

940

1.30

2.02

1.3

329.86

312.32

ug/g

0.34

488

Hodgkin lymphoma

185

1.70

2.02

1.6

1.4

260.81

329.96

ug/g

1.17

105

Vascular dementia (mixed)

2.03

2.02

1.3

1.4

292.42

268.87

ug/g

0.23

Oral lichen ruber planus, hypothyreosis or thyroxin

148

1.80

2.02

1.3

262.69

307.02

ug/g

0.50

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

116

897

1.30

2.02

1.3

1.5

251.86

269.85

ug/g

0.46

548

Other nonthrombocytopenic purpura

2.20

2.02

1.8

1.4

272.11

311.40

ug/g

—

Spermatocele

577

1.38

2.01

1.6

1.5

220.36

240.40

ug/g

0.43

357

Other spirochaetal diseases

335

2887

1.17

2.01

1.3

1.4

299.58

274.42

ug/g

1.57

192

1685

Malignant neoplasm of tonsil

119

1.89

2.00

1.4

1.6

218.60

272.14

ug/g

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

126

1.85

2.00

1.6

1.4

265.92

318.68

ug/g

0.57

Myeloproliferative diseases

107

820

1.32

2.00

1.4

1.5

285.83

274.91

ug/g

0.24

476

Gastrointestinal stromal tumor and sarcoma

105

1.96

2.00

1.6

1.4

260.10

287.17

ug/g

—

Intracranial and intraspinal abscess and granuloma

2.07

1.98

1.4

1.5

192.15

280.87

ug/g

1.22

Vitiligo

2.07

1.98

1.4

241.84

332.24

ug/g

0.99

Burns and corrosions confined to eye and internal organs

233

1.61

1.98

1.6

1.4

308.13

282.80

ug/g

0.36

136

Chronic Coagulation defects

202

1.66

1.98

1.6

1.4

341.17

309.14

ug/g

0.35

113

Contact with other hot fluids

241

1.60

1.97

1.3

1.4

301.86

297.17

ug/g

0.04

143

Traumatic amputation of lower leg

4.78

1.97

1.4

1.8

294.00

207.67

ug/g

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.54

1.97

2.0

1.3

222.33

272.41

ug/g

—

Renal cell carcinoma of kidney

281

1.55

1.97

1.4

238.58

276.97

ug/g

0.59

169

Other deformities of toe(s)

273

1.56

1.97

1.5

1.4

316.63

274.18

ug/g

0.65

163

Disorders of optic nerve, not elsewhere classified

172

1.72

1.96

1.5

1.4

195.31

300.13

ug/g

1.72

Primary angle-closure glaucoma

404

1.45

1.96

1.4

248.50

281.27

ug/g

0.71

231

Diabetes insipidus

2.17

1.95

1.6

1.3

273.50

303.81

ug/g

—

Autism

127

1.83

1.95

1.7

1.4

339.70

354.87

ug/g

—

Other secondary gonarthrosis

488

1.41

1.95

1.5

321.14

272.45

ug/g

1.03

301

Female infertility, associated with anovulation

445

1.42

1.95

1.2

1.3

340.28

315.18

ug/g

0.45

201

Arthropathy in ulcerative colitis

113

1.90

1.95

1.7

1.4

289.54

301.58

ug/g

0.10

Haemorrhagic disorder due to circulating anticoagulants

2.16

1.94

1.1

1.5

337.40

277.08

ug/g

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

113

1.89

1.94

1.5

1.4

259.50

309.01

ug/g

0.61

Embedded teeth, including avohilmo

667

1.34

1.93

1.2

1.3

285.85

316.15

ug/g

0.65

331

Ankylosing spondylitis, ICD10

107

824

1.31

1.93

1.3

1.4

258.78

290.19

ug/g

0.75

469

Benign neoplasm: Connective and other soft tissue, unspecified

2.09

1.93

1.4

1.3

313.70

339.43

ug/g

—

Corneal scars and opacities

227

1.61

1.93

1.5

201.88

287.84

ug/g

1.98

140

Ankylosing hyperostosis [Forestier]

1.96

1.93

1.5

1.4

261.29

294.11

ug/g

0.36

Dementia in other diseases classified elsewhere

364

1.47

1.92

1.4

1.5

273.41

262.68

ug/g

0.15

213

Burn and corrosion of trunk

235

1.59

1.92

1.4

1.5

285.04

300.51

ug/g

0.15

137

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

235

1.59

1.92

1.4

263.07

296.19

ug/g

0.53

139

Gonococcal infection

283

1.54

1.92

1.5

1.4

229.24

301.29

ug/g

1.39

159

Benign neoplasm: Long bones of lower limb

283

1.54

1.92

1.5

248.22

294.57

ug/g

0.78

166

Disorders in reading

2.03

1.92

1.1

1.4

357.14

338.54

ug/g

—

Postpartum haemorrhage

197

2068

0.83

1.92

1.2

1.4

318.41

308.07

ug/g

0.29

1088

Other and unspecified primary disorders of muscles

2.22

1.91

1.4

258.00

311.40

ug/g

—

Other disorders of pigmentation

406

1.44

1.91

1.6

1.4

268.32

290.17

ug/g

0.38

239

Haemorrhagic and haematological disorders of fetus and newborn

129

1.80

1.91

2.0

1.3

337.33

386.32

ug/g

0.52

Other or ill-defined heart diseases

422

1.43

1.91

1.4

268.48

278.97

ug/g

0.16

240

Antenatal screening

180

1238

0.82

1.90

1.3

1.4

350.12

304.66

ug/g

1.64

632

Respiratory and cardiovascular disorders specific to the perinatal period

154

1.70

1.90

1.2

1.3

399.31

363.90

ug/g

0.41

Drug-induced neutropenia

679

1.34

1.89

1.4

261.24

281.88

ug/g

0.48

399

Asthma mixed form (mode), excluding more controls

398

1.44

1.89

1.5

1.4

326.62

290.59

ug/g

0.82

212

Brain meningioma, excluding all cancers (controls excluding all cancers)

432

1.43

1.89

1.4

283.12

300.19

ug/g

0.23

246

Disturbances of smell and taste

374

1.46

1.89

1.8

1.4

292.35

293.95

ug/g

0.02

222

Other factor of the environment

100

1.94

1.88

1.4

374.67

284.63

ug/g

—

Other and unspecified nonorganic psychotic disorders

218

1824

1.20

1.88

1.4

293.23

285.73

ug/g

0.20

131

1007

Non-small cell lung cancer

122

1541

0.79

1.88

1.3

1.5

268.66

260.39

ug/g

0.16

939

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

107

1.89

1.87

1.6

1.4

304.14

286.82

ug/g

0.15

Bacterial meningitis

309

1.51

1.87

1.4

1.5

262.41

283.60

ug/g

0.33

181

Other and unspecified disease of Bartholin gland

261

1.55

1.86

1.3

1.4

311.86

306.18

ug/g

0.05

150

Open bite

375

1.45

1.85

1.4

307.65

326.33

ug/g

0.27

196

Other benign neoplasm of uterus: Other parts/unspecified

409

1.44

1.85

1.5

1.4

286.73

277.20

ug/g

0.13

240

Hypoplasia of dental enamel , including avohilmo

180

1.66

1.85

1.2

1.4

355.53

357.61

ug/g

0.02

Polycystic ovarian syndrome

375

1.45

1.85

1.4

1.3

354.60

336.41

ug/g

0.18

167

Arthropod-borne viral fevers and viral haemorrhagic fevers

116

909

1.28

1.85

1.3

1.4

289.44

276.14

ug/g

0.26

538

Alzheimer’s disease, wide definition, excluding more controls

173

959

1.23

1.85

1.3

1.4

270.80

258.11

ug/g

0.34

591

Monoplegia

130

1.80

1.84

1.2

1.4

356.51

291.46

ug/g

0.94

Malignant neoplasm of cervix uteri

145

1.76

1.84

1.2

1.3

292.44

316.93

ug/g

0.25

Hypothermia

130

1.80

1.84

1.6

1.4

194.88

276.44

ug/g

1.04

Malignant neoplasm of ovary

489

0.63

1.84

1.4

250.56

296.66

ug/g

0.61

276

Other intracranial haemorrhages

238

1.57

1.83

1.7

1.4

269.40

262.84

ug/g

0.07

143

Benign neoplasm: Spinal meninges

2.10

1.83

1.8

1.3

282.60

302.93

ug/g

—

Rheumatic fever incl heart disease

262

1.54

1.83

1.5

287.85

276.31

ug/g

0.15

153

Other misadventures during surgical and medical care

168

1.69

1.83

1.4

1.5

212.04

290.22

ug/g

1.20

100

Generalized epilepsy

360

1.46

1.82

1.3

1.4

290.69

310.56

ug/g

0.31

200

Contact with machinery

128

1018

1.27

1.82

1.5

273.38

260.13

ug/g

0.34

623

Complications of genitourinary prosthetic devices, implants and grafts

215

1.60

1.81

1.4

257.73

310.72

ug/g

0.86

124

Benign neoplasm: Lip

153

1.72

1.81

1.6

1.4

254.87

313.01

ug/g

0.76

Secondary and unspecified malignant neoplasm of lymph nodes

101

780

1.30

1.81

1.5

285.01

280.31

ug/g

0.09

473

Chondromalacia

271

1.53

1.81

1.4

1.5

301.99

303.39

ug/g

0.02

162

Complications associated with artificial fertilization

2.02

1.81

1.4

1.2

386.86

347.70

ug/g

—

Pterygium

231

1.58

1.81

1.3

1.5

327.68

276.20

ug/g

0.59

144

Asthma mixed form (mode)

402

1.43

1.81

1.5

1.4

326.62

291.90

ug/g

0.78

217

Open wound of thorax

116

1.84

1.81

1.4

1.5

242.52

291.87

ug/g

0.59

Other injuries of spine and trunk, level unspecified

2.22

1.80

1.3

1.5

280.83

276.40

ug/g

—

Cardiodefibrillation

475

4221

1.13

1.80

1.4

248.94

259.27

ug/g

0.57

293

2575

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

2.21

1.80

1.7

1.3

221.38

320.88

ug/g

—

Abscess of external ear

109

1.87

1.79

1.2

1.5

315.15

307.40

ug/g

0.07

Vascular dementia (undefined)

245

1.55

1.78

1.7

1.4

263.70

258.79

ug/g

0.06

152

Benign leiomyoma with endometriosis

224

1893

1.19

1.76

1.5

1.4

286.27

281.13

ug/g

0.16

128

1090

Secondary right heart disease

363

1.45

1.76

1.4

245.71

285.84

ug/g

0.83

223

Lymphoid leukaemia

472

1.39

1.76

1.4

1.5

274.90

273.99

ug/g

0.01

293

Pedal cyclist injured in other and unspecified transport accidents

128

1022

1.26

1.76

1.4

245.14

288.72

ug/g

1.73

564

Toxic effect of carbon monoxide

147

1.73

1.76

1.6

1.5

208.55

294.58

ug/g

1.33

Mental and behavioural disorders due to cannabinoids

185

1.64

1.76

1.3

1.4

309.53

313.37

ug/g

0.03

Hyperaldosteronism

257

1.54

1.76

1.4

286.82

280.78

ug/g

0.05

152

Other localized connective tissue disorders

178

1.66

1.75

1.3

1.4

227.22

303.92

ug/g

1.42

102

Dislocation, sprain and strain of joints and ligaments of thorax

265

1.53

1.75

1.2

1.5

297.88

290.08

ug/g

0.10

150

Mental retardation, excluding more controls

260

1.53

1.75

1.3

1.5

305.77

318.23

ug/g

0.15

161

Lyme disease

328

2857

1.15

1.75

1.3

1.4

299.58

274.03

ug/g

1.61

192

1667

Cyst of Bartholin Gland

306

1.49

1.74

1.3

288.48

319.71

ug/g

0.39

166

Other specified/unspecified hearing loss

741

1.30

1.74

1.4

257.06

270.84

ug/g

0.25

444

Transitory endocrine and metabolic disorders specific to fetus and newborn

115

1.82

1.74

1.7

1.4

348.70

376.19

ug/g

—

Burn and corrosion confined to eye and adnexa

194

1.62

1.73

1.6

1.4

307.76

283.24

ug/g

0.33

116

Lesion of femoral nerve

2.12

1.73

1.5

1.3

311.44

286.86

ug/g

—

Other and unspecified iridocyclitis

373

1.44

1.73

1.3

1.4

255.71

285.51

ug/g

0.51

219

Other benign neoplasms of uterus

517

1.37

1.73

1.5

1.4

277.88

291.53

ug/g

0.22

309

Benign neoplasm: Pharynx, unspecified

2.35

1.73

1.6

1.3

90.67

342.97

ug/g

—

Carcinoma in situ, bladder

202

1.60

1.73

1.4

1.5

238.59

275.74

ug/g

0.48

127

Single spontaneous delivery

492

2934

0.89

1.72

1.3

1.4

296.21

281.89

ug/g

0.80

266

1614

Vascular dementia

616

1.32

1.71

1.6

1.5

243.47

258.73

ug/g

0.30

391

Benign neoplasm of major salivary glands

121

965

1.26

1.70

1.4

262.28

276.98

ug/g

0.35

567

Benign neoplasm of breast

164

1352

1.22

1.70

1.4

266.52

290.56

ug/g

0.86

773

Congenital malformations of pulmonary and tricuspid valves

2.23

1.70

1.3

1.5

217.00

292.64

ug/g

—

Specific developmental disorder of motor function

109

1.83

1.70

1.4

328.13

384.93

ug/g

0.74

Papilloedema, unspecified

172

1.65

1.69

1.5

1.4

274.54

312.45

ug/g

0.33

Other appendicitis

105

825

1.28

1.67

1.3

1.4

274.97

290.52

ug/g

0.32

472

Donors of organs and tissues

1.92

1.67

1.5

1.3

306.75

331.14

ug/g

—

Secondary parkinsonism+Parkinsonism in other disease

228

1.55

1.67

1.3

1.4

246.05

277.04

ug/g

0.38

129

Alzheimer’s disease (Late onset), excluding more controls

160

874

1.23

1.67

1.3

1.4

272.25

259.28

ug/g

0.34

541

Graves disease, strict definition

117

932

1.26

1.66

1.6

1.4

280.68

303.22

ug/g

0.56

496

Acute and transient psychotic disorders

140

1138

1.24

1.66

1.4

252.47

289.86

ug/g

1.42

645

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

116

924

1.26

1.66

1.2

1.4

318.04

291.17

ug/g

0.79

497

Acute nephritic syndrome

173

1.64

1.66

1.4

1.5

263.40

282.92

ug/g

0.16

107

Glaucoma, exfoliation

130

1049

1.25

1.65

1.5

1.4

238.25

273.41

ug/g

1.57

640

Paranoid personality disorder

150

1.69

1.65

1.4

301.50

306.19

ug/g

0.04

Benign neoplasm: Skin, unspecified

360

1.43

1.65

1.4

1.5

353.23

289.00

ug/g

1.43

212

Vertical strabismus

302

1.47

1.65

1.5

1.4

260.43

295.55

ug/g

0.43

178

Dislocation of lens

105

1.84

1.65

1.3

1.5

245.83

263.27

ug/g

0.13

Benign neoplasm of middle ear and respiratory system

731

1.29

1.63

1.6

1.5

277.87

276.78

ug/g

0.02

437

Amblyopia ex anopsia

319

1.45

1.63

1.5

1.4

306.61

302.54

ug/g

0.05

173

Malignant neoplasm of head and neck

740

1.29

1.63

1.5

1.4

257.19

271.05

ug/g

0.31

449

Dislocation, sprain and strain of joints and ligaments of elbow

531

1.35

1.62

1.3

1.4

293.91

296.40

ug/g

0.04

291

Other and unspecified pemphigoid

2.12

1.62

1.7

1.4

304.67

291.04

ug/g

—

HSIL lesion of the cervix uteri, vagina or vulva

218

1853

1.18

1.62

1.3

1.4

340.55

310.18

ug/g

1.08

123

952

Other congenital malformations of intestine

2.05

1.62

1.3

352.22

303.34

ug/g

—

All dysplastic lesions of the cervix uteri

278

2404

1.16

1.61

1.3

1.4

331.45

308.12

ug/g

1.03

163

1228

Alzheimer disease, including avohilmo

320

2639

0.87

1.61

1.3

1.4

253.19

261.92

ug/g

0.34

170

1629

Malignant neoplasm of oropharynx

136

1.72

1.61

1.3

1.6

212.44

277.68

ug/g

—

Benign neoplasm: Appendix

2.04

1.61

1.3

209.00

287.86

ug/g

—

Benign neoplasm of meninges

129

1045

1.24

1.60

1.5

1.4

296.98

280.20

ug/g

0.39

598

Hereditary corneal dystrophies

296

1.47

1.60

1.5

292.56

293.49

ug/g

0.01

178

Puerperal sepsis

173

1444

1.20

1.60

1.4

296.30

291.39

ug/g

0.12

799

159

1.64

1.59

1.7

1.3

342.88

384.97

ug/g

0.48

Benign mammary dysplasia

199

1683

1.19

1.59

1.4

303.56

283.59

ug/g

0.81

122

957

Secondary parkinsonism

215

1.55

1.58

1.3

1.4

232.94

284.68

ug/g

0.74

121

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

114

1.78

1.58

1.7

1.4

236.00

302.12

ug/g

0.57

Infectious mononucleosis

620

1.31

1.58

1.4

326.17

312.30

ug/g

0.24

307

Respiratory tuberculosis, confirmed

129

1.73

1.58

1.7

1.4

330.38

277.44

ug/g

0.48

Prepatellar bursitis

338

1.43

1.58

1.4

1.5

251.23

264.22

ug/g

0.16

214

LSIL lesion of the cervix uteri

122

984

1.25

1.57

1.3

324.42

310.71

ug/g

0.35

502

404

1.39

1.57

1.6

1.5

245.71

262.87

ug/g

0.27

245

Burns and corrosions of multiple and unspecified body regions

168

1.63

1.57

1.3

1.5

225.94

280.42

ug/g

0.63

103

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

355

3138

1.14

1.56

1.4

282.35

271.78

ug/g

0.47

212

1822

Transient global amnesia

121

977

1.25

1.56

1.6

1.4

279.45

273.07

ug/g

0.14

578

Dissection of aorta

232

1.52

1.56

1.5

197.48

276.77

ug/g

1.52

139

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

106

1.80

1.55

1.2

1.3

446.00

385.41

ug/g

—

Tic disorders

2.00

1.55

1.6

1.5

289.60

311.29

ug/g

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

348

1.42

1.55

1.6

1.5

262.78

286.14

ug/g

0.37

200

Neonatal jaundice from other and unspecified causes

111

1.77

1.55

2.1

1.3

335.83

386.12

ug/g

0.44

Shoulder region

115

1.77

1.55

1.4

1.5

278.92

277.41

ug/g

0.01

100

1.82

1.54

1.3

281.57

343.66

ug/g

—

Other and specified injuries of hip and thigh

169

1.62

1.54

1.4

262.24

293.20

ug/g

0.49

Use of donepezil

157

1811

0.83

1.53

1.3

1.4

275.62

261.26

ug/g

0.38

1135

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

113

1.76

1.53

1.7

1.3

354.00

379.94

ug/g

—

Acute drug-induced interstitial lung disorder

2.21

1.53

1.1

1.4

261.20

305.34

ug/g

—

Colon adenocarcinoma

141

1160

1.22

1.52

1.4

1.5

237.12

264.95

ug/g

0.88

701

Motor disorders

115

1.76

1.52

1.4

328.13

396.85

ug/g

1.01

Striae atrophicae

1.90

1.52

1.4

1.3

341.70

325.57

ug/g

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

108

1.79

1.52

1.3

1.4

142.92

313.97

ug/g

5.41

Benign neoplasm: Parotid gland

748

1.28

1.52

1.4

263.21

277.74

ug/g

0.29

446

Benign neoplasm: salivary glands, exclude unknown (D119)

106

846

1.26

1.52

1.4

271.74

277.27

ug/g

0.10

495

Non-Hodgkin lymphoma, all

316

1.44

1.52

1.3

1.5

233.90

270.12

ug/g

0.71

200

Use of rotigotine

101

1.82

1.51

1.4

255.13

279.89

ug/g

0.20

Benign neoplasm: Tonsil

101

1.82

1.51

1.3

1.4

305.18

301.54

ug/g

0.02

Other specified/unspecified necrotizing vasculopathies

116

1.75

1.51

1.8

1.4

312.40

275.14

ug/g

0.54

Other osteochondrodysplasias

2.04

1.51

1.4

386.43

320.55

ug/g

—

Tic and related disorders

1.93

1.51

1.8

1.4

309.33

319.70

ug/g

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

168

1669

0.84

1.50

1.3

1.4

266.26

280.33

ug/g

0.39

101

1009

Chronic lymphocytic leukaemia, helper endpoint

178

1.59

1.50

1.4

235.57

295.81

ug/g

0.93

107

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

178

1.59

1.50

1.4

235.57

295.81

ug/g

0.93

107

Benign neoplasm: Pharynx, unspecified

2.16

1.46

1.6

1.3

90.67

301.47

ug/g

—

Nonischemic cardiomyopathy

489

1.34

1.46

1.4

265.49

270.17

ug/g

0.06

295

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

2.55

1.46

1.6

1.3

316.86

329.44

ug/g

—

Thyroiditis

664

1.29

1.46

1.4

292.94

298.46

ug/g

0.09

362

Macular cyst

220

1.52

1.45

1.3

1.5

274.65

273.64

ug/g

0.01

124

Pseudomembranous colitis

2.01

1.45

1.5

1.3

274.00

327.72

ug/g

—

Chorioretinal inflammation

228

1.51

1.45

1.5

1.4

255.88

310.61

ug/g

0.97

135

Carcinoma in situ of skin of lower limb, including hip

172

1.60

1.45

1.1

1.5

287.67

267.97

ug/g

0.17

100

Burns classified according to extent of body surface involved

2.01

1.45

1.2

1.6

234.63

312.93

ug/g

—

Lupus erythematosus

212

1.53

1.45

1.4

1.5

278.46

298.57

ug/g

0.17

123

Contact with sharp object, undetermined intent

156

1.62

1.45

1.4

1.5

321.66

286.59

ug/g

0.34

Spinal osteochondrosis

2.00

1.45

1.8

1.3

291.38

316.84

ug/g

—

Benign neoplasm: other/unspecified salivary gland

196

1.55

1.44

1.3

1.4

263.48

308.75

ug/g

0.75

118

Benign neoplasm: Larynx

204

1.53

1.44

1.7

1.4

264.99

311.46

ug/g

0.58

115

Benign neoplasm of brain and other parts of central nervous system

508

1.33

1.43

1.4

286.55

302.10

ug/g

0.29

292

Viral haemorrhagic fevers, not elsewhere classified/unspecified

728

1.27

1.43

1.4

291.38

281.12

ug/g

0.16

426

L02BA Anti-estrogens

161

1911

0.84

1.43

1.3

1.4

279.43

287.61

ug/g

0.21

103

1061

Other abnormal findings in urine

118

1.72

1.43

1.9

1.4

267.21

303.00

ug/g

0.27

Chronic suppurative otitis media

622

1.29

1.43

1.4

274.19

291.27

ug/g

0.32

347

Occupational exposure to risk-factors

287

1.44

1.42

1.4

1.5

288.62

277.92

ug/g

0.16

172

Viral agents as the cause of diseases classified to other chapters

189

1.55

1.42

1.5

1.4

308.91

307.39

ug/g

0.01

108

Status post-ami

503

0.71

1.42

1.3

1.5

258.79

252.27

ug/g

0.11

310

Drug-induced obesity

1.93

1.41

1.1

1.3

272.00

340.84

ug/g

—

Universal erythroderma, KELA reimbursement

111

1.74

1.41

1.4

1.5

241.82

261.49

ug/g

0.16

Vestibular neuronitis

107

864

1.25

1.41

1.4

278.23

280.50

ug/g

0.03

504

Carcinoma in situ of vulva

1.99

1.41

1.2

1.3

379.14

314.77

ug/g

—

Autism spe

134

1.66

1.40

1.7

1.4

339.70

367.31

ug/g

—

145

1.62

1.40

1.8

1.3

342.87

384.30

ug/g

0.47

Parapsoriasis

150

1.62

1.39

1.3

1.4

237.36

296.99

ug/g

1.00

Contact with other hot metals

119

1.71

1.39

1.5

274.27

292.23

ug/g

0.18

Exposure to smoke, fire and flames

198

1.53

1.39

1.4

1.5

256.18

290.53

ug/g

0.36

115

Other secondary coxarthrosis

297

1.43

1.39

1.6

1.5

266.35

295.59

ug/g

0.38

176

Mandibular retrognathia

544

1.31

1.39

1.4

287.01

308.81

ug/g

0.37

283

Burn and corrosion of ankle and foot

104

1.76

1.38

1.3

1.4

284.42

298.44

ug/g

0.08

Seropositive rheumatoid arthritis, wide

362

3233

1.12

1.38

1.4

282.82

271.92

ug/g

0.49

215

1879

Pneumothorax

590

1.30

1.38

1.4

1.5

253.23

273.33

ug/g

0.37

350

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

331

1.40

1.38

1.5

247.56

290.20

ug/g

0.94

195

Molar incisor enamel hypoplasia

202

1.52

1.38

1.3

1.4

355.53

357.14

ug/g

0.01

106

Benign neoplasm: Cerebral meninges

115

939

1.23

1.37

1.4

299.46

280.27

ug/g

0.43

542

Other disorders of central nervous system

1.86

1.37

1.3

1.4

320.75

316.88

ug/g

—

Exophthalmic conditions

1.79

1.37

1.2

1.3

281.89

314.63

ug/g

—

Other drug-induced secondary parkinsonism

1.91

1.36

1.4

293.86

285.81

ug/g

—

Mixed disorders of conduct and emotions

135

1.64

1.36

1.2

1.3

243.41

380.29

ug/g

—

Conduct disorder

143

1.62

1.36

1.5

1.4

289.36

332.13

ug/g

0.36

Malignant neoplasm of renal pelvis

0.00

1.36

0.0

1.5

—

246.92

—

Pemphigus

2.18

1.35

1.7

1.4

146.80

270.09

ug/g

—

Cerebral palsy

128

1.66

1.34

1.5

1.3

311.57

348.56

ug/g

0.43

Graves ophthalmopathy, strict

192

1.53

1.34

1.2

1.4

250.31

305.53

ug/g

0.78

114

Melanoma in situ

291

1.42

1.33

1.3

1.4

299.81

301.27

ug/g

0.02

167

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.84

1.33

1.5

1.6

324.00

255.74

ug/g

—

Migraine without aura, drug-induced

1.76

1.33

1.7

1.4

356.17

323.75

ug/g

0.24

Other degenerative diseases of the basal ganglia

121

1.68

1.32

1.5

188.50

255.91

ug/g

—

Other facial nerve disorders

225

1.48

1.32

1.5

276.60

303.61

ug/g

0.30

124

Generalized epilepsy, mode (most common among epilepsy diagnosis)

275

1.43

1.32

1.2

1.4

325.25

307.40

ug/g

0.25

157

Unspecific neurodegenerative disorder

413

3157

0.90

1.32

1.3

1.4

266.94

259.69

ug/g

0.31

228

1956

Use of rivastigmine

146

1223

1.20

1.32

1.3

1.4

246.19

267.19

ug/g

0.62

756

Cerebral aneurysm, nonruptured

110

899

1.23

1.31

1.5

1.4

291.05

281.47

ug/g

0.19

518

Other bursitis of knee

106

1.72

1.31

1.3

1.4

280.38

299.00

ug/g

—

Pervasive developmental disorders excl. Autism + Asperger

1.83

1.31

1.8

1.3

352.33

368.98

ug/g

—

Carcinoma in situ of vulva

1.93

1.31

1.2

1.3

379.14

290.43

ug/g

—

Lifestyle-related condition

1.79

1.31

1.5

1.3

367.00

296.44

ug/g

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

137

1.62

1.30

1.7

1.4

330.38

273.84

ug/g

0.52

Maternal care for known or suspected disproportion

355

0.64

1.30

1.2

1.3

360.58

316.04

ug/g

0.38

178

Injury of muscle and tendon at hip and thigh level

109

891

1.23

1.30

1.3

1.4

296.41

281.47

ug/g

0.35

521

Other superficial mycoses

153

1.59

1.30

1.5

279.46

298.34

ug/g

0.17

Unspecified contracted kidney

2.14

1.30

1.5

1.4

360.20

286.15

ug/g

—

Postpartum hemorraghe, all women as controls

197

2270

0.86

1.29

1.2

1.3

318.41

314.78

ug/g

0.09

1160

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.04

1.29

1.6

1.3

280.00

289.11

ug/g

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

210

1.49

1.29

1.3

1.4

263.67

308.33

ug/g

0.54

125

Hand

2.10

1.28

1.1

1.4

394.33

268.35

ug/g

—

Prolapse and hernia of ovary and fallopian tube

324

1.39

1.28

1.3

294.25

271.78

ug/g

0.36

182

Other/unspecified seropositive rheumatoid arthritis

356

3194

1.12

1.28

1.4

282.35

272.00

ug/g

0.46

212

1861

Delivery

507

2942

0.91

1.27

1.3

1.4

300.56

281.91

ug/g

1.17

273

1616

Maternal care for other known or suspected fetal problems

239

1337

1.15

1.27

1.3

317.56

314.79

ug/g

0.06

104

669

Congenital deformities of hip

146

1.59

1.27

1.2

1.3

328.33

335.52

ug/g

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

616

1.27

1.4

1.5

311.05

278.55

ug/g

0.52

368

Retinoschisis and retinal cysts

203

1.50

1.26

1.3

1.5

237.34

280.58

ug/g

0.59

120

Non-small cell lung cancer, squamous

328

0.64

1.26

1.0

1.5

188.33

260.15

ug/g

1.05

212

Non-small cell lung cancer, squamous, helper endpoint

328

0.64

1.26

1.0

1.5

188.33

260.15

ug/g

1.05

212

Urethral stricture

449

1.32

1.26

1.5

248.75

262.31

ug/g

0.21

270

Evidence of alcohol involvement determined by blood alcohol level

115

1.68

1.26

1.8

1.4

224.18

296.68

ug/g

0.80

Exposure to unspecified smoke, fire and flames

1.89

1.25

1.0

1.4

233.00

286.70

ug/g

—

Thyrotoxicosis with toxic multinodular goitre

591

1.28

1.25

1.3

1.4

296.02

286.42

ug/g

0.14

335

Perichondritis of external ear

147

1.59

1.24

1.2

1.4

283.57

281.67

ug/g

0.02

Congenital malformations of anterior segment of eye

1.94

1.24

1.6

1.4

264.40

321.33

ug/g

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

459

1.32

1.24

1.5

1.3

341.29

317.76

ug/g

0.40

217

Melanoma in situ of trunk

108

1.70

1.24

1.4

1.5

271.75

266.25

ug/g

0.05

Dementia in Alzheimer disease

136

1381

0.84

1.24

1.3

1.4

250.29

261.14

ug/g

0.26

860

Behavioural disorders

147

1.58

1.24

1.6

1.4

278.17

328.44

ug/g

0.47

Pemphigoid

229

1.46

1.23

1.5

1.4

255.93

277.64

ug/g

0.16

127

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

320

1740

1.13

1.23

1.4

1.5

258.89

267.47

ug/g

0.28

193

1059

Sequelae of other and unspecified infectious and parasitic diseases

486

1.30

1.23

1.6

1.4

301.92

293.70

ug/g

0.11

272

Benign neoplasm: Conjunctiva

288

1.40

1.22

1.5

299.11

281.63

ug/g

0.23

166

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.82

1.22

1.4

303.80

317.03

ug/g

—

Other disorders of binocular vision

1.74

1.22

1.5

1.4

271.71

318.70

ug/g

—

Accidental poisoning by and exposure to alcohol

124

1.63

1.22

1.3

1.4

282.14

313.20

ug/g

—

Sixth [abducent] nerve palsy

280

1.41

1.21

1.3

1.4

270.07

267.64

ug/g

0.03

165

Burn and corrosion of hip and lower limb, except ankle and foot

172

1.53

1.21

1.4

340.47

290.41

ug/g

0.62

Open wound of neck

1.87

1.21

1.5

1.3

247.51

299.94

ug/g

—

Malignant neoplasm of bone and articular cartilage

1.87

1.21

1.7

1.5

251.67

287.53

ug/g

—

Postdysenteric arthropathy

1.86

1.21

1.5

230.25

295.73

ug/g

—

Emergency coronary revascularization (for ACS)

737

4919

1.08

1.21

1.5

1.4

255.52

259.69

ug/g

0.23

476

2974

Malignant neoplasm of oesophagus

197

1.49

1.20

1.3

1.6

282.77

256.12

ug/g

0.39

120

Disorders of eyelid in diseases classified elsewhere

272

1.41

1.20

1.7

1.4

298.04

284.95

ug/g

0.16

161

Cauda equina syndrome

117

1.65

1.20

1.6

1.5

241.72

279.51

ug/g

0.37

Melanocytic naevi of lower limb, including hip

393

1.33

1.19

1.6

1.5

247.54

291.70

ug/g

0.84

225

Inflammation of lacrimal passages (chronic)

133

1.60

1.19

1.4

297.00

291.88

ug/g

0.04

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

579

4669

1.09

1.19

1.4

1.3

303.25

295.19

ug/g

0.41

350

2498

Calcific tendinitis

1.81

1.18

1.3

1.4

375.63

324.26

ug/g

—

Hyperkinetic disorders (excl. ADHD)

116

1.64

1.18

1.1

1.4

291.33

351.66

ug/g

—

Encephalitis

231

1.44

1.18

1.7

1.4

263.92

316.21

ug/g

0.51

130

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

307

1.38

1.18

1.4

1.5

215.61

295.90

ug/g

1.82

173

Toxic effect of alcohol

190

1.49

1.17

1.4

217.86

290.69

ug/g

0.80

112

Carcinoma in situ of other and unspecified sites

282

1.40

1.17

1.4

1.5

216.38

258.97

ug/g

0.71

179

Myeloproliferative diseases (CML excluded)

740

1.24

1.17

1.4

293.66

277.72

ug/g

0.36

433

Persistent delusional disorders

713

1.24

1.17

1.4

269.70

285.88

ug/g

0.31

399

Other disorders originating in the perinatal period

1.76

1.17

1.4

1.3

335.50

368.56

ug/g

—

Crossbite

503

1.28

1.16

1.4

319.35

320.09

ug/g

0.01

259

Viral pneumonia (known virus, not influenza)

199

1.47

1.16

1.2

1.4

275.64

292.23

ug/g

0.17

112

Disorders of synovium and tendon in diseases classified elsewhere

158

1.54

1.16

1.3

1.5

279.56

293.69

ug/g

0.13

Constitutional tall stature

2.54

1.16

1.0

1.4

452.40

422.50

ug/g

—

Unspecified parasitic disease

1.88

1.15

1.8

1.4

310.83

295.07

ug/g

—

Mature T/NK-cell lymphomas, hilmo

103

1.68

1.14

1.8

1.5

269.83

262.23

ug/g

0.07

Antepartum haemorrhage, not elsewhere classified

688

1.24

1.14

1.3

310.97

310.99

ug/g

0.00

354

Dental caries 3 and operation codes, only avohilmo

467

2140

1.10

1.14

1.4

300.72

282.40

ug/g

0.91

242

1223

Abdominal aortic aneurysm (AAA)

799

1.22

1.13

1.5

247.38

248.56

ug/g

0.02

506

Other osteochondropathies

635

1.25

1.13

1.3

1.4

427.22

288.20

ug/g

0.75

353

Postzoster neuralgia

119

1.62

1.13

1.2

1.4

358.18

275.43

ug/g

1.62

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

546

1.27

1.13

1.4

1.3

332.06

331.38

ug/g

0.01

257

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

192

1.47

1.12

1.4

243.63

294.83

ug/g

0.73

112

Non-seminoma of testis

2.30

1.11

1.6

1.4

316.86

326.44

ug/g

—

Malignant neoplasm of endocrine gland

691

1.24

1.11

1.4

318.45

291.83

ug/g

0.64

385

Other and unspecified acne

1.69

1.11

1.3

1.4

227.31

318.02

ug/g

—

Contusion of ankle

311

1.36

1.11

1.7

1.5

247.29

303.63

ug/g

1.06

176

Acute hepatitis A

2.00

1.10

1.9

1.5

263.75

258.16

ug/g

—

Hypertrophy of (infrapatellar) fat pad

1.76

1.10

1.4

1.3

227.00

323.98

ug/g

—

Other encephalitis

218

1.44

1.10

1.7

1.4

268.15

317.17

ug/g

0.44

123

Erythema nodosum

269

1.39

1.09

1.4

248.53

287.70

ug/g

0.58

158

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

205

1956

0.88

1.09

1.4

270.86

278.09

ug/g

0.20

128

1182

Other meningitis

128

1.58

1.09

1.3

1.4

225.50

315.95

ug/g

1.41

Dementia due to Parkinsons disease, excluding more controls

136

1.56

1.09

1.5

264.15

256.47

ug/g

0.06

Calcific aortic valvular stenosis, diagnosis (helper)

351

3113

1.11

1.09

1.4

245.06

259.37

ug/g

0.71

220

1904

Operations 2 for CAVS

351

3113

1.11

1.09

1.4

245.06

259.37

ug/g

0.71

220

1904

Schizotypal disorder

202

1.45

1.08

1.4

277.00

307.17

ug/g

0.28

107

Iliotibial band syndrome

1.78

1.08

1.4

1.3

308.38

346.70

ug/g

—

Congenital malformations of cardiac septa

610

1.24

1.07

1.5

1.4

273.19

313.72

ug/g

0.96

331

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

1.96

1.07

1.3

260.80

295.22

ug/g

—

Infections of genitourinary tract in pregnancy

107

894

1.20

1.07

1.3

1.4

298.31

298.29

ug/g

0.00

476

Respiratory disorders in diseases classified elsewhere

113

1.62

1.07

1.6

1.4

292.42

296.71

ug/g

0.03

Hepatocellular carcinoma

145

1.53

1.07

1.0

1.6

341.08

255.10

ug/g

1.13

Calcific aortic valvular stenosis, including rheumatic fever

352

3124

1.10

1.06

1.4

245.03

259.39

ug/g

0.72

221

1909

Follicular lymphoma, hilmo

392

1.31

1.06

1.4

1.5

282.73

276.81

ug/g

0.10

234

Other disorders of binocular movement

178

1.47

1.06

1.5

1.4

247.36

326.84

ug/g

1.32

102

Normotensive glaucoma

102

850

1.21

1.06

1.4

1.5

270.82

272.34

ug/g

0.02

512

Calcific aortic valvular stenosis, operated

351

3119

1.10

1.05

1.4

245.06

259.55

ug/g

0.73

220

1909

Calcific aortic valvular stenosis

351

3119

1.10

1.05

1.4

245.06

259.55

ug/g

0.73

220

1909

Carcinoma in situ of skin of ear and external auricular canal

1.81

1.05

1.6

1.5

344.17

256.05

ug/g

—

Atrial septal defect

355

1.33

1.05

1.5

1.4

266.24

318.87

ug/g

0.87

204

Localized skin eruption due to drugs and medicaments

1.69

1.05

1.1

1.3

395.00

298.57

ug/g

—

Anomalies of pupillary function

162

1.50

1.05

1.4

291.00

315.73

ug/g

0.17

Benign neoplasm: Spinal cord

1.69

1.05

1.5

1.4

213.33

330.59

ug/g

—

Schizoaffective disorder

660

1.23

1.05

1.4

316.89

296.23

ug/g

0.41

356

Cutis laxa senilis

1.77

1.04

1.3

249.88

272.35

ug/g

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.66

1.04

1.4

1.3

313.70

301.89

ug/g

—

Other and unspecified vascular occlusions

101

842

1.21

1.04

1.5

1.4

241.91

271.78

ug/g

0.91

501

Other and unspecified corneal deformities and disorders

289

1.36

1.04

1.4

213.39

295.48

ug/g

1.64

169

Injury of nerves at forearm level

114

1.60

1.04

1.3

1.4

120.17

284.37

ug/g

—

Septal defects

576

1.25

1.04

1.5

1.4

291.79

318.65

ug/g

0.52

319

Melanocytic naevi of ear and external auricular canal

2.10

1.04

1.0

1.1

329.71

360.43

ug/g

—

Other melanin hyperpigmentation

196

1.44

1.03

1.5

255.95

271.42

ug/g

0.18

122

Androgenic alopecia

1.72

1.03

1.4

1.3

326.50

334.91

ug/g

—

Other congenital malformations of circulatory system

230

1.41

1.03

1.6

1.5

353.32

300.58

ug/g

0.85

143

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

272

1.37

1.02

1.4

375.57

329.25

ug/g

0.73

144

Tuberculosis, IBD comorbidity

635

1.23

1.02

1.5

1.4

263.72

270.11

ug/g

0.09

374

Benign neoplasm: Spinal meninges

1.68

1.02

1.8

1.3

282.60

306.37

ug/g

—

Hirsutism in women

155

1.50

1.02

1.6

1.3

283.40

335.52

ug/g

0.53

Any dementia, excluding more controls

394

2497

1.10

1.02

1.4

267.79

255.81

ug/g

0.57

210

1554

All dysplastic lesions of the vagina

239

1.39

1.01

1.4

305.95

302.15

ug/g

0.03

128

Other bullous disorders

231

1.40

1.00

1.6

1.4

284.72

302.59

ug/g

0.17

141

Chronic iridocyclitis

440

1.28

1.00

1.4

1.5

239.16

293.87

ug/g

1.47

260

Unspecified abortion

467

1.27

1.00

1.4

323.11

308.08

ug/g

0.22

259

Other retinal artery occlusion

181

1.45

0.99

1.5

204.75

268.81

ug/g

0.90

109

Other injuries of upper limb, level unspecified

1.69

0.99

1.3

1.4

222.57

308.03

ug/g

—

Crushing injury of ankle and foot

0.00

0.99

0.0

1.6

—

246.89

—

Use of riluzole

0.00

0.99

0.0

1.5

—

302.38

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

148

1.50

0.99

1.4

1.3

252.12

298.13

ug/g

0.59

Family history of other conditions

1.69

0.99

1.4

1.3

323.84

313.82

ug/g

—

Graves ophthalmopathy

215

1.41

0.98

1.2

1.4

272.88

305.64

ug/g

0.35

126

Multiple delivery

882

0.81

0.98

1.3

1.4

408.14

287.87

ug/g

4.20

463

Pre-eclampsia or poor fetal growth

338

3071

1.10

0.97

1.4

1.3

305.99

302.64

ug/g

0.10

187

1609

Sequelae of infectious and parasitic diseases

703

1.21

0.97

1.6

1.4

275.74

288.62

ug/g

0.24

400

Seropositive rheumatoid arthritis, strict definition

148

1701

0.87

0.97

1.4

287.84

278.18

ug/g

0.28

982

Maternal care for cervical incompetence

372

1.30

0.96

1.4

244.08

310.18

ug/g

1.27

204

Left ventricular outflow tract obstruction, narrow definition

416

1.28

0.96

1.4

1.5

272.33

297.90

ug/g

0.32

249

Benign neoplasm: Parathyroid gland

1.71

0.96

1.5

1.3

312.57

304.67

ug/g

—

Bullous pemphigoid

174

1.45

0.96

1.3

1.4

272.50

278.82

ug/g

—

Intrahepatic Cholestasis of Pregnancy (ICP)

559

1.24

0.96

1.4

1.3

332.06

327.27

ug/g

0.07

270

Hodgkin lymphoma, hilmo

225

1.39

0.95

1.6

1.4

260.81

300.42

ug/g

0.56

127

Postpartum hemorraghe, parous women as controls

197

1945

0.88

0.95

1.2

1.3

318.41

321.09

ug/g

0.06

1015

Crushing injury of wrist and hand

125

1.54

0.95

1.5

1.6

216.85

286.80

ug/g

0.80

HSIL lesion of the cervix uteri

183

1614

1.14

0.95

1.3

1.4

332.61

313.54

ug/g

0.50

101

825

Benign neoplasm: Bronchus and lung

1.63

0.95

1.3

316.88

323.42

ug/g

—

Benign neoplasm: Vagina

109

1.58

0.95

1.3

331.00

307.90

ug/g

—

Benign neoplasm of ovary

214

1908

1.13

0.94

1.4

264.83

300.71

ug/g

1.85

137

1081

Distal bite

258

1.36

0.94

1.4

335.28

323.76

ug/g

0.13

128

Malignant melanoma

172

1513

1.14

0.94

1.4

285.74

268.57

ug/g

0.62

111

909

Focal epilepsy

242

2172

1.12

0.94

1.4

260.26

278.19

ug/g

0.73

140

1259

Hypertrichosis

175

1.44

0.94

1.6

1.3

273.71

337.59

ug/g

0.79

Malignant neoplasm of prostate

400

2747

0.92

0.93

1.4

1.5

259.33

245.12

ug/g

0.69

249

1697

Pedestrian injured in collision with car, pick-up truck or van

209

1.40

0.93

1.7

1.4

266.86

305.36

ug/g

0.39

123

Lymphangioma, anys site

1.85

0.93

1.4

1.3

316.80

313.40

ug/g

—

Melanocytic naevi of scalp and neck

201

1.41

0.92

1.4

257.89

310.47

ug/g

0.44

117

Cysts of oral region, not elsewhere classified

366

1.29

0.92

1.6

1.4

231.94

275.13

ug/g

0.75

225

Burn and corrosion of head and neck

176

1.43

0.91

1.3

1.5

254.06

269.52

ug/g

0.14

103

Convergence insufficiency and excess

102

1.59

0.91

1.5

1.4

235.50

340.70

ug/g

—

Essential (haemorrhagic) thrombocythaemia

279

1.34

0.91

1.5

1.4

274.17

300.68

ug/g

0.36

159

Superficial injury of neck

143

1.48

0.90

1.3

1.4

288.73

303.46

ug/g

0.11

Benign neoplasm: Lip

185

1.42

0.90

1.6

1.5

254.87

282.32

ug/g

0.30

112

Embedded and impacted teeth

234

1785

1.12

0.90

1.4

301.02

311.22

ug/g

0.27

117

893

Congenital malformations of the respiratory system

160

1.45

0.90

1.7

1.4

297.94

305.21

ug/g

0.07

Caught, crushed, jammed or pinched in or between objects

412

1.27

0.89

1.4

294.51

303.14

ug/g

0.12

229

Polycystic ovarian syndrome, broad definition

802

1.19

0.89

1.3

353.70

331.02

ug/g

0.40

375

Other and unspecified haemorrhagic conditions

119

1.53

0.89

1.7

1.4

303.17

313.05

ug/g

—

Malignant neoplasm of oral cavity

289

1.33

0.89

1.5

259.21

268.70

ug/g

0.12

171

Other and unspecified disorders of psychological development

1.70

0.88

1.0

1.4

435.80

366.03

ug/g

—

Localized scleroderma [morphea]

136

1.49

0.88

1.3

1.4

227.08

305.84

ug/g

1.03

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.75

0.87

1.6

1.4

280.00

315.48

ug/g

—

Central retinal artery occlusion

161

1.44

0.87

1.4

1.5

286.90

261.52

ug/g

—

Systemic atrophies primarily affecting the central nervous system

368

0.73

0.87

1.2

1.5

236.67

280.46

ug/g

0.62

218

Other disorders of breast and lactation associated with childbirth

128

1.50

0.86

1.4

1.3

283.33

345.35

ug/g

—

Liveborn infants according to place of birth

1.80

0.86

1.1

1.3

419.40

379.92

ug/g

—

Other and unspecified acute skin changes due to ultraviolet radiation

221

1.37

0.86

1.4

1.5

293.62

269.26

ug/g

0.31

126

Disorders of brain, other and unspecified

1.69

0.86

1.4

267.43

333.24

ug/g

—

Tuberculosis, wide

668

1.20

0.86

1.5

1.4

270.95

271.75

ug/g

0.01

393

Paralytic strabismus

650

1.21

0.86

1.4

275.14

280.44

ug/g

0.09

385

Other and unspecified mental retardation

145

1.46

0.86

1.1

1.3

345.22

342.00

ug/g

0.03

Scleritis

1.58

0.85

1.8

1.4

263.10

299.47

ug/g

—

Oral leukoplakia, including avohilmo

239

1.35

0.85

1.3

1.4

247.06

278.31

ug/g

0.45

139

Torsion of testis

104

1.55

0.85

1.4

1.5

109.24

310.73

ug/g

—

Alzheimer disease

275

2278

0.91

0.85

1.3

1.4

259.43

261.33

ug/g

0.05

137

1418

Acute myringitis

1.79

0.85

1.5

1.4

198.80

317.80

ug/g

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

371

1.28

0.84

1.4

1.5

241.06

283.97

ug/g

0.82

229

L01XX Other antineoplastic agents

515

1.23

0.84

1.4

1.5

298.12

277.12

ug/g

0.44

315

Polypectomy (DHB20)

624

1.21

0.84

1.4

1.5

261.35

267.42

ug/g

0.09

376

Injury of muscle and tendon at ankle and foot level

205

1.38

0.84

1.4

277.30

305.48

ug/g

0.33

124

Injury of nerves at ankle and foot level

1.72

0.83

1.7

1.4

256.83

309.54

ug/g

—

Congenital malformations of aortic and mitral valves

345

1.28

0.83

1.4

1.5

269.13

292.23

ug/g

0.25

206

Alzheimer’s disease (Atypical or mixed), excluding more controls

468

1.22

0.83

1.2

1.4

248.56

258.19

ug/g

0.15

297

Carcinoma in situ of other and unspecified genital organs

146

1.45

0.83

1.2

1.4

321.30

325.52

ug/g

—

Gestational diabetes (for exclusion)

368

2399

1.09

0.83

1.3

308.87

317.01

ug/g

0.28

192

1208

Open bite that required surgery (Lefort1 or BSSRO)

1.71

0.83

1.0

1.3

361.94

357.70

ug/g

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

304

1664

1.10

0.83

1.4

1.5

256.69

265.56

ug/g

0.29

182

1012

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.71

0.83

1.1

1.3

274.80

335.21

ug/g

—

Focal epilepsy, strict definition

222

2001

1.11

0.83

1.4

258.31

278.03

ug/g

0.76

126

1159

Cicatricial alopecia [scarring hair loss]

1.67

0.83

1.2

1.4

384.67

310.80

ug/g

—

Carcinoma in situ of breast, intraductal

101

865

1.17

0.82

1.3

1.4

305.78

307.20

ug/g

0.02

489

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.57

0.82

1.3

1.4

359.11

322.91

ug/g

—

Abnormal spermatozoa

123

1070

1.15

0.82

1.4

1.5

290.58

245.39

ug/g

1.51

678

Other benign neoplasm of uterus: Other parts/unspecified

472

1.24

0.82

1.5

1.4

286.73

273.75

ug/g

0.18

269

Benign neoplasm of thyroid gland

267

1.32

0.81

1.5

1.4

267.00

320.89

ug/g

0.80

153

Alopecia areata

224

1.35

0.80

1.5

1.4

307.71

312.12

ug/g

0.04

131

Placenta praevia

363

0.74

0.80

1.4

1.3

261.78

311.41

ug/g

0.43

185

Horner syndrome

106

1.53

0.80

1.0

1.4

456.20

280.54

ug/g

—

Other and unspecified injuries of wrist and hand

321

1.29

0.79

1.6

1.5

305.62

302.55

ug/g

0.03

179

Valvular operations

155

1373

1.13

0.79

1.4

266.57

262.80

ug/g

0.09

103

810

Benign neoplasm: Skin of scalp and neck

173

1.40

0.79

1.4

1.3

247.64

313.38

ug/g

0.64

Parkinson's disease, including avohilmo

176

1572

1.12

0.79

1.4

276.17

262.30

ug/g

0.41

108

963

Aphakia

106

1.52

0.79

1.9

1.4

219.45

254.17

ug/g

0.33

Maternal care for known or suspected fetal abnormality and damage

114

1165

0.87

0.78

1.3

356.46

310.57

ug/g

1.51

596

Acute appendicitis, with complications

235

2135

1.10

0.77

1.5

1.4

290.93

273.32

ug/g

0.64

141

1257

Motorcycle rider injured in other and unspecified transport accidents

466

1.23

0.77

1.5

1.4

291.46

295.34

ug/g

0.05

265

Lagophthalmos

107

1.52

0.77

1.4

1.5

299.45

280.94

ug/g

0.14

Abnormal findings on antenatal screening of mother

530

1.21

0.76

1.3

336.04

325.87

ug/g

0.14

244

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

659

0.82

0.76

1.5

1.4

253.38

300.03

ug/g

1.25

380

Focal epilepsy, mode (most common among epilepsy diagnosis)

207

1870

1.11

0.76

1.3

1.4

260.30

278.41

ug/g

0.66

118

1077

Benign neoplasm: Appendix

1.56

0.76

1.3

1.4

209.00

278.85

ug/g

—

Exposure to excessive natural cold

1.62

0.75

1.2

1.5

245.40

278.36

ug/g

—

N06DA Anticholinesterases

312

2738

0.92

0.75

1.3

1.4

261.42

260.05

ug/g

0.04

171

1677

Use of anticholinesterases

312

2738

0.92

0.75

1.3

1.4

261.42

260.05

ug/g

0.04

171

1677

Use of biperiden

487

1.22

0.74

1.3

1.4

277.49

283.36

ug/g

0.08

282

Benign neoplasm: Skin of upper limb, including shoulder

133

1.44

0.74

1.2

1.4

323.68

319.86

ug/g

0.04

Sequelae of other accidents

108

1.50

0.74

1.1

1.5

318.71

296.66

ug/g

—

Other benign neoplasms of uterus

588

1.20

0.74

1.5

1.4

277.88

275.48

ug/g

0.03

342

Congenital malformations of great arteries

181

1.37

0.74

1.3

276.27

350.08

ug/g

0.87

101

Outcome of delivery

132

928

0.88

0.74

1.2

1.4

329.95

309.01

ug/g

0.50

474

Traumatic ischaemia of muscle

100

1.52

0.73

1.2

1.4

281.38

288.47

ug/g

—

Complications predominantly related to the puerperium

290

2669

1.09

0.73

1.4

1.3

309.60

296.85

ug/g

0.50

151

1398

Tarsal tunnel syndrome

1.54

0.73

1.7

1.4

208.13

328.91

ug/g

—

Bus occupant injured in other and unspecified transport accidents

1.70

0.73

1.3

1.4

192.00

300.23

ug/g

—

Benign neoplasm: Cranial nerves

211

1.34

0.72

1.3

1.5

298.12

316.00

ug/g

0.20

125

Malignant neoplasm of thyroid gland

664

1.18

0.71

1.4

326.34

291.97

ug/g

0.90

369

Other and unspecified degenerative diseases of nervous system

177

1.37

0.71

2.0

1.5

173.33

270.25

ug/g

1.19

100

Rubella [German measles]

309

1.27

0.71

1.2

1.5

310.97

262.14

ug/g

0.64

189

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

245

2568

0.91

0.71

1.3

1.4

278.23

292.97

ug/g

0.55

135

1443

Noise effects on inner ear

327

1.26

0.71

1.6

1.5

285.00

260.03

ug/g

0.39

205

Tooth agenesis EXCLUDE clefts and syndromes

247

1.30

0.70

1.7

1.4

334.98

321.59

ug/g

0.15

117

Use of levodopa decarboxylase inhibitor

146

1302

1.12

0.70

1.5

259.58

261.55

ug/g

0.04

791

Other specified disorders of external ear

301

1.27

0.70

1.3

1.5

347.72

274.43

ug/g

1.79

184

Benign neoplasm of other and unspecified female genital organs

400

1.23

0.70

1.3

1.4

329.00

305.69

ug/g

0.31

221

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

749

1.17

0.70

1.4

1.3

324.91

313.32

ug/g

0.21

385

Lymphangioma, anys site

1.66

0.69

1.4

316.80

285.63

ug/g

—

Abnormalities of forces of labour

953

0.86

0.69

1.4

316.43

300.48

ug/g

0.31

516

Use of interferon beta-1a

192

0.67

0.68

1.5

1.3

278.03

325.03

ug/g

—

102

Chronic suppurative otitis media, including avohilmo

742

1.16

0.68

1.4

279.27

290.76

ug/g

0.21

412

Malignant melanoma of skin

126

1117

1.13

0.67

1.4

290.78

271.57

ug/g

0.58

657

Erectile dysfunction

706

1.17

0.67

1.4

1.5

294.62

247.69

ug/g

1.34

461

Dental caries 1 and operation codes, only avohilmo

402

1887

1.07

0.66

1.5

1.4

297.52

278.95

ug/g

0.91

220

1082

Prophylactic surgery

1.64

0.66

1.0

1.3

251.00

316.30

ug/g

—

Inflammatory disorders of breast

531

1.19

0.66

1.3

303.56

307.35

ug/g

0.05

274

Toxic effect of contact with venomous animals

358

1.24

0.65

1.4

1.5

281.24

298.39

ug/g

0.20

209

Hypotension due to drugs

1.49

0.64

1.7

1.4

373.50

262.08

ug/g

—

Ankylosing spondylitis, strict definition

368

1.23

0.64

1.4

279.72

308.28

ug/g

0.33

202

Bicuspidal aortic valve syndrome

296

1.26

0.64

1.4

1.5

260.32

278.56

ug/g

0.17

173

Nystagmus and other irregular eye movements

112

1.44

0.64

1.4

227.70

337.02

ug/g

—

Subacute thyroiditis

296

1.26

0.64

1.5

1.4

297.00

303.08

ug/g

0.06

164

Melanocytic naevi of other and unspecified parts of face

441

1.21

0.64

1.4

315.48

322.44

ug/g

0.08

236

Parkinson's disease, strict definition

155

1397

1.11

0.64

1.4

1.5

274.19

261.19

ug/g

0.35

857

Medical treatment for female infertility

162

1787

0.90

0.64

1.3

315.04

322.55

ug/g

0.14

902

Pneumoconiosis due to asbestos and other mineral fibres

138

1.39

0.63

1.4

1.5

277.58

240.98

ug/g

0.39

Chromosomal abnormalities, not elsewhere classified

181

1.33

0.63

1.3

348.07

328.25

ug/g

0.27

102

Other benign neoplasms of connective and other soft tissue

851

1.14

0.62

1.5

1.4

304.36

307.24

ug/g

0.05

481

Other congenital malformations of peripheral vascular system

1.47

0.62

2.0

1.4

267.56

303.62

ug/g

—

Serous carcinoma of ovary

368

0.78

0.62

1.2

1.4

277.19

293.85

ug/g

0.21

210

Monoarthritis, not elsewhere classified

334

1.23

0.61

1.5

1.4

208.31

273.65

ug/g

1.02

198

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

122

1286

0.89

0.60

1.3

1.4

268.66

281.42

ug/g

0.26

774

Other congenital malformations of skin

353

1.22

0.60

1.5

1.4

293.26

309.91

ug/g

0.16

194

Alzheimer’s disease (Early onset), excluding more controls

239

1.27

0.60

1.2

1.4

297.20

275.02

ug/g

0.28

140

Golimumab

290

1.25

0.60

1.5

311.62

299.27

ug/g

0.14

161

Congenital malformations of breast

131

1.38

0.59

1.3

1.4

324.13

316.03

ug/g

—

Chalazion

118

1053

1.12

0.59

1.4

268.07

282.95

ug/g

0.34

607

Oral leukoplakia

166

1.34

0.59

1.3

1.4

238.23

284.84

ug/g

0.75

LSIL lesion of the vagina

140

1.37

0.59

1.5

1.4

343.23

315.61

ug/g

0.22

Eclampsia

0.00

0.59

0.0

1.2

—

380.88

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

762

1.15

0.58

1.4

1.3

324.91

310.62

ug/g

0.27

391

Exposure to other specified electric current

1.47

0.58

1.4

1.3

457.80

329.03

ug/g

—

Vascular syndromes of brain in cerebrovascular disorders

382

1.21

0.58

1.6

1.5

292.94

271.59

ug/g

0.26

235

Foreign body in ear

149

1.35

0.58

1.1

1.4

333.83

301.96

ug/g

0.37

Myocardial infarction, unclassifiable

206

1997

0.92

0.58

1.4

238.41

256.96

ug/g

0.70

121

1220

Premature separation of placenta [abruptio placentae]

196

0.71

0.58

1.4

1.3

263.86

321.65

ug/g

—

Polyhydramnios

346

1.22

0.57

1.3

302.35

314.32

ug/g

0.10

174

Pregnancy examination and test

154

870

1.11

0.57

1.3

1.4

329.62

308.25

ug/g

0.50

432

Reiter disease

1.68

0.57

1.2

1.5

161.83

302.31

ug/g

—

Rheumatic valve diseases

167

1.33

0.57

1.6

1.4

244.53

284.96

ug/g

0.45

Alzheimer’s disease, wide definition

213

1930

0.92

0.56

1.3

1.4

260.50

261.93

ug/g

0.03

106

1214

Measles

107

1.42

0.56

1.9

1.4

212.41

318.22

ug/g

—

Acute poliomyelitis

133

1.37

0.56

1.6

1.3

259.31

295.92

ug/g

0.35

Crowding of teeth, including avohilmo

538

1.15

0.55

1.2

1.4

341.42

339.42

ug/g

0.02

260

Paraplegia, diplegia of upper limbs

177

1.31

0.55

1.8

1.4

244.12

287.17

ug/g

0.56

Poor fetal growth

105

936

1.12

0.55

1.4

1.3

317.58

327.58

ug/g

0.17

449

Retinal breaks without detachment

181

1661

1.09

0.55

1.5

1.4

271.36

273.89

ug/g

0.06

107

982

Maxillary retrognathism

125

1.37

0.54

1.4

307.19

313.13

ug/g

0.03

Desensitization to allergens

414

1.19

0.53

1.4

310.33

326.09

ug/g

0.14

211

Car occupant injured in noncollision transport accident

295

1.23

0.53

1.3

1.5

241.33

302.13

ug/g

1.11

161

Other, unspecified and serous retinal detachments

268

1.24

0.53

1.3

1.5

309.21

288.49

ug/g

0.24

156

Diffuse large B-cell lymphoma

424

1.19

0.52

1.7

1.5

205.08

281.14

ug/g

2.26

256

Aneurysms, operations, SAH

192

1771

1.09

0.52

1.5

1.4

300.50

272.60

ug/g

1.05

114

1058

Migraine with aura, drug-induced

0.60

0.52

1.2

1.3

351.50

311.18

ug/g

—

Benign neoplasm: Vagina

126

1.36

0.52

1.3

331.00

289.84

ug/g

—

Parkinson's disease

166

1522

1.09

0.52

1.4

1.5

274.56

261.61

ug/g

0.38

104

934

Carcinoma in situ of skin of ear and external auricular canal

1.46

0.52

1.6

1.5

344.17

235.91

ug/g

—

Congenital malformations of the nervous system

170

1.30

0.52

1.2

1.4

374.29

342.37

ug/g

0.30

Peripheral retinal degeneration

278

1.23

0.51

1.5

273.65

299.74

ug/g

0.32

159

Iridocyclitis in diseases classified elsewhere

144

1.33

0.51

1.5

1.4

236.25

279.04

ug/g

—

malignant neoplasm of male genital organs

419

2807

0.95

0.51

1.4

1.5

257.19

247.07

ug/g

0.44

260

1733

Papillary adenocarcinoma of thyroid gland

491

1.17

0.50

1.3

1.4

342.13

300.81

ug/g

1.29

277

Pedal cyclist injured in transport accident

246

2296

1.07

0.50

1.4

241.95

278.70

ug/g

2.16

145

1301

Fourth [trochlear] nerve palsy

198

1.27

0.50

1.5

1.4

279.87

291.70

ug/g

0.11

119

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

189

1.28

0.50

1.3

1.4

215.50

295.24

ug/g

1.60

112

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.44

0.49

1.2

1.4

348.17

363.67

ug/g

—

Guillain-Barre syndrome

136

1.33

0.49

1.7

1.4

218.11

290.03

ug/g

—

Use of amantadine

136

1.33

0.49

1.4

1.3

317.57

306.25

ug/g

0.08

Other crystal arthropathies

136

1.33

0.49

1.6

1.5

246.22

274.02

ug/g

—

Melanocytic naevi of ear and external auricular canal

1.58

0.49

1.0

1.3

329.71

325.75

ug/g

—

Benign neoplasm: Bronchus and lung

110

1.38

0.49

1.3

1.5

316.88

293.30

ug/g

—

Pregnancy hypertension

489

4201

1.05

0.49

1.4

299.67

296.68

ug/g

0.11

294

2232

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

145

1.32

0.49

1.4

1.3

236.57

350.97

ug/g

1.46

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

268

0.78

0.49

1.0

1.4

188.33

290.19

ug/g

1.64

164

Use of ropinirole

326

1.20

0.49

1.4

1.5

295.15

275.97

ug/g

0.23

198

Carcinoma in situ, bladder

262

1.23

0.49

1.4

1.5

238.59

259.90

ug/g

0.25

165

Cellulitis of external ear

1.41

0.48

1.2

1.3

195.52

318.39

ug/g

—

Injury of urinary and pelvic organs

163

1.30

0.48

1.3

1.5

213.73

272.75

ug/g

—

Viral infections of central nervous system, not elsewhere classified/unspecified

1.41

0.48

1.2

1.4

365.08

302.65

ug/g

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

1.46

0.48

1.5

1.3

211.17

311.85

ug/g

—

Other ill-defined and unspecified causes of mortality

494

1.16

0.47

1.4

1.5

211.71

260.99

ug/g

0.92

313

Respiratory tuberculosis, confirmed and not-confirmed

466

1.16

0.47

1.5

262.74

272.70

ug/g

0.13

280

Respiratory tuberculosis

466

1.16

0.47

1.5

262.74

272.70

ug/g

0.13

280

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

457

1.16

0.47

1.3

1.5

317.98

294.21

ug/g

0.34

279

Contact with sharp glass

309

1.20

0.47

1.4

281.10

300.31

ug/g

0.23

177

HSIL lesion of the vagina

120

1.34

0.46

1.6

1.3

268.00

303.69

ug/g

—

Suppurative otitis media, unspecified

200

1.26

0.46

1.7

1.5

258.36

299.98

ug/g

0.43

114

Benign neoplasm: Parathyroid gland

1.40

0.46

1.5

1.4

312.57

298.52

ug/g

—

Cholesteatoma of middle ear

472

0.84

0.46

1.3

1.5

307.37

272.23

ug/g

0.68

286

Xanthelasma of eyelid

1.44

0.46

1.0

1.4

223.80

293.48

ug/g

—

Hypothyroidism due to medicaments and other exogenous substances

1.44

0.46

1.2

1.5

273.80

299.79

ug/g

—

Postpartum haemorrhage due to anatomy

707

0.88

0.46

1.2

292.37

343.09

ug/g

0.94

318

Pregnancy, childbirth and the puerperium

398

1977

1.05

0.45

1.4

294.02

278.74

ug/g

0.67

212

1082

Lumbosacral root disorders, not elsewhere classified

1.38

0.44

1.5

1.4

291.57

315.54

ug/g

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

130

1.31

0.44

1.4

281.00

289.35

ug/g

—

Complications of labour and delivery

789

4556

0.96

0.44

1.3

1.4

304.28

290.06

ug/g

1.08

405

2525

Pre-eclampsia or eclampsia

245

2302

1.07

0.44

1.4

302.61

297.04

ug/g

0.15

144

1238

Melanocytic naevi of upper limb, including shoulder

157

1.28

0.43

1.8

1.4

309.93

328.52

ug/g

0.21

Von Willebrand disease

104

1.36

0.43

1.5

1.3

340.62

320.96

ug/g

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

1.63

0.43

1.4

—

285.49

ug/g

—

Impacted teeth

148

1270

1.09

0.43

1.4

1.3

308.76

317.89

ug/g

0.18

603

Nontraumatic intracranial haemmorrhage

191

2047

0.93

0.43

1.4

263.21

266.11

ug/g

0.07

110

1229

Lung cancer and mesothelioma

168

1548

0.93

0.43

1.3

1.4

268.58

258.41

ug/g

0.27

102

944

Other disorders of amniotic fluid and membranes

124

1125

1.09

0.43

1.5

1.3

349.52

310.30

ug/g

0.89

568

Etanercept

556

1.14

0.42

1.5

1.4

280.63

293.23

ug/g

0.19

304

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

158

1.27

0.42

1.3

316.00

345.22

ug/g

—

Alzheimer’s disease (Late onset)

193

1770

0.93

0.42

1.3

1.4

264.75

259.97

ug/g

0.12

1118

Craniosynostosis EXCLUDE syndromes

0.00

0.41

0.0

1.5

—

347.71

—

Benign neoplasm: Penis

0.00

0.41

0.0

1.6

—

296.03

—

Abnormalities of ear ossicles

0.00

0.41

0.0

1.5

—

280.54

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

370

3151

0.95

0.41

1.4

278.74

296.21

ug/g

0.94

230

1761

Viral conjunctivitis

186

1.24

0.40

1.3

1.4

352.86

294.62

ug/g

0.70

106

Carcinoma in situ of other and unspecified genital organs

168

1.26

0.40

1.2

1.4

321.30

315.03

ug/g

—

Pyogenic granuloma

132

1.30

0.40

1.2

1.4

307.00

287.89

ug/g

—

Pulmonary oedema

123

1.31

0.40

1.4

285.44

266.96

ug/g

—

Primary ovarian failure

168

1.26

0.40

1.5

1.3

335.08

329.39

ug/g

0.03

Benign neoplasm: Skin of lip

1.37

0.40

1.4

187.57

317.18

ug/g

—

Pedal cyclist injured in noncollision transport accidents

113

1035

1.09

0.40

1.4

270.24

292.14

ug/g

0.52

578

Postpartum haemorrhage due to retained placenta

1003

0.91

0.40

1.3

301.35

326.85

ug/g

0.55

510

Complications following abortion and ectopic and molar pregnancy

362

1.17

0.40

1.5

1.4

241.53

293.53

ug/g

0.55

204

Premature rupture of membranes

182

1432

0.93

0.39

1.3

362.47

310.16

ug/g

2.04

740

Glaucoma secondary to eye inflammation

1.42

0.39

1.1

1.4

325.38

308.29

ug/g

—

Tuberculosis of other organs

187

1.24

0.39

1.6

1.5

277.20

265.12

ug/g

0.09

106

Vascular dementia (sudden onset)

0.00

0.39

0.0

1.5

—

221.83

—

Loose body in joint

187

1.24

0.39

1.3

1.4

237.23

283.65

ug/g

0.46

114

Erosion and ectropion of cervix uteri

242

1.20

0.39

1.4

1.3

275.41

276.25

ug/g

0.01

132

Burn and corrosion of shoulder and upper limb, except wrist and hand

169

1.25

0.39

1.4

222.71

304.61

ug/g

0.73

100

Chronic lymphocytic leukaemia

233

1.21

0.39

1.4

1.5

235.57

271.21

ug/g

0.48

144

Congenital malformations of eye, ear, face and neck

542

1.13

0.38

1.4

255.33

311.36

ug/g

0.90

291

Disorder of thyroid, unspecified

107

1.32

0.37

1.6

1.3

252.13

303.92

ug/g

—

Malignant neoplasm of other and unspecified female genital organs

143

1.27

0.37

1.4

1.3

264.67

291.42

ug/g

0.33

Benign neoplasm: other/unspecified salivary gland

253

1.19

0.37

1.3

1.4

263.48

290.47

ug/g

0.39

156

Burn and corrosion of wrist and hand

309

1.17

0.36

1.6

1.4

279.94

290.43

ug/g

0.10

178

Amputation of thigh

198

1.22

0.36

1.5

222.67

262.33

ug/g

0.32

117

Communicating hydrocephalus

179

0.78

0.36

1.2

1.4

329.56

285.33

ug/g

—

101

Malignant neoplasm of larynx

117

1.29

0.35

1.7

1.6

252.30

243.37

ug/g

—

Adhesive middle ear disease

126

1.28

0.35

1.3

1.4

305.10

306.06

ug/g

—

Acute myeloid leukaemia and myelodysplastic syndromes

126

1.28

0.35

1.3

1.4

247.27

280.95

ug/g

0.30

Juvenile osteochondrosis

255

1.18

0.34

1.3

1.5

348.08

306.89

ug/g

0.47

137

Tuberculosis of other organs, strict

209

1.20

0.34

1.5

1.4

298.11

267.15

ug/g

0.29

118

Asymptomatic human immunodeficiency virus [HIV] infection status

1.34

0.34

1.2

1.6

203.17

233.26

ug/g

—

Use of selegiline

415

1.14

0.34

1.4

1.5

290.81

272.57

ug/g

0.26

251

Benign neoplasm: Skin of lower limb, including hip

200

1.20

0.34

1.8

1.4

285.31

323.31

ug/g

0.56

118

Maternal care for known or suspected abnormality of pelvic organs

226

1645

0.95

0.33

1.3

316.96

305.39

ug/g

0.29

102

867

Polycythaemia vera

256

1.18

0.33

1.5

1.4

316.25

300.14

ug/g

0.14

148

Malignant neoplasm of eye, brain and central nervous system

371

0.86

0.33

1.4

293.09

295.28

ug/g

0.03

213

Dermatitis herpetiformis

164

1.23

0.33

1.7

1.4

336.70

303.68

ug/g

—

100

Mental retardation, wide definition

378

1.14

0.33

1.3

1.4

308.05

317.26

ug/g

0.11

222

Mumps

229

1.18

0.32

1.4

1.5

324.50

275.71

ug/g

0.62

137

Brain meningioma

512

1.12

0.32

1.5

1.4

283.12

288.25

ug/g

0.06

290

Injury of nerves and spinal cord at neck level

183

1.21

0.32

2.0

1.5

239.94

267.22

ug/g

0.25

105

Foreign body or object entering through skin

531

1.11

0.32

1.6

1.5

303.80

285.30

ug/g

0.30

303

Asymmetry of jaw

110

1.28

0.32

1.6

1.3

297.50

324.82

ug/g

—

Intracerebral haemorrhage

108

1162

0.93

0.31

1.4

1.5

217.55

266.84

ug/g

1.74

720

Male infertility

305

1.15

0.31

1.7

1.5

295.35

271.93

ug/g

0.25

180

Subarachnoid haemorrhage

1016

0.92

0.30

1.4

305.79

276.21

ug/g

0.67

611

Embolic stroke

390

1.13

0.30

1.3

1.4

182.10

274.48

ug/g

2.25

237

Corneal degeneration

120

1.26

0.30

1.2

1.4

293.39

276.52

ug/g

—

Conotruncal defects

102

1.28

0.30

1.4

211.57

328.06

ug/g

—

Other and unspecified injuries of abdomen, lower back and pelvis

102

1.28

0.30

1.6

1.5

271.50

277.92

ug/g

—

Respiratory distress of newborn

120

1.24

0.29

1.3

440.00

380.39

ug/g

—

Embolic stroke with flimmer

194

1.19

0.29

1.3

1.5

155.54

262.69

ug/g

1.87

115

Benign neoplasm of brain and other parts of central nervous system

611

1.10

0.29

1.4

286.55

284.39

ug/g

0.03

350

Failed induction of labour

401

1.12

0.29

1.2

1.3

341.00

324.45

ug/g

0.18

190

Other abnormal products of conception

312

1994

1.04

0.29

1.4

1.3

317.53

307.48

ug/g

0.34

166

1040

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

241

1.17

0.29

1.4

247.40

302.59

ug/g

1.35

133

Other diseases of spinal cord

241

1.17

0.29

1.4

308.72

291.68

ug/g

0.18

139

Dementia due to Parkinson's disease

176

1.20

0.29

1.5

1.4

264.15

264.48

ug/g

0.00

104

Gestational [pregnancy-induced] hypertension

266

2542

1.05

0.28

1.4

1.3

312.70

305.88

ug/g

0.20

158

1309

Other specified and unspecified disorders of eyelid

112

1.26

0.28

1.4

285.63

281.81

ug/g

—

Multiple gestation

776

1.08

0.28

1.4

348.70

312.35

ug/g

0.78

402

Schizoid personality disorder

149

1.21

0.28

1.3

1.5

224.05

291.05

ug/g

0.73

Benign neoplasm: Spinal cord

122

1.24

0.27

1.5

1.4

213.33

293.39

ug/g

—

Other bursal cyst

122

1.24

0.27

1.4

264.00

315.59

ug/g

—

Sequelae of poliomyelitis

1.22

0.27

1.3

1.5

186.50

268.95

ug/g

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

527

3544

0.97

0.27

1.3

1.4

277.95

299.14

ug/g

1.57

313

1964

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

527

3544

0.97

0.27

1.3

1.4

277.95

299.14

ug/g

1.57

313

1964

Otosclerosis

779

1.08

0.26

1.3

1.4

308.23

273.02

ug/g

0.80

447

Alzheimer’s disease (Early onset)

363

0.88

0.26

1.2

1.5

297.20

272.21

ug/g

0.33

225

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

338

1.13

0.26

1.8

1.4

287.00

306.19

ug/g

0.25

192

Maternal care related to the fetus and amniotic cavity and possible delivery problems

486

2948

0.97

0.26

1.3

314.39

298.14

ug/g

0.84

234

1581

Short Achilles tendon (acquired)

214

0.84

0.26

1.3

1.4

214.20

305.20

ug/g

—

123

Benign neoplasm of male genital organs

149

0.80

0.26

1.4

1.6

188.59

263.01

ug/g

—

Malignant neoplasm of brain

267

0.86

0.26

1.3

1.5

300.21

290.37

ug/g

0.09

154

Melanoma in situ

368

1.12

0.25

1.3

1.4

299.81

276.21

ug/g

0.35

227

Unspecified human immunodeficiency virus [HIV] disease

1.19

0.25

1.4

1.6

172.36

270.56

ug/g

—

Twin gestation

753

1.08

0.24

1.4

346.38

310.99

ug/g

0.73

389

Use of galantamine

570

1.09

0.24

1.4

1.5

281.23

258.94

ug/g

0.46

349

Mental retardation

359

1.12

0.24

1.3

1.5

305.77

325.92

ug/g

0.26

209

Pedal cyclist injured in collision with motor vehicle

255

1.14

0.24

1.5

199.86

292.79

ug/g

1.98

142

Other obstetric trauma

423

0.90

0.24

1.3

1.4

364.98

312.19

ug/g

0.70

207

Hydrocephalus

677

1.08

0.24

1.3

1.4

298.49

277.09

ug/g

0.41

404

Chronic mastoiditis

227

1.15

0.24

1.4

369.22

283.26

ug/g

—

135

Other operation for atrial fibrillation

1.36

0.23

1.6

248.00

257.04

ug/g

—

Overjet

170

1.17

0.23

1.3

1.4

388.50

343.36

ug/g

—

Ill-defined and unknown causes of mortality

572

1.09

0.23

1.4

1.5

205.77

266.52

ug/g

1.41

357

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

327

0.88

0.23

1.2

1.4

277.19

301.84

ug/g

0.34

182

Undefined dementia

844

0.94

0.22

1.4

294.14

259.96

ug/g

0.84

513

Scissor bite

171

1.17

0.22

1.3

1.4

274.11

343.22

ug/g

—

Benign neoplasm of other and unspecified female genital organs

448

1.10

0.22

1.3

1.4

329.00

302.73

ug/g

0.36

254

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

116

1.21

0.22

1.3

1.4

268.83

306.87

ug/g

—

Optic neuritis

372

1.10

0.22

1.5

1.4

320.74

311.99

ug/g

0.09

203

Haemolytic disease of fetus and newborn

0.00

0.22

0.0

1.4

—

317.20

—

Drowning to ice

0.00

0.21

0.0

1.4

—

234.67

—

Other histiocytosis syndromes

0.00

0.21

0.0

1.6

—

160.80

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.21

0.0

1.0

—

461.40

—

Carcinoma in situ of oropharynx, excluding all cancers

0.00

0.21

0.0

1.5

—

295.06

—

malignant neoplasm of female genital organs

169

1765

0.96

0.21

1.4

259.41

280.17

ug/g

0.68

1014

Mandibular retrognathia AND surgery (BSSRO)

220

0.86

0.21

1.3

1.4

312.47

311.36

ug/g

—

123

Actinic reticuloid

0.00

0.21

0.0

1.7

—

149.67

—

Corrosions classified according to extent of body surface involved

0.00

0.21

0.0

1.7

—

227.60

—

Contact with nonpowered hand tool

382

1.10

0.21

1.4

1.5

291.56

276.90

ug/g

0.18

223

Tuberculosis

536

1.08

0.21

1.5

265.33

268.69

ug/g

0.04

320

Carcinoma in situ of oral cavity and pharynx

0.00

0.21

0.0

1.5

—

352.06

—

Other retinal disorders in diseases classified elsewhere

0.00

0.21

0.0

1.6

—

271.83

—

Myocardial infarction, with ST-elevation

165

1723

0.96

0.21

1.4

1.5

265.90

256.68

ug/g

0.24

105

1048

Dislocations, sprains and strains involving multiple body regions

0.00

0.21

0.0

1.4

—

358.46

—

Lens-induced iridocyclitis

0.00

0.21

0.0

1.5

—

258.57

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

173

1.16

0.21

1.2

1.4

316.82

317.40

ug/g

0.00

102

Injury of muscle and tendon at forearm level

145

1.18

0.20

1.4

1.5

244.00

292.96

ug/g

—

Accident to watercraft causing drowning and submersion

0.00

0.20

0.0

1.5

—

251.55

—

Malignant otitis externa

0.00

0.20

0.0

1.6

—

234.41

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.20

0.0

1.4

—

295.76

—

Venous complications and haemorrhoids in pregnancy

136

1.18

0.20

1.4

314.48

327.19

ug/g

0.07

Routine general health check-up of defined subpopulation

108

1.21

0.20

1.4

1.3

318.83

308.80

ug/g

—

Other puerperal infections

583

0.93

0.20

1.2

1.3

351.92

322.60

ug/g

0.51

269

Malignant neoplasm of corpus uteri

912

0.94

0.20

1.4

245.09

280.38

ug/g

0.79

536

Carcinoma in situ of breast, intraductal

101

957

1.06

0.19

1.3

1.4

305.78

284.63

ug/g

0.52

546

Other renal tubulo-interstitial diseases

212

1.14

0.19

1.2

1.4

301.94

309.85

ug/g

0.08

115

Benign neoplasm: Larynx

279

1.11

0.19

1.7

1.5

264.99

281.91

ug/g

0.17

159

Any dementia

409

2956

0.97

0.19

1.4

267.76

259.51

ug/g

0.37

219

1825

Mild mental retardation

196

0.86

0.18

1.5

304.80

312.65

ug/g

—

112

Malignant neoplasm of tongue

175

1.15

0.18

1.5

286.58

275.49

ug/g

0.09

101

Benign neoplasm: Skin of scalp and neck

213

1.13

0.18

1.4

247.64

294.25

ug/g

0.42

119

Non-small cell lung cancer, adenocarcinoma, helper endpoint

570

0.93

0.18

1.3

1.5

317.98

268.61

ug/g

0.92

354

Non-small cell lung cancer, adenocarcinoma

570

0.93

0.18

1.3

1.5

317.98

268.61

ug/g

0.92

354

Traumatic amputation of wrist and hand

363

0.91

0.18

1.6

1.5

253.18

262.52

ug/g

0.08

216

Later onset COPD

310

2368

1.03

0.18

1.4

246.00

254.18

ug/g

0.31

191

1470

Pre-eclampsia

217

2100

1.03

0.18

1.4

304.67

299.24

ug/g

0.13

125

1109

Postpartum care and examination

126

768

1.05

0.17

1.3

1.4

335.65

313.94

ug/g

0.47

379

Demyelinating diseases of the central nervous system

747

1.06

0.17

1.5

1.4

290.21

300.31

ug/g

0.14

390

Benign neoplasm: Vulva

186

1.13

0.17

1.2

1.4

324.60

325.00

ug/g

—

106

Malignant neoplasm of mesothelium and soft tissue

381

0.92

0.16

1.4

1.5

230.44

277.91

ug/g

0.76

236

Mixed conductive and sensorineural hearing loss

131

1258

1.04

0.16

1.4

270.26

265.10

ug/g

0.11

770

Personal history of malignant neoplasm

321

1.09

0.16

1.5

1.4

291.65

291.36

ug/g

0.00

189

Mental and behavioural disorders associated with the puerperium

1.20

0.16

1.1

1.4

274.80

314.79

ug/g

—

L02BB Anti-androgens

720

0.94

0.16

1.3

1.5

267.06

252.31

ug/g

0.23

468

Delivery, wide proxy

437

2375

0.98

0.16

1.4

302.02

282.95

ug/g

1.03

231

1297

Carcinoma in situ of cervix uteri

692

1.06

0.15

1.2

1.3

349.77

325.10

ug/g

0.37

330

Unspecified dementia

804

0.95

0.15

1.4

1.5

294.14

260.69

ug/g

0.81

494

Crystal arthropathies, rheuma endpoint

160

1.13

0.14

1.6

1.5

246.22

272.85

ug/g

—

Dementia

479

3364

0.98

0.13

1.4

272.10

260.03

ug/g

0.66

262

2095

Benign neoplasm of thyroid gland

325

1.08

0.13

1.5

1.4

267.00

295.43

ug/g

0.35

186

Third [oculomotor] nerve palsy

148

0.88

0.12

1.5

277.57

293.05

ug/g

—

Bilateral sagittal split ramus osteotomy operation

287

1.08

0.12

1.3

1.4

287.30

314.46

ug/g

0.27

155

Disorders of globe

200

1.10

0.12

1.3

1.4

283.29

295.82

ug/g

0.11

117

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

212

2033

1.03

0.12

1.4

261.29

294.77

ug/g

1.69

119

1158

Benign neoplasm of ovary

214

2090

1.02

0.12

1.4

264.83

288.51

ug/g

0.99

137

1179

Other disorders of prostate

220

1.09

0.12

1.4

1.6

233.36

240.19

ug/g

0.07

150

Impacted maxillary molar

364

0.93

0.11

1.2

1.3

325.07

325.56

ug/g

0.00

162

Dental caries 2 and operation codes, only avohilmo

1027

6307

1.01

0.11

1.4

301.78

278.61

ug/g

1.71

576

3564

Other and unspecified injuries of thorax

143

1.12

0.11

1.6

1.4

295.78

300.26

ug/g

—

LeFortI or BSSRO operation

337

1.07

0.11

1.4

297.15

313.75

ug/g

0.15

176

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

611

1.05

0.11

1.2

1.3

276.14

317.46

ug/g

0.74

290

Struck by thrown, projected or falling objec

396

1.06

0.11

1.2

1.4

282.78

296.71

ug/g

0.15

223

Mandibular prognathia

115

1.13

0.10

1.5

1.4

256.50

324.73

ug/g

—

Coronary artery bypass grafting

311

2325

1.02

0.10

1.4

242.64

254.86

ug/g

0.54

209

1415

Benign neoplasm: Skin of upper limb, including shoulder

173

1.10

0.10

1.2

1.4

323.68

300.10

ug/g

0.30

Benign neoplasm: Cranial nerves

261

1.07

0.10

1.3

1.5

298.12

288.34

ug/g

0.10

154

Biological medicines for asthma

106

1.14

0.10

1.1

1.4

363.86

308.65

ug/g

—

Slow fetal growth and fetal malnutrition

1.03

0.09

1.6

1.4

396.80

328.07

ug/g

—

Benign neoplasm of male genital organs

107

1.12

0.08

1.4

1.5

188.59

291.31

ug/g

—

Melanocytic naevi of upper limb, including shoulder

185

1.08

0.08

1.8

1.4

309.93

307.26

ug/g

0.03

101

Use of levodopa decarbox-comt-inhibitor

283

1.06

0.08

1.3

1.5

274.98

274.77

ug/g

0.00

174

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

399

0.95

0.08

1.8

1.5

287.00

285.07

ug/g

0.02

236

Mental and behavioural disorders of puerperium, not classified elsewhere

1.13

0.07

1.1

1.4

274.80

335.70

ug/g

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

215

0.93

0.07

1.2

1.5

316.82

284.42

ug/g

0.19

132

Vascular dementia (subcortical)

215

0.93

0.07

1.5

157.73

257.45

ug/g

1.69

131

MS-disease / Multiple Sclerosis

621

0.97

0.07

1.5

1.4

278.14

303.50

ug/g

0.37

317

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

112

0.89

0.07

1.6

1.5

339.60

284.45

ug/g

—

Other congenital malformations of face and neck

245

0.94

0.07

1.3

1.5

229.68

307.01

ug/g

—

145

Degenerative diseases of the nervous system

360

2678

1.01

0.07

1.4

256.08

263.24

ug/g

0.27

187

1659

Endovascular or surgical operations to intracerebral aneurysms

640

0.97

0.07

1.6

1.4

291.01

282.47

ug/g

0.11

377

Divergent concomitant strabismus

690

0.97

0.06

1.4

265.06

300.69

ug/g

0.60

377

Alzheimer’s disease (Atypical or mixed)

669

1.03

0.06

1.2

1.5

248.19

258.38

ug/g

0.16

415

Small cell lung cancer

158

1.08

0.06

1.4

1.5

281.00

258.61

ug/g

—

Small cell lung cancer, helper endpoint

158

1.08

0.06

1.4

1.5

281.00

258.61

ug/g

—

Polyarteritis nodosa and related conditions

119

1.09

0.06

1.2

1.4

340.60

291.93

ug/g

—

Other disorders of thyroid

129

1.09

0.05

1.6

1.3

252.13

309.58

ug/g

—

Sequelae of tuberculosis

129

1.09

0.05

2.2

1.4

253.22

268.30

ug/g

—

Perioral dermatitis

188

1.07

0.05

1.4

338.50

307.59

ug/g

—

106

633

1.03

0.05

1.3

1.5

319.40

257.66

ug/g

1.07

404

Other conjunctival vascular disorders and cysts

208

1.06

0.05

1.6

1.5

278.67

291.82

ug/g

0.10

121

Obstructed labour due to maternal pelvic abnormality

172

1744

0.99

0.05

1.3

1.4

297.70

286.11

ug/g

0.33

982

Thyroiditis, unspecified

110

1.09

0.05

1.2

1.4

193.71

308.48

ug/g

—

Benign neoplasm: Brain, supratentorial

110

1.09

0.05

1.6

1.4

300.29

319.09

ug/g

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

252

0.95

0.05

1.5

217.88

265.90

ug/g

0.65

146

Benign neoplasm: Brain, supratentorial

130

0.92

0.04

1.6

1.4

300.29

310.38

ug/g

—

L02BX Other hormone antagonists and related agents

427

1.03

0.04

1.4

1.5

266.34

248.13

ug/g

0.28

279

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

547

1.02

0.03

1.4

275.32

300.80

ug/g

0.50

320

Other benign neoplasms of connective and other soft tissue

985

0.98

0.03

1.5

1.4

304.36

287.36

ug/g

0.36

549

Supervision of high-risk pregnancy

192

1172

0.99

0.03

1.3

1.4

319.19

306.06

ug/g

0.31

605

Maternal care for known or suspected malpresentation of fetus

158

1166

1.01

0.03

1.3

323.41

313.69

ug/g

0.19

589

Benign neoplasm: Vulva

219

0.96

0.03

1.2

1.4

324.60

300.83

ug/g

—

126

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

103

1018

1.01

0.02

1.4

250.55

292.80

ug/g

1.15

594

Complications of the puerperium, not elsewhere classified

309

0.97

0.02

1.6

1.3

332.03

334.32

ug/g

0.02

144

Schizophrenia

159

1602

0.99

0.02

1.3

1.4

298.45

280.75

ug/g

0.48

907

Use of other anti-dementia drugs

239

2091

0.99

0.02

1.3

1.4

268.32

259.22

ug/g

0.30

128

1303

Use of memantine

239

2091

0.99

0.02

1.3

1.4

268.32

259.22

ug/g

0.30

128

1303

Dementia, including avohilmo

525

3610

1.00

0.01

1.4

270.97

259.21

ug/g

0.68

284

2247

Normal-pressure hydrocephalus

438

0.98

0.01

1.4

1.5

281.65

267.58

ug/g

0.15

262

Malignant neoplasm, without specification of site

243

1.03

0.01

1.6

1.4

225.85

275.18

ug/g

0.56

146

Other obstructed labour

722

1.01

0.01

1.4

280.57

296.09

ug/g

0.30

401

Other demyelinating diseases of the central nervous system

313

1.02

0.01

1.5

1.4

313.66

306.46

ug/g

0.06

172

Melanocytic naevi of other and unspecified parts of face

523

1.01

0.01

1.4

315.48

297.07

ug/g

0.23

282

Hypertrophic cardiomyopathy

364

1.02

0.00

1.4

1.5

226.83

276.29

ug/g

0.80

217

Carcinoma in situ of cervix uteri

728

1.00

0.00

1.2

1.3

349.77

314.02

ug/g

0.59

354

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

365

0.99

0.00

1.2

1.4

281.09

308.73

ug/g

0.40

221

Labour and delivery complicated by umbilical cord complications

435

1.01

0.00

1.4

354.76

306.01

ug/g

0.76

225

Abnormal findings on diagnostic imaging of breast

136

1.03

0.00

1.1

1.4

318.47

294.88

ug/g

—

Use of glatiramer acetate

144

0.97

0.00

1.6

1.3

281.14

323.92

ug/g

—

Benign neoplasm: Skin of lip

117

1.03

0.00

1.4

187.57

297.55

ug/g

—

Hydatidiform mole

123

0.98

0.00

1.0

1.3

308.33

338.62

ug/g

—

Malignant neoplasm of other connective and soft tissue

203

0.98

0.00

1.4

1.5

225.21

273.13

ug/g

0.52

120

Infections of breast associated with childbirth

288

1.01

0.00

1.1

1.3

377.69

334.17

ug/g

0.53

144

Ovarian hyperstimulation (induction)

131

0.99

0.00

1.2

1.3

369.50

367.54

ug/g

—

Respiratory tuberculosis, not confirmed

347

1.01

0.00

1.5

237.82

270.66

ug/g

0.47

201

Family history of certain disabilities and chronic diseases leading to disablement

337

1.01

0.00

1.4

228.41

302.05

ug/g

0.82

173

Keratoconus

195

0.97

0.00

1.5

325.52

295.17

ug/g

—

116

Benign neoplasm: Skin of lower limb, including hip

235

1.02

0.00

1.8

1.5

285.31

283.50

ug/g

0.02

138

Wegener granulomatosis

130

1.00

0.00

1.8

1.5

280.13

286.34

ug/g

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Elastase.pancreatic [Mass/mass] in Stool

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS